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Abstract
Terpenoids represent the most structurally and stereochemically diverse family of 
natural products with more than 55,000 terpenoid structures discovered to date from 
all life forms. Sesquiterpenes are a class of the terpenoid family, and their formation 
from famesyl diphosphate is catalyzed by sesquiterpene synthases. This project 
focuses on trying to decipher the reaction mechanisms of two sesquiterpene synthases, 
6-cadinene synthase from Gossypium arboreum and (2s)-|3-famesene synthase from 
Mentha x piperita and to provide a method for the generation of unnatural terpenes 
with potential commercial applications in both the pharmaceutical and agrochemical 
industries.
Modifications by substitution of residues around the active site of 6-cadinene synthase 
did not lead to any functional divergence, indicating an unusual structural component 
that determines the product specificity of this enzyme. Domain-swapping experiments 
based on phylogenetic information suggested that the subdomain encoded by exon 4 
is most likely the key structure element controlling the product specificity of this 
enzyme. Manipulation of the active site volume of (£)-|3-famesene synthase by 
site-directed mutagenesis revealed a rigid active site cavity that is precisely defined 
for generating mainly acyclic products. The active site hybrid constructed by 
replacing the active surface of (£)-p-famesene synthase with the corresponding part 
from 6-cadinene synthase lost activity, suggesting the catalytic specificity of this 
enzyme is modulated at a distance by residues surrounding the active site, which may 
have a huge influence on the active site volume. Mechanistic studies utilizing a 
substrate analogue revealed a new reaction mechanism for (£)-P-famesene synthase. 
Functional approaches to explore the N-termini region of 6-cadinene synthase and 
(£)-p-famesene synthase provided direct evidence that suggested dual roles for this 
region.
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Chapter 1: Introduction
1.1 Terpenoids
Terpenoids represent the structurally and stereochemically most diverse family of 
natural products.’More than 55,000 terpenoids have been discovered to date from 
nature (7). The extraordinarily diverse carbon skeletons of terpenoids are formally 
derived from the branched C5 skeleton of isoprene (1) (2). Dimethylallyl diphosphate 
(DMAPP, 2) and isopentenyl diphosphate (IPP, 3) are biological equivalents of 
isoprene and are the universal precursors of the isoprenoids in all living organisms 
(Scheme 1.1) (5).
The most significant building reaction in the terpenoids pathway is a chain elongation 
reaction catalysed by isoprenyl diphosphate synthases to yield increasingly longer 
polyisoprenoid diphosphates, such as geranyl diphosphate (GDP CIO, 4), famesyl 
diphosphate (FDP C l5, 5) and geranylgeranyl diphosphate (GGDP C20, 6). In 
addition, longer acyclic intermediates, such as squalene (C30, 7), phytoene (C40, 8), 
all-trans polyprenyl diphosphates (C5n, 9) and czs-polyprenyl diphosphates (C5n, 10) 
can be further derived from either FDP or GGDP. All these acyclic precursors can 
then be modified to generate acyclic, monocyclic or multicyclic products (4-6).
Thus, terpenoids can be grouped based on the number of C5 units: hemiterpenes (C5), 
monoterpenes (CIO), sesquiterpenes (C l5), diterpenes (C20), triterpenes (C30) and so 
on. Different attachment patterns such as non-head-to-tail chain elongation or 
irregular conformations have also been discovered (Scheme 1.2). The biosynthesis of 
sterols and carotenoids goes through a cyclopropanation reaction as the first step in 
the specific pathway among eukarya, archaea and some bacteria (7, 8). A branching 
reaction has only been identified from a few plants (9) and a cyclobutanation reaction 
has only been reported in the study of mealybug mating pheromones (10).
(2)
'OPP
(3)
OPP
(4)
HOPP
'OPP
=> hemiterpenes C5
(1)
monoterpenes CIO
OPP
squalene (7) triterpenes C30
diterpenes
phytoene (8) :> carotenoids C40
OPP
(9)
bactoprenol 
ubiquinones Q5n 
menaquinones 
plastoquinone
polyprenols 
=> dolichols C5n
natural rubber
OPP
Scheme 1.1: Biogene tic scheme for the formation o f the main terpenoid series through the 
regular head to tail fusion.
The fundamental chain elongation of terpene biosynthesis involves condensations of 
DMAPP (2) with IPP (3), corresponding to the ionization of DMAPP (2) triggered by 
the enzyme’s metal cluster (Scheme 1.3) (11). The following electrophilic attack 
between the resulting carbocation and C3-C4 ji bond of IPP generates a tertiary 
carbocation at C3. GDP is formed after stereospecific elimination of the C2-H* proton
(77, 72)). Further chain elongations forming FDP and GGDP were suggested to share 
similar coupling mechanisms based on the crystal structures of both famesyl 
diphosphate synthase and geranylgeranyl diphosphate synthase (75 ,14). On the other 
hand, to form cyclobutanation, branching and cyclopropanation products, one 
molecule of IPP is replaced by DMAPP. These reactions also employ the allylic 
carbocation derived from DMAPP by allowing alternative trajectories of 
carbon-carbon bond formation (Scheme 1.3) (75).
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Scheme 1.2: Scheme for the formation o f non-head-to-tail conformation structures.
The enzymes that catalyse chain elongation can be divided into two subfamilies 
according to the stereochemistry of the newly formed double bond. Those that 
generate E double bond conformations usually synthesise shorter chain products (e.g. 
GDP, FDP and GGDP) found early in the pathway. Others that generate Z double 
bond conformations synthesize longer chain diphosphates (e.g. natural rubber).
Scheme 1.3: A dissociative electrophilic alkylation mechanism for chain elongation (A), 
cyclopropanation, branching and cyclobutanation (B).
1.2 Biological functions of terpenoids
Low molecular weight organic compounds produced by organisms are generally 
divided into two groups. The ones that are required for reproduction or growth are 
defined as primary metabolites, while those that have no apparent function in the 
basic processes of growth and development are defined as secondary metabolites (16). 
Very little was known about the functionality of terpenoids before the middle of the 
last century and the compounds were even defined as products of detoxification or 
overflow metabolism (16). However, since the 1970s, quite a few terpenoids were 
identified to be toxins, repellents or attractants (17).
1.2.1 Primary metabolites
Sterols, carotenoids, growth regulators and polyprenol substituents of dolichols, 
quinones and proteins are classified as primary metabolites (16). Generally, these 
terpenoids are important for membrane integrity, photoprotection and orchestration of
developmental programs and biochemical functions of specific membrane systems.
Sterols are an essential component for the formation of liquid-ordered membrane 
states (membrane fluidity), which has been suggested to be related to many important 
biological functions, such as signal transduction, cellular sorting, cytoskeleton 
reorganization, asymmetric growth and infectious disease (18). Sterols are widely 
dispersed among organisms and all of them contain the common sterol ring system, 
which is derived from C30 terpenene squalene (7) or its analogue squalene oxide. 
Animals employ cholesterol (11) as the major sterol; ergosterol (12) is found in fungi 
and more than 40 plant sterols have been discovered to contain more complex sterol 
compositions, in which the major constituents are stigmasterol (13) and sitosterol (14) 
(Scheme 1.4).
Cholesterol (11) was first isolated from gallstones and is an essential membrane 
component in higher eukaryotes. With the help of cholesterol (11), the cell membrane 
becomes semipermeable between cellular compartments and it also alters the 
functions of membrane proteins. In addition, it participates in several membrane 
trafficking and transmembrane signalling processes (19). Recent research indicates an 
important role for cholesterol (11) in several diseases, such as the pathogenesis of 
cardiac and brain vascular diseases, dementias, diabetes and cancer (20, 21).
Stigmasterol (13) and sitosterol (14) from plants are involved in the polarized growth 
of pollen tube and root hair. The asymmetric distribution of these components in the 
membrane causes the asymmetric growth of plant cells (18). These sterols are also 
suggested to have a temperature dependent ordering effect on membranes; in other 
words they have a significant disordering effect when temperatures are below the 
phase transition. In addition, plant sterols can lower the concentrations of cholesterol 
in serum (22). The appearance of plant sterols in the cell could reduce the absorption 
of cholesterol from the gut by a competition effect. This significant effect makes plant 
sterols useful drug candidates for cholesterol-lowering purposes.
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Scheme 1.4: Molecular structures o f animal, fungus and plant sterols.
The carotenoids are traditionally thought to be a group of natural plant pigments, 
although they have been identified also in animals and microorganisms. More than 
600 different carotenoids have been isolated and characterized from natural sources 
and they are all biosynthesized from two GGDP units (23). The basic acyclic and 
cyclic structures are illustrated by lycopene (15) and (3,(3-carotene (16) (Figure 1.1). A 
long chain of alternating double and single bonds forms the central part of the 
molecule and the variable structures can be further modified by cyclization at one or 
both ends. Also, modifications can be carried out by hydrogenation and addition of 
oxygen-containing functional groups. The conjugated polyene structure can determine 
many functions such as light absorption properties, photochemical properties, 
consequent light-harvesting and photoprotective action (25).
7
lycopene (15)
P,p-carotene (16)
Figure 1.1: (A) Structures o f an acyclic lycopene and a dicyclic f$,f$-carotene. (B) The seven 
different end groups found in natural carotenoids.
Carotenoids can also serve as antioxidants via the corresponding carotenoid radicals 
that react with oxidizing agents (24). The conjugated structure of carotenoids allows 
the unpaired electron to be highly delocalized over the whole structure, providing a 
stabilizing effect to facilitate subsequent reactions. The radicals can be removed by 
reacting with each other to generate harmless products or by disrupting the free 
radical chain reaction.
Quinones are another type of natural terpenoid compounds that play a role in nature as 
the electron transfer mediator in many essential biochemical phenomena, such as iron 
respiration by microorganisms and nutrient acquisition by plant and microorganisms 
(25, 26). More than a thousand different quinones are produced by bacteria, fungi, 
plants and insects, most of which contain a species-specific polyisoprene chain (27). 
Quinones can undergo facile and reversible electron transfer reactions, which profits 
from the unique structural characteristics (Figure 1.2) allowing resonance stabilization
of semiquinone radical intermediates during redox chemistry (28). The electron 
transfer reactions can also be irreversible due to side-reactions. Nowadays, quinone 
containing compounds are widely used for their antitumour and anticancer activity 
(27).
OH x / n  
plastoquinone
OH x , n 
menaquinone
(QH2) (QH-) (Q)
Figure 1.2: Structures o f  quinones in different redox conditions. (QH 2 ): Hydroquinone. 
(Q H #): semiquinone radical. (Q): Quinone.
1.2.2 Secondary metabolites
Many monoterpenes, sesquiterpenes and diterpenes are classified as secondary 
metabolites, which are important for ecological viability among organism. However, 
these substances have been demonstrated to play important roles among organisms 
and have valuable Applications in medicine, agriculture and industry (17).
Using genetically transformed organisms, in which certain terpenoids are 
overproduced without an effect on other traits, can test functions of terpenoids. In a 
recent example, an engineered Arabidopsis thaliana plant was used to emit large 
amounts of the monoterpene alcohol linalool (17) (Figure 1.3) (29). Compared with 
wild-type A. thaliana, the transgenic plants showed significantly increased repellent 
activity towards aphids, suggesting a defense function for this monoterpenoid.
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Figure 1.3: Structures o f  terpenoids with established functions. Rha = rhamnose, Glu 
glucose.
Plant terpenoids also have important roles in resistance to diseases caused by fungi 
and bacteria. A study of the function of triterpenoid saponins 18 was carried out by 
employing an oat species (Avena strigosa). Saponins are terpene glycosides that serve
1 0
as detergents (Figure 1.3). They are toxic to fungi due to their ability to form 
complexes with sterols in fungal membranes, leading to the loss of membrane 
integrity (30). Compared with wild-type lines, mutants that are deficient in generating 
saponins are much more easily attacked by fungal pathogens (31).
Animals, especially insects, can employ terpenoids as protective substances, an 
example of which is the iridoid monoterpene 19 of leaf beetles (Figure 1.3) (32). The 
terpenoids can be directly sprayed at enemies as effective repellents for small 
predators such as fire ants.
Terpenoids may also function as defense agents in the marine world. The study of 
caulerpenyne (20) and certain diterpenes of marine algae revealed unusual defense 
effects by converting polyacetates into the potent feeding deterrent halimedatrial 
when algal tissue is wounded (Figure 1.3) (33). Other research showed some marine 
organisms employ terpenoids not only to combat predators and pathogens, but also to 
prevent their surfaces from being colonized by bacteria and fungi (34).
Based on the terpenoid defences present in nature, many have been further developed 
for medical use. Artemisinin (21) (Figure 1.3), a sesquiterpene lactone from Artemisia 
annua and its derivatives have been widely used as antimalarial drugs. The 
compounds can inhibit the growth of the sarco-endoplasmic reticulum in all asexual 
stages of the malarial parasite, leading to the death of the parasite (35). Another 
widely used medicine with a diterpene structure is the anticancer compound paclitaxel 
22 (Taxol) (Figure 1.3). This compound can kill tumour cells by binding to tubulin, 
which interferes with microtubule dynamics and arrests cell division during mitosis 
(3d).
As well as defense functions, terpenoids also play essential roles in interactions 
among organisms by acting as messengers. The most important reason for organisms 
to choose terpenoids (especially monoterpenes and sesquiterpenes) to exchange
li
information is due to their low molecular weight and lipophilic character with high 
vapour pressures at ordinary temperatures, which allow them to serve as good 
conveyors of information over distances. In addition, the significant structural variety 
of terpenes allows messages to be very specific.
Terpenoids are one of the major components of fruit and flower volatiles (57). Studies 
of Manduca sexta (the tobacco homworm) revealed that this pollinator contains a 
group of receptor cells that can respond to certain oxygenated monoterpenes and 
sesquiterpenes, such as geraniol (23), nerolidol (24) and famesol (25) (Figure 1.3) 
(38). In the other plants, emission of blends of terpenoid components has also been 
discovered when the foliage is under attack (39, 40). These compounds act as a ‘call 
for help’, attracting predators and parasitoids that feed on herbivores.
Terpenoids can also be employed by the underground parts of plants. The 
sesquiterpene (£)-|3-caryophyllene (26) was shown to be released by maize roots 
when the plant is under attack, which attracts nematodes that prey on insect larvae 
(Figure 1.3) (41). Nonvolatile terpenoids, such as strigol (27) and other strigolactones 
can be involved in underground communications (Figure 1.3). These compounds 
stimulate the growth of Arbuscular mycorrhizal fungi from mutualistic, which 
facilitates nutrient acquisition of the plant (41). In some cases, terpenoids released by 
plants may also help their enemies, such as herbivorous insects or parasitic plants, to 
locate their host. Guided by a blend of monoterpenes, seedlings of parasitic plant 
dodder (Cuscuta pentagona) grow toward nearby host tomato plants, while other 
parasitic plants may use strigolactones for a similar function (42, 43).
1.3 Biosynthesis of terpenoids
In the 19th century, the hemiterpene isoprene was believed to be the fundamental 
component for the generation of longer terpenoids, such as monoterpenes and 
sesquiterpenes. Isoprene itself was first isolated from the low boiling fraction of the
1 2
dry distillation of rubber in 1826 (44), while the term ‘isoprene’ was first used by 
Williams in 1860 (45). Based mainly on studies of monoterpenoids, Otto Wallach 
proposed the ‘isoprene rule’, which suggests that monoterpenoids are generated by 
attachment of two isoprene units either in a regular head to tail fashion or in an 
irregular sequence (46). The first formulation that supports the isoprene rule was 
provided in 1897, which was considered as an early example of a Diels-Alder 
condensation (Scheme 1.5). The corresponding organic synthesis of this theory was 
carried out in the same year (45). Until now, the isoprene rule has already been 
identified among more complex terpenoids structures, such as sesquiterpenoids and 
triterpenoids (45).
Scheme 1.5: Proposed mechanism for the formation o f monoterpene 
and sesquiterpene by isoprene units by Otto Wallach.
The isoprene unit can be identified in many terpenoid structures as an essential 
component and some simple terpenoids can be also chemically synthesized from it. 
However, it is not the biological precursor for terpenoids. DMAPP (2) and IPP (3) 
were found to correspond to the biological equivalents of isoprene and then defined as 
the universal precursors of terpenoids in all living organisms^ 7). The formation of 
the isoprene unit was first studied in liver tissues and in yeast in the 1950s, leading to 
the discovery of the well-known mevalonic acid (MVA) pathway (Scheme 1.6) (48). 
This pathway is widespread for production of polyisoprenoids and sterols in fungi, 
plants, animals, most other eukaryotes, archaea and some eubacteria.
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Scheme 1.6: The mevalonate (MVA) pathway.
Acetyl-CoA (28) is first extended by a two carbon acetyl modules via a Claisen 
condensation reaction catalyzed by acetoacetyl-CoA thiolase (Scheme 1.6). Another 
similar chain extension is catalyzed by HMG-CoA synthase to form
3-hydroxy-3-methylglutaryl-CoA (30) via an aldol-type reaction. The most important 
precursor, mevalonic acid (31), is then formed by a reduction using 2 equivalents of 
NADPH. A diphosphate group is added onto the resulting acid from two ATP 
molecules and mevalonate diphosphate decarboxylase removes CO2 to yield IPP (3) 
after a second Pj is added. Isomerisation catalysed by IPP isomerase then leads to 
DMAPP (2).
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However, the MVA pathway is not the only pathway employed by organisms to 
produce isoprenoids. An alternative route toward biosynthesis of IPP and DMAPP 
was discovered during a study of the unique features of bacterial hopane triterpenoids
i  ^  n
using C-labeled acetate as the only carbon source (49). Incorporation of [1- C]- and
[2-13C]-acetate into the hopane series from three bacteria (Rhodopseudomonas
palustris, Rhodopseudomonas acidophila and Methylobacterium organophilum)
revealed an unusual labelling pattern observed in the isoprene unit that did not fit well
with a direct incorporation of acetate into the MVA pathway. A further investigation
1 ^by incorporation of a whole series of C-labeled glucose isotopomers into hopanoids 
of the bacterium Zymomonas mobilis demonstrated that the carbon skeleton is derived 
from a C2 subunit formed from pyruvate (34) by decarboxylation and a C3 subunit 
derived from a triose phosphate derivative (Scheme 1.7) (50, 51). In addition,
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incorporation of doubly labelled [4,5- C2] glucose and uniformly labelled [U- C6] 
glucose showed that an intramolecular rearrangement was involved in the reaction 
(52). This rearrangement is incompatible with the MVA pathway. Incorporation of
n  1
C-labeled pyruvate and C-labeled glycerol using E. coli mutants, each lacking a 
single enzyme of the triose phosphate metabolism, showed that D-glyceraldehyde 
phosphate (GAP, 35) together with pyruvate (34) are the precursors of the alternative 
pathway (51).
The first step of this route is the formation of 1-deoxy-D-xylulose 5-phosphate (DXP, 
36) by the condensation of GAP and pyruvate catalyzed by the thiamine 
diphosphate-dependent DXP synthase (dxs). The second step of this biosynthetic 
pathway is catalysed by the DXP reductoisomerase (dxr). This enzyme converts DXP 
into 2-C-methyl-D-erythritol 4-phosphate (MEP, 37) through an acid catalyzed 
rearrangement coupled with an NADPH-dependent reduction. In the next step, a 
cytidyl moiety is introduced into MEP via a diphosphate bond to produce
4-diphosphocytidyl-2-C-methyl-D-erythritol (38) and in turn this reaction was 
catalysed by 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ygbP). The 
resulting intermediate 38 is phosphorylated by 4-(cytidine
5’-diphospho)-2-C-methyl-D-erythritol kinase (ychB) and then cyclised to form 
2-C-methyl-D-erythritol 2,4-cyclodiphosphate (40) after loss of the cytidyl moity in a 
reaction catalysed by 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ygbB). 
The two final dehydration steps were catalyzed by the 2-C-methyl-D-erythritol 
2,4-cyclodiphosphate reductase (gcpE) and 4-hydroxy-3-methylbut-2-enyl 
diphosphate reductase (lytB), resulting DMAPP (2) and IPP (3) as final products.
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Scheme 1.7: Methylerythritolphosphate (MEP) pathway.
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The MVA pathway has been well-established to account for production of 
polyisoprenoids and sterols in fungi, plant cytoplasm, animals, most other eukaryotes, 
archaea and some bacteria. Much work towards the MVA pathway related enzymes 
has been carried out (53). These enzymes are essential for animals and human, 
therefore they have been identified as potentially useful drug targets for modulation of 
polyisoprenoid and sterol biosynthesis. Genetic work has also illustrated that 
disruption of genes encoding various enzymes in the MVA pathway showed positive 
effects on treatment of human pathogenic diseases (54).
The alternative MEP pathway of isoprenoid biosynthesis is widely distributed among 
pathogenic bacteria and is the predominant pathway (55). As exceptions, some 
bacteria possess both pathways (54, 56). Such bacteria utilise the MVA pathway for 
the production of isoprenoids classified as secondary metabolic products and the MEP 
pathway for the biosynthesis of essential isoprenoids that are classified as primary 
metabolic products. Genetic studies showed that the yeasts (Saccharomyces cerevisiae 
and Schizosaccharomyces pombe), the microsporidian intracellular parasite 
(Encephalitozoon cuniculi), the cryptomonad (Guillardia theta) and all completely 
sequenced animal species (Homo sapiens, Mus musculus, Rattus norvegicus, Danio 
rerio, Drosophila melanogaster, Anopheles gambiae, Caenorhabditis elegans) have 
complete sets of mevalonate genes, while genes of the MEP pathway are absent (55). 
The fact that animals exclusively use the MVA pathway makes the alternative 
pathway a valuable target for the development of new specific antibacterial and 
antiparasitic drugs.
1.4 Terpene synthases
The essential function of a terpene synthase is to catalyse the formation of terpenoid 
products from linear polyisoprenoid substrate(s) in a reaction that usually shows 
remarkable structural and stereochemical precision. Enzymatic terpenoid formation 
generally proceeds in three steps: generation of a highly reactive carbocation,
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transformation of the resulting carbocation and quenching of the terminal carbocation 
by a base (addition of a diphosphate group/hydroxyl group or deprotonation). In terms 
of the first reaction step, the terpenoid synthases can be divided into two classes (57). 
Most class I terpenoid synthases generate an allylic carbocation by the departure of 
the diphosphate group. The isoprenyl diphosphate synthases, monoterpene synthases 
and sesquiterpene synthases belong to this class. Class II terpenoid synthases generate 
the carbocation by the protonation of the carbon-carbon double bond or the 
corresponding epoxide ring. Enzymes from this class include the diterpene, triterpene 
and tetraterpene synthases.
Terpenoid synthases have similar physical and chemical properties, such as requiring 
a divalent metal ion for catalysis and the universal electrophilic reaction mechanism. 
As an exception, the presence of metal ions are not absolutely required for the class II 
terpenoid synthases (58). The specificity of the terpenoid synthase reaction can vary 
dramatically. High fidelity enzymes generate mostly one product with extraordinary 
structural and stereochemical precision. For example, 6-cadinene synthase from G. 
arboreum generates exclusively (+)-6-cadinene as the product (5P). In contrast, 
promiscuous enzymes could generate different structures such as y-humulene synthase, 
which generates 52 different cyclization products (60).
1.4.1 Isoprenyl diphosphate synthases
Isoprenyl diphosphate synthases (also known as prenyltransferases) catalyse 
isoprenoid chain elongations to generate prenyl diphosphates with various chain 
lengths using the C5 precursors DMAPP (2) and IPP (3) (11). The carbon chain 
length of linear terpenoids in nature varies from geranyl diphosphate (GDP, CIO) to 
natural rubber (C> 100,000) and many of these linear compounds can then be cyclized 
to generate cyclic or multicyclic products by terpene synthases.
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The isoprenyl diphosphate synthases can be divided into two subgroups based on their 
protein structure and product stereochemistry (61). (£)-isoprenyl diphosphate 
synthase catalyse the synthesis of all-fr<ms-prenyl diphosphates with various chain 
lengths from CIO to C50. On the other hand, (Z)-isoprenyl diphosphate synthases 
catalyze the successive c/s-condensation of IPP with the allylic diphosphate to 
generate more diverse long chain prenyl diphosphates, from ds-FDP (C l5) to natural 
rubber (C> 100,000).
The crystal structure of avian famesyl diphosphate synthase reveals the first view of a 
tertiary structure of sesquiterpenoid synthase (13). This enzyme is a homodimer with 
a hydrophobic active site surrounded by 10 a-helices. A more recent crystal structure 
of famesyl diphosphate synthase from E. coli complexed with substrate IPP and the 
nonreactive substrate analogue dimethylallyl-iS'-thiolodiphosphate (DMASPP) 
revealed two aspartate-rich DDXX(XX)D motifs on helices D and H liganded with a 
trinuclear magnesium cluster (Figure 1.4) (62). Mg2+A and Mg2+B each form 
six-membered ring chelate structures with two unesterified diphosphate oxygens. 
Asp 105 and A sp lll from E. coli famesyl diphosphate synthase make bidentate 
coordination interactions with Mg2+A and Mg2+c. Although the first aspartate-rich 
motif (D105DXXXXD1H) in the bacterial enzyme is different form that of the avian 
enzyme (DDXXD), the first and last aspartate residues of this motif in each enzyme 
make identical interactions with Mg2+A and Mg2+c. The third Mg2+B ion coordinates 
with the first aspartate in the second aspartate-rich motif (Asp244 of E. coli famesyl 
diphosphate synthase). Thus, both motifs together bind a trinuclear magnesium cluster 
that triggers the departure of the diphosphate group and the initial carbocation 
formation.
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DMSPP
D il l
D244
Figure 1.4: Cartoon representations o /E . coli fam esyl diphosphate synthase (PDB 1RQI) (A) 
and (B) the active site o f  the enzyme complexed with three magnesium ions (shown as green 
spheres), dimethylallyl-S-thiodiphosphate (DMASPP) and IPP. Chain A of the dimer is 
coloured cyan and chain B is green. Helices of chain B are labeled with capital letters. 
Aspartate residues from the two magnesium binding motifs are shown as sticks.
The tertiary enzyme-Mg2+-substrate complex observed from the crystal structure of 
famesyl diphosphate synthase suggests that the first step o f this chain elongation is 
the metal-triggered ionization o f DMAPP, forming an allylic carbocation intermediate. 
Alkylation from the distal double bond o f IPP to C l o f DMAPP generates a 10-carbon 
intermediate with a positive charge at C3 position. The first chain elongation that 
yields GDP is terminated by a stereospeciflc elimination o f the pro-R hydrogen (62). 
The second chain elongation reaction takes place by addition o f another molecule of 
IPP to GDP, forming famesyl diphosphate at the end of the catalytic cycle (Scheme 
1.1). The recently solved crystal structure o f geranylgeranyl diphosphate synthase
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displays a similar overall enzyme structure as famesyl diphosphate synthase, which 
has been defined as the class I terpenoid synthase fold (14). In addition, they also 
share a similar coupling mechanism and a conformational change upon ligand binding 
was also observed by comparison of unliganded and liganded crystal structures of 
famesyl diphosphate synthase and geranylgeranyl diphosphate synthase (14, 62). A 
study of 35 isoprenyl diphosphate synthases that synthesize famesyl (C l5), 
geranylgeranyl (C20) and higher chain length isoprenoid diphosphate revealed that 
the size of the side chains of residues FI 12 and FI 13 (avian famesyl diphosphate 
synthase numbering) were crucial for determining the ultimate length of the 
hydrocarbon chains (63). Higher chain length synthases usually have amino acids 
with smaller and more flexible side chains at these positions. Substitutions in FI 12 
and FI 13 of avian famesyl diphosphate synthase with smaller residues also conferred 
the avian enzyme with ability of generating diphosphates in the C20 to C70 range 
(63).
1.4.2 Isoprene synthases
Isoprene represents the simplest structural unit of the terpene family. Roughly 100 Tg 
of isoprene is generated from natural sources each year (64) and it is suggested that 
isoprene emission protects against environmental stresses such as transiently high 
temperatures and oxidative damage (65, 66). According to the computational studies, 
isoprene helps stabilise lipid membranes against thermally induced phase transitions 
(67). It also influences the defense mechanisms of herbivore infested plants (68, 69). 
In addition, isoprene and its derivatives are currently being investigated for their 
industrial values in fuel science and materials science (70, 71).
Isoprene synthase (ISPS) catalyses the metal-dependent conversion from DMAPP (3) 
to isoprene (1). This simple elimination reaction catalysed by ISPS may go through an 
allylic carbocation intermediate as the initiation step proposed for most class I 
terpenoid synthases, or it could also proceed via concerted fashion. In either case, a
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proper active site base is required, while no such candidate residue was spotted in the 
active site that could function as the general base from analysis of the crystal structure 
of ISPS from gray poplar hybrid Populus*canescens (PcISPS). Surprisingly, analysis 
of the structure of PcISPS complex with DMASPP that serves as the inhibitor in the 
crystal structure studies, which suggests the diphosphate group itself could serve as 
the general base (Scheme 1.8) (72). Specifically, the PcISPS-DMASPP complex 
indicates that the substrate analogue binds to the enzyme with a favourable 
seven-membered-ring chair-like conformation, which brings one of the charged 
oxygen atom close to the C3 atom of DMASPP.
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Scheme 1.8: Proposed catalytic mechanism for ISPS (72).
The crystal structure of PcISPS and the structure of its complex with the unreactive 
substrate analogue DMASPP and three Mg2+ ions were solved recently as 
homodimers (72). The PcISPS structure is constructed with two a-helical domains. 
Similar to the structure of famesyl diphosphate synthase, the C-terminal domain of 
PcISPS is functionally active and adopts the a-helical class I terpenoid synthase fold. 
The N-terminal domain adopts an a-barrel class II terpenoid synthase fold with no 
known catalytic activity (Figure 1.5). The aspartate-rich metal binding motif 
(D345DXXD) that is conserved in most class I terpene synthases was found on the
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helix D o f PcISPS and another characteristic NSE/DTE motif (N489DXXSXXXE) was 
observed on helix H (Figure 1.5). Both motifs chelate the trinuclear magnesium 
cluster, in which Mg2+A and Mg2+C are mainly coordinated by D345 and Mg2+e by 
E497 (Figure 1.5). The magnesium ions also coordinate with oxygen atoms of the 
DMASPP diphosphate group and this interaction could initiate the potential ionisation 
step.
Figure 1.5: Cartoon representations o f  chain B o f  PcISPS complexed with DMASPP (shown 
as sticks) (PDB 3N0G) (A) and the active site o f  the enzyme complexed with three magnesium 
ions (shown as green spheres) and DMASPP (B). The helices of monomer are labeled with 
primed capital letters. Residues from the two magnesium binding motifs are shown as sticks.
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1.4.3 Monoterpene synthases
Monoterpene synthases catalyze the metal-dependent formation of acyclic, 
monocyclic and bicyclic CIO olefins, alcohols, ethers and diphosphate esters (Scheme 
1.9). Monoterpenes have been isolated almost exclusively from plants, including 
angiosperms and gymnosperms. The enzymes from gymnosperms require monovalent 
cations such as K+ together with divalent cations Mn2+ or Fe2+ as cofactor, whereas 
the angiosperm synthases prefer Mg2+ without any requirement for monovalent 
cations (4).
myrcene (45) geraniol (47)
(Z)-J3-ocimene (46) linalool (48)
geranyl cation (42)
a-terpinyl cation (44)
linalyl diphosphate (43)
bomyl diphosphate
limonene (49) terpineol (50) cineole (51) (52) a-pinene (53)
Scheme 1.9: Biosynthesis o f representative monoterpenes from GDP.
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All monoterpene synthases follow a common carbocationic reaction mechanism 
initiated by the departure of diphosphate group to form a geranyl cation (42). From 
here, acyclic products are formed by proton loss or addition of water (Scheme 1.9). 
The formation of cyclic products, on the other hand, needs preliminary conversion of 
the geranyl cation to linalyl diphosphate (LDP, 43), facilitating the cyclization to a 
six-membered ring. Kinetic studies with LDP as an alternative substrate in 
combination with GDP support the intermediacy of LDP and also indicate the 
isomerization reaction as the slow step during catalysis (73). Subsequent electrophilic 
attack of Cl by the C6-C7 double bond of the cisoid conformer of LDP yields the 
universal monocyclic intermediate, a-terpinyl cation (44). From this intermediate, 
monoterpene synthases catalyse loss of protons, hydride shifts, water capture and 
internal cyclizations to form different structures (Scheme 1.9). The fact that the 
individual intermediate (44) may undergo multiple modifications suggests a rationale 
for the ability of monoterpene synthases to produce multiple products. Studies showed 
that the minor products of the monoterpene synthase have fewer cyclisations than the 
major product, suggesting that the minor products are formed from premature 
termination of the reaction cascade (74).
The first crystal structure of a monoterpene synthase was solved for the homodimeric 
(+)-bomyl diphosphate synthase (75). The monomer contains two a-helical domains 
(Figure 1.6). The C-terminal domain exhibits the characteristic class I terpenoid 
synthase fold, catalyzing the metal-dependent cyclization of GDP (Scheme 1.9) (75). 
The N-terminal domain is homologous to the glycosyl hydrolase domain and has no 
well-defined function; nevertheless, the N-terminal polypeptide segment caps the 
active site in the C-terminal domain upon ligand binding (57).
Two arginines (R55, R56 of (+)-bomyl diphosphate synthase) (Figure 1.6) have been 
found in many monoterpene synthases (75). Polypeptide deletion studies on the 
limonene synthase of Mentha spicata revealed that the enzyme activity was not 
affected by deletion of the N-terminal region before this tandem arginine motif.
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Deletion o f this motif rendered the limonene synthase unable to accept GDP as a 
substrate. However, LDP is still usable by the deletion mutant, suggesting that the 
arginine motif might participate in the isomerization of GDP to linalyl cation (76).
D496
Figure 1.6: Cartoon representations o f  chain A o f  bornyl diphosphate synthase complexed 
with diphosphate group (shown as orange sticks) (PDB 1N1Z) (A) and the active site o f  the 
enzyme complexed with three magnesium ions (shown as green spheres) and diphosphate 
group (PPJ (B). The helices of monomer are labeled with primed capital letters. Aspartate 
residues from the two magnesium binding motifs and the tandem arginines are shown as cyan 
sticks.
The structure o f (+)-bomyl diphosphate synthase complexed with PP; reveals the
important molecular recognition o f the diphosphate moiety involving a magnesium
cluster and several hydrogen bond interactions (Figure 1.6) (75). The first and last
aspartate residues in the DDXXD m otif o f helix D, Asp351 and Asp355 contact
Mg2+A and Mg2+c. The second magnesium binding m otif (NSE/DTE motif), Asp496,
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Thr500 and Glu504, chelates M g2+B on the opposite site of the active site cleft. This 
pattern is very similar to that observed with E. coli famesyl diphosphate synthase and 
suggests a universal molecular recognition of isoprenoid diphosphates by class I 
terpenoid synthases. A variety of hydrophobic and aromatic residues were found in 
the active site cavity, which may contribute to the binding conformation of the 
substrate and carbocation intermediates.
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A conformational change triggered by the formation of tertiary enzyme-PPj-Mg 3 
complex was observed, which would lead to a sequestered active site pocket that is 
isolated from bulk solvent (75). The N-terminus (E50-A63) and loop segments 
D227-D234, T500-D509 and F578-S583 are disordered in the unliganded structure, 
while all of these disordered regions become ordered and cap the active site in the 
enzyme-ligand complex. In addition, a single water molecule was found to be trapped 
in the active site cavity after the conformational change. This water molecule makes 
hydrogen bonding interactions with the diphosphate group, the backbone carbonyl of 
Ser451 and the side chain of Tyr426. Thus, it is docked firmly in the active site, 
which prevents it from reacting with carbocation intermediates to prematurely quench 
the reactions. However, it could still function as a diphosphate-assisted general base 
to generate cyclic olefin side products such as pinenes and limonene (77).
1.4.4 Sesquiterpene synthases
The formation of sesquiterpenes from FDP follows similar carbocation-based reaction 
mechanisms as those of monoterpene synthases. However, the longer carbon chain 
skeleton of FDP and the additional double bond greatly increase the structural 
diversity of products, many of which contain bicyclic structures. Often, the first step 
of sesquiterpene formation is believed to be the ionization of FDP to the 
corresponding transoid famesyl cation (54) (5). The reaction can be terminated here 
by proton abstraction or water capture to form acyclic products (Scheme 1.10).
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Scheme 1.10: Biosynthesis o f representative sesquiterpenes from FDP.
From the resulting famesyl cation, the cyclization reactions can go through three
different pathways (Scheme 1.10). Reaction of the Cl cation with the distal double
bond could occur by two different pathways forming either 1 0 -membered
((£, £)-germacradieny 1 cation, 55) or 11-membered ((£)-humulyl cation, 56) rings.
However, due to the (E)-geometry of the C2-C3 double bond of FDP, a
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1 ,6 -cyclization including the central double bond is precluded by steric constraints
(78). To accomplish 1,6-cyclizations, sesquiterpene synthases generate the famesyl 
cation (54) and recapture diphosphate group at C3 to form transoid nerolidyl 
diphosphate (57). A tightly bound cisoid nerolidyl diphosphate (58) is then formed via 
preliminary isomerization of the C2-C3 double bond. The cisoid conformer of the 
nerolidyl cation can then be cyclized from either the central or distal double bond to 
form 1,6-bisabolyl cation (59), 1,7-cycloheptanyl cation (60),
l,10-(Z,£)-germacradienyl cation (61) or l,ll-(Z)-humulyl cation (62) products. 
Subsequent cyclisations can involve electrophilic attack on either of two remaining 
double bonds. In addition to cyclization, the diverse modifications of the 
sesquiterpene skeletons also include hydride shifts, methyl migrations or 
rearrangements prior to termination of the reaction by deprotonation or nucleophile 
capture. Generally, the sesquiterpene synthases require divalent metal ions Mg2+ or 
Mn2+ as cofactor (79, 80).
Aristolochene synthase (AS) is the only known sesquiterpene synthase that does not 
follow the famesyl cation (54) mechanism (Scheme 1.11). This was shown using 
fluorinated FDP analogues, mechanism based inhibitors and site-directed mutagenesis
(81, 82).
©
FDP (5)
germacrene A (66)germacradienyl cation 
(55)
H
(+)-aristolochene (73) eudesmane cation
(72)
Scheme 1.11: AS-mediated conversion o f FDP to (+)-aristolochene.
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The mechanistic studies by employing substrate analogue 12,13-difluoro-FDP (74) 
rule out the possible existence of the famesyl cation in the enzymatic reaction 
catalysed by AS from both Penicillium roqueforti and Aspergillus terreus (81, 82). 
Due to the electronic effects of fluoro substituents, the electrophilic attack of Cl by 
the CIO, Cl 1 Jt-bond would be inhibited if famesyl cation was generated in the first 
place. In this case, the accumulation of the 12,13-difluorofamesyl cation would go 
through an elimination, forming 12,13-difluoro-(3£, 6 is)-a-famesene (75) and 
12,13-difluoro-(£)-|3-famesene (76) instead (Figure 1.7). However, the observation 
that 74 acts as an competitive inhibitor of AS indicates that the formation of the 
germacradienyl cation (55) takes place in a concerted reaction, in which famesyl 
diphosphate ionisation is accompanied by electrophilic attack of Cl by the CIO, Cl 1 
jt-bond. In addition, another fluorinated substrate analogue, 2-fluoro-FDP (77) has 
been shown to be a weak substrate (81), also suggesting the absence of famesyl cation 
during the cyclisation pathway.
. , s^ i'CH2F
pp9=h2c^
12,13-difluoro-FDP (74)
B
OPP
© ^ ^ c h 2f  
f h 2c
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c h 2f
f h 2c
12,13-d ifluoro-(3£,6£)-a-farnesene 
(75)
CH2F
f h 2c
12,13-difluoro-(£)-p-farnesene 
(76)
r
2-fluoro-FDP (77) aza-analogue (78)
Figure 1.7: (A) Outcome o f the hypothetical mechanism for the conversion o f  
12,13-difluoro-FDP (74) through an initial ionization step. (B) Structure o f 2-fluoro-FDP (77) 
and the aza-analogue (78) that mimics the eudesmane cation (72).
Further investigations toward understanding the reaction mechanism of AS were
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performed to identify the intermediates during the catalysis. Mutagenesis studies of 
aromatic residues Y92, FI 12 and F I78 (83-85) suggest these residues play an 
important role in anchoring the distal double bond in the precatalytic conformation of 
FDP and hence influence formation of the neutral intermediate, germacrene A (6 6 ). 
Replacement of Y92 of P. roqueforti aristolochene synthase (PR-AS) with residues of 
decreasing steric bulk (e.g. Phe, Val, Cys and Ala) led to a increasing production of 
acyclic sesquiterpene products. The site-specific mutant AS-F112A produces 36% 
(£)-|3-famesene and 53.5% (3E,6 fs)-a-famesene as the major products. Another 
mutant AS-F178V generates 50% germacrene A as the major product, which strongly 
suggests the appearance of germacrene A as an intermediate in the catalytic pathway. 
A recent study (86) further evaluated the contributions of aromatic residues by amino 
acid replacements in positions 8 8 , 89 and 108 of PR-AS. These residues may have the 
potential to interact with the three aromatic residues described above (Y92, FI 1 2  and 
F I78). The substitution of either V8 8  or T89 by the bulkier phenylalanine led to an 
increase in germacrene A production. Replacement of LI 08 with serine or alanine led 
to a suppression of the native aristolochene synthase activity. Instead, the enzymatic 
reaction gave a mixture of (fs)-{3-, (3E,6E)-a- and (3Z, 6 fs)-a-famesene as the 
predominant reaction products. These results demonstrated the existance of the 
germacrene A intermediate and the involvement of the aromatic and aliphatic residues 
around the active site of PR-AS.
The existence of eudesmane cation (72) had been probed for a long time with little 
evidence to support its existence. Our group recently provided an approach to identify 
72 by employing the aza analogue (78) that effectively mimics the topological and 
electrostatic properties of the eudesmane cation (72) (87). 78 acted as a competitive 
inhibitor with a K[ value (0.35 ± 0.12 pM) similar to the Michaelis constant (KM = 
0.53 ± 0.21 pM)) determined for PR-AS. This observation greatly supports the 
intermediacy of eudesmane cation as an intermediate in AS catalysis. Mutagenetic 
approaches further demonstrated that the indole ring of active site residue W334 of 
PR-AS is responsible for stabilisation of the eudesmane cation (72) through cation-jc
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interactions (88). Substitutions of residues without aromatic side chains (e.g. Leu) 
greatly altered the product specificity towards the neutral intermediate germacrene A. 
Replacement of tryptophan by para-substituted phenylalanines with strong 
electron-withrawing groups (e.g. Cl, CF3 and NO2) had only minor effects on the Km 
values but led to 30-250 folds reduction on the A^at values and the main product 
distribution of these mutants shifted from aristolochene to germacrene A.
Bacterial and fungal sesquiterpene synthases such as aristolochene synthase from 
Aspergillus terreus and Penicillium roqueforti, pentalenene synthase from 
Streptomyces UC5319 and trichodiene synthase from Fusarium sporotrichioides are 
usually active as single domain enzymes (89, 90). Plant sesquiterpene synthases such 
as epj-aristolochene synthase from Nicotiana tabacum and S-cadinene synthase from 
gossypium arboretum contain an additional N-terminal domain (91). The C-terminal 
domain of sesquiterpene synthases from bacteria, fungi and plants adopt the 
characteristic class I terpenoid synthase fold. This type of enzyme usually contains the 
aspartate-rich DDXXD(E) and another NSE/DTE metal ion binding motifs, 
suggesting the binding of the trinuclear magnesium cluster is required for catalysis. 
The additional N-terminal domain presents a fold most related to that of the glycosyl 
hydrolases and weakly homologous to the class II terpenoid synthase fold (92).
The crystal structure of aristolochene synthase from Aspergillus terreus is employed 
here to present the important tertiary structural features from microbial sesquiterpene 
synthases (93). Aristolochene synthase adopts the a-helical class I terpene synthase 
fold and is reported to be a monomer in solution (94). The crystal structure reveals the 
assembly of two dimers in the asymmetric unit to form a tetramer (Figure 1.8). The 
observed attenuation of enzyme activity at high concentrations (greater than 27 nM) 
could be due to the oligomerization (95).
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Figure 1.8: Cartoon representation o f  tetramer o f  aristolochene synthase from A. terreus 
(PDB 20A6). Chain A is coloured tint, chain B is magenta, chain C is cyan and chain D is 
green.
The tertiary structure o f A. terreus aristolochene synthase contains 13 a-helices, 
connected by short loops. The aspartate-rich D90DXXE motif is located on helix D on 
the upper wall o f the active site cleft; the other metal binding motif, N219S223E227 
motif, is located on helix H on the opposite wall o f the active site cleft. The 
enzyme-Mg2+3 -PPj complex was only observed in subunit D (Figure 1.9). In this 
complex, Asp90 was observed to coordinate directly to Mg2+A and M g 2+c . Asp91 
makes a salt bridge interaction with Arg314, which donates a hydrogen bond to PPj.  
M g 2+A and M g 2+c  are also coordinated by P P j  and water molecules. The NSE motif 
coordinates to Mg2+B in a fashion identical to that observed in bomyl diphosphate 
synthase (see section 1.4.3). In addition to the metal coordination interactions 
mentioned above, the PPi anion also makes hydrogen bonds with some basic residues, 
including A rgl75, Lys226, Arg314 and also aromatic residue Tyr315.
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Figure 1.9: Cartoon representations o f  chain D o f  aristolochene synthase (PDB 20A6) (A), 
the active site o f  the enzyme complexed with three magnesium ions (shown as green spheres) 
and PP, (shown as sticks) (B) and magnesium ions (shown as green nb spheres) coordinated 
with PP, and water molecules (shown as red nb spheres) (C). The helices of the monomer are 
labeled with capital letters. Residues from the two magnesium binding motifs and the ones 
ordinated with PP* are shown as sticks.
The binding o f Mg2+3 -PPj to monomer D triggers a significant conformational change, 
which causes helices C l, D l, F, G1 and H to shift inward and the previously 
disordered H-a-1 loop becomes ordered (Figure 1.10) (93). This conformational 
change leads to a closed active site, bringing ligand-binding residues closer together 
and sequestering the active site from bulk solvent.
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Figure 1.10: Superposition o f  unliganded (tint) and 
liganded (green) tertiary structures aristolochene synthase.
The aristolochene synthase from Penicillium roqueforti catalyses the same cyclisation 
from FDP to aristolochene, but also produces minor amounts o f intermediate 
germacrene A (7.5%) and the side-product valencene (1%). However, Aspergillus 
terreus aristolochene synthase generate exclusive aristolochene as the only product. 
The overall structure o f both enzymes is very similar and they share 61% amino acid 
sequence identity. The majority o f amino acid substitutions between the two enzymes 
are found on the protein surfaces, while most active site residues are highly conserved 
(93). This fact suggests that formation of the minor products may arise either from an 
adjustments o f residues surrounded the active site (to change the active site shape and 
volume), or by rearrangements o f hydrogen bond networks.
Unlike microbial sesquiterpene synthases, all plant sesquiterpene synthases contain 
two domains. The first plant sesquiterpene synthase for which a crystal structure was 
solved was c/?/'-aristolochene synthase from Nicotiana tabacum, which displayed two 
a-helical domains (Figure 1.11) (91).
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Figure 1.11: Cartoon representation o f  5-epi-aristolochene synthase 
(PDB 5EAS). The C-terminal domain is coloured green and all the 
helices from C-terminal domain are labeled with capital letters. The 
N-terminal domain is coloured cyan.
The crystal structure o f e/?z-aristolochene synthase complexed with famesyl 
hydroxyphosphonate (Figure 1.12) showed that Asp301 and Asp305 from helix D (the 
first and the last residues from DDXXD motif) are liganded with M g 2+A and M g 2+c ,  
which is different from coordination interactions observed from trichodiene synthase 
but identical to that o f (+)-bomyl diphosphate synthase. M g 2+B is liganded by Asp444, 
Thr448 and Glu452 from the NSE/DTE motif (on the helix H) following the same 
pattern as had been observed for (+)-bomyl diphosphate synthase and trichodiene 
synthase. The variety o f metal ions coordination with diphosphate group among these 
terpenoid synthases indicates a strategy for the evolution of divergent cyclization 
products in each enzyme active site. In addition, two arginines, R441 and R264, seem 
to facilitate binding of the diphosphate group by providing positive charge localized at 
the opening o f the active site. The active site closure upon ligand binding was also 
observed, in which the movement o f the A-C loop could promote ionization of FDP 
by interaction with R264. The movement o f J-K loop and N-terminal region may also 
help to close the active site.
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D305
Figure 1.12: Cartoon representation o f  the active site o f  
5-epi-aristolochene synthase complexed with three magnesium 
ions (shown as green spheres) and substrate analogue famesyl 
hydroxyphosphonate (FHP) (PDB 5EAT). Residues from the 
two magnesium binding motifs and two arginines are shown as 
sticks.
1.4.4.1 S-Cadinene synthase
6-Cadinene synthase (DCS) is a sesquiterpene cyclase that catalyses the cyclization of 
FDP to 6-cadinene (79). Most genes coding for DCS have been isolated from the 
cotton species (59, 96-100). In addition, another DCS gene has been isolated from 
melon (Cucumis melo L.) (101). In cotton plants, 6-cadinene is the biosynthetic 
precursor o f gossypol (80), which consists o f two highly oxygenated forms of 
6-cadinene joined together by a binaphthyl linkage (Scheme 1.12). Gossypol is an 
important secondary metabolite among cotton plants, which defends the plant from 
bacterial and fungal pathogens (16). It accumulates in lysigenous glands found in 
stems, leaves and the cotyledons o f seeds, resulting in cotton plants being much more 
resistant to microbe and insect predation. In addition, gossypol reduces the growth of 
cancer cells (102) and inhibits male fertility in humans (99). Desoxyhemigossypol (81) 
and hemigossypol (82) also accumulate in wild type cotton plants, serving as 
phytoalexins or defense compounds against microbial infection.
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HO-
OPP
desoxyhemigossypol (81)FDP (5) 8-cadinene (79)
OH
CH OH
HO
OH
HO
gossypol (80)
CH OH
hemigossypol (82) 
Scheme 1.12: Biosynthesis o f gossypol from 6-cadinene.
The biosynthetic mechanism of generating 8 -cadinene from FDP has been 
investigated by several groups (PP, 104-109). It has been proposed that the 
mechanism begins with formation of NPP (57), followed by rotation of the C2, 
C3-bond to bring Cl within bonding distance of CIO (107) (Scheme 1.13). NPP then 
undergoes a Cl-CIO ring closure to generate c/'s-germacradienyl cation (61) with the 
stereochemistry found in 8 -cadinene. Prior to the second ring closure, the carbocation 
has to be repositioned within the macrocycle by a 1,3-hydride shift. The reaction is 
terminated by deprotonation from C6  to release 8 -cadinene (79).
OPP 
FDP (5)
5-cadinene (79)
Popp
farnesyl cation (54)
rotaion
OPP
NDP (transoid) (57) NDP (cisoid) (58)
I
cadinenyl cation (83) cis-germacradienyl cation 
(61)
Scheme 1.13: Proposed catalytic mechanism for 6-cadinene synthase via NDP as 
intermediate.
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In agreement with the proposed mechanism, NPP (57) has been shown to be a 
substrate of DCS (104,105) and its formation within the active site of the enzyme has 
been demonstrated by [l,2 -13C2]acetate and [2-14C] and [4-14C]mevalonate labelled 
feeding experiments (108,110).
The biosynthesis of cadinene-type sesquiterpenes could also be achieved via a
1,10-cyclisation but without going through NPP (57) as intermediate (107) (Scheme 
1.14). In this alternative pathway, the first ring closure goes through a direct 
displacement of the diphosphate group by the distal double bond of FDP, forming a 
toms-germacradienyl cation (55). The neutral germacrene D (84) is formed by a
1,3-hydride shift and deprotonation from C15 (105). The second ring closure upon 
reprotonation of germacrene D leads to the formation of cadinanyl cation (83), as in 
the NDP pathway, followed by deprotonation to form the final product.
-►
trans-germacradienyl cation
OPP
FDP (5) germacrene D (84)
I I I
cadinenyl cation (83)
©H
germacrene D (84)8-cadinene (79)
Scheme 1.14: Proposed catalytic mechanism for 5-cadinene synthase via germacrene D as 
intermediate.
Formation of 6 -cadinene (79) via this proposed mechanism was first suggested by 
Arigoni (107) based on mechanistic studies of avocettin formation via y-cadinene 
(107). Tritium-labelling experiments showed that all-is-FDP was not isomerized to the
2,3-Z isomer. Instead, a 1,3-hydride shift was observed, which led to the postulation 
of the intermediacy of germacrene D. In this mechanism, there is no interconversion
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between (2E, 6 £)-FDP and its Z-isomer NDP, while the conversion of the is-double 
bond to a Z-double bond is achieved by a ring flip of germacrene D.
However, a recent investigation of the catalytic mechanism of DCS using a variety of 
substrate analogues strongly challenged the mechanisms described above (109). The 
catalytic mechanism of DCS involving germacrene D as an intermediate was ruled out 
by investigating the hypothetical protonation step. Since formation of 5-cadinene 
along this pathway would require protonation of the exocyclic double bond of 
germacrene D, the reaction cascade is expected to be pH-dependent. An isotopic 
exchange with the medium is also expected. However, the production of 6 -cadinene 
was shown not to be pH-dependent and the isotopic exchange with the media was not 
observed either by incubations of DCS with FDP and [15-2H3]FDP (85) (Figure 1.13) 
in deuterated and aqueous buffer respectively.
[15-2H3]FDP (85) (2Z.6E)-2F-FDP (86)
(2E, 6E)-2F-FDP (87) 6F-FDP (88)
Figure 1.13: Structures o f FDP analogues.
Investigation of the NDP pathway was first carried out by employing fluorinated 
substrate analogues. (2Z,6FT)-2F-FDP (8 6 ) and (2£,6£)-2F-FDP (87) that contain a 
fluorine atom on C2 would greatly prevent the initial ionization step via depletion of 
electron density in the allylic moiety (111). Indeed, 8 6  and 87 acted as efficient 
inhibitors, suggesting the involvement of NDP (57) during the catalysis. Another 
fluorinated compound 6 F-FDP (8 8 ) was designed to inhibit the second ring closure 
and this compound has been demonstrated to disrupt the catalytic cycle of AS (112)
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and TEAS (113). Thus, if the catalytic mechanism of DCS goes through intermediates 
61 and then 83, the corresponding deprotonated forms of 61 (89, 90 and 91) would be 
expected (Scheme 1.15). While, incubation of 6 F-FDP (8 8 ) with DCS generates no 
sesquiterpene product, suggesting an early involvement of the central C6 , C7 double 
bond in the catalysis.
iPPO
6F-FDP (88)
DCS-----
I
l
6F-helminthogermacrene A 6F-germacrene C6F-germacrene D
(89) (90) (91)
Scheme 1.15: Outcome o f the hypothetical derailment o f the DCS catalytic cycle with 
6F-FDP at the germacrene cation stage.
Additional evidence supporting the possible 1,6-ring closure as the first ring closure 
step in 8 -cadinene biosynthesis was obtained from incubations with (2Z,6£)-FDP (92). 
Substrate analogue 92 can be recognised as the isomer of all-tran FDP and cisoid 
NDP, thus it should present as cisoid famesyl cation after ionisation by DCS, which 
will greatly facilitate either 1,6 or 1,10 ring closure. DCS convert 92 into a mixture of 
the bisabolenes (93, 94 and 95) and 8 -cadinene (40%) (Scheme 1.16), which is 
comparable to that observed with feeding NDP directly to DCS.
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+Z-a-bisabolene (95)
+
p-bisabolene (94)Z-y-bisabolene (93)
PPO
(2Z,6E>FDP (92) +
5-cadinene (79)
Scheme 1.16: Hydrocarbons generated by incubation o f DCS with (2Z,6E)-FDP.
These results, especially the inhibition of the enzyme by 6 F-FDP, indicate a 1 ,6 -ring 
closure mechanism via NPP (58) and a-bisabolyl cation (96) as a plausible means in 
6 -cadinene biosynthesis (Scheme 1.17).
a-bisabolyl cation (96)
PPO'"
cisoid-NDP (58)
PPO
v
6-cadinene (79) cadinenyl cation (83)
Scheme 1.17: Possible biosynthesis o f 6-cadinene via NDP and a-bisabolyl cation.
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1.4.4.1.1 Characterisation o f DCS
The cDNA encoding DCS for our study was obtained from Gossypium arboretum  
(tree cotton) (59). The gene encodes 554 amino acids corresponding to a protein with 
a molecular weight o f 64096. The crystal structure o f this protein has recently been 
solved, revealing a two domain overall structure (Figure 1.14) (114).
Figure 1.14: Cartoon representation o f  8-cadinene synthase (PDB 3G4D).
The C-terminal domain is coloured green and the N-terminal domain is 
coloured cyan.
The C-terminal domain is defined as the catalytically active domain, which adopts the 
a-helical class I terpenoid synthase fold. The active site consists o f six a-helices, 
which form an 18 A deep active site cleft (Figure 1.15). The crystal structure confirms 
that the characteristic aspartate-rich motif (D307DTYD331) is located on helix D, which 
interacts with Mg2+A and Mg2+c- However, the typical second magnesium binding 
m otif (NSE/DTE) is replaced by a unique second aspartate-rich motif, D451DVAE455 
that chelates Mg2+B. In terms of this feature, DCS is more similar to the famesyl 
diphosphate synthase, which also contains two aspartate-rich motifs, rather than the 
majority o f class I terpenoid synthases. The additional N-terminal domain o f DCS 
adopts an a-helical fold, which shows some similarity to a class II terpenoid synthase 
fold (92). The function o f this domain is still unknown, although it has been proposed 
to cap the active site during catalysis (57).
43
D311R448D452
D307
E455
>308
D451
R270
Figure 1.15: Cartoon representation o f  the active site o f  6-cadinene 
synthase complexed with three magnesium ions (shown as green 
spheres) and substrate analogue 2F-FDP (shown as orange sticks)
(Chain A, PDB 3G4F). Residues from the two magnesium binding 
motifs are shown as sticks. Two arginine residues that have contact 
with diphosphate group are shown as sticks.
DCS is a dimer in the crystal structure, although size exclusion chromatography 
experiments show that DCS is a monomer in solution, suggesting that the 
crystallographic dimer is not biologically relevant (106). In monomers A and B, 
several polypeptide regions are disordered and excluded from the final model, 
including the N-termini (M1-K24 and M1-P29, respectively) and the loop segments 
K42-I44 and K42-D45, F460-D464 and F460-D464, and G530-T534 and Y533-V536, 
respectively (Figure 1.16). Most o f these segments are adjacent to the entrance of the 
active site in the C-terminal domain except the segments K42-I44 or K42-D45. 
According to previous studies o f monoterpene and sesquiterpene synthases, one or 
more such disordered polypeptide segments become ordered upon ligand binding and 
the conformational change leads to the closure o f active site that shields the active site 
pocket from bulk solvent (7, 57).
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Figure 1.16: Cartoon representations o f  6-cadinene synthase (left) (PDB 3G4D) and the 
enzyme complexed with substrate analogue 2F-FDP (right) (PDB 3G4F). The C-terminal 
domain is coloured green. The helices of C-terminal domain of unliganded enzyme are labeled 
with capital letters. The N-terminal domain is coloured cyan. Substrate analogue 2F-FDP is 
shown as orange sticks.
In the case o f DCS, binding of the magnesium cluster and the substrate analogue 
2F-FDP do not lead to an obvious conformational change; the N-terminal region 
M1-K24, loop segments K42-I44, F460-D464 and G530-T534 remain disordered (the 
structures o f these polypeptides did not show up in the electron-density map) in each 
monomer (Figure 1.16) (114). This suggests that the conformational changes between 
liganded and unliganded catalytic domains o f plant enzymes are relatively smaller 
than those observed from fungal enzymes, which may relate to the additional 
N-terminal domain.
The binding o f the substrate analogue 2F-FDP to each monomer is similar. Some 
differences are related to the formation o f hydrogen bonds. In monomer A, an oxygen 
atom of the diphosphate group appears to form a hydrogen bond with R448 and 
another charged oxygen atom donates a hydrogen bond to a water molecule, which 
accepts a hydrogen bond from R270 (Figure 1.15). In monomer B, the corresponding 
interactions are too long to be defined as hydrogen bonds.
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1.4.4.2 (E)-(5-Farnesene synthase
(£)-P-Famesene synthase (EBFS) is a sesquiterpene synthase that catalyzes the 
formation of the acyclic sesquiterpene (2s)-|3-famesene (57) from FDP (Scheme 1.18). 
(£)-p-Famesene is widely distributed among animals and plants. More than 600 
research papers have reported the appearance of this natural product with unique 
functions in chemical communication (115). (£)-p-Famesene is found in the essential 
oil of hundreds of plant species of both gymnosperms, such as Torreya taxifolia 
(Florida torreya) and Larix leptolepis (larch) and angiosperms, such as Robinia 
pseudoacacia (black locust), Medicago sativa (alfalfa), Chamomilla recutita 
(chamomile), Vitis vinifera (grapes), Cannabis sativa (hemp), Zea mays (com), Piper 
nigrum (black pepper), Daucus carota (carrot) and Mentha x piperita (peppermint), as 
reviewed (115).
In insects and plants, (£)-p-famesene serves as a semiochemical in most cases. It was 
found as a pheromone (chemical substances could trigger a social response in 
members of the same species) in the urine of male mice (116) and is also emitted by 
andrenid bees (117) and by several genera of ants (118) to serve both as a defensive 
allomone (chemical substance that produced and released by an individual of one 
species of organism that affect the behaviour of a member of another species to 
benefit of the emitter) and as a trail pheromone. As an allomone, it functions as a 
feeding stimulant to the sand fly Lutzomyia longipalpis, which is an important vector 
of the blood disease leishmaniasis (119). The compound can serve as a prey-finding 
kairomone (chemical substances that are emitted by an organism in a way that 
benefits an individual of another species which receives it, without benefiting the 
emitter) among several species of predatory carabid beetles (120).
(£)-P-Famesene also plays an important role in chemical communication of plants 
and animals. The compound stimulates kairomonal oviposition of the European com 
borer when emitted by com (121). Increasing amounts of (£)-P-famesene were
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produced and released by com when it was attacked by lepidopterans. (7s)-p-famesene 
then serves as a synomone (chemical substances that are producted by one organism 
that affects the behaviour of a member of another species) and can be detected by the 
parasitic wasp to locate the hosts (122).
The most significant role of (7s)-|3-famesene in plant-insect interactions is as an alarm 
pheromone in aphids (123). Aphids are one of the most destructive pests in agriculture, 
often causing plant vims infections in their host. Because of the development of 
insecticide resistance and the ability of some species to reproduce asexually, it is hard 
to control their population. Aphids become agitated and disperse from their host plant 
when exposed to (7s)-|3-famesene (124), preventing colonization. High concentrations 
of (£)-p-famesene can also be toxic to aphids (725). However, little progress has been 
made in controlling aphid population by application of (7s)-|3-famesene to plants, 
mainly due to its volatility and instability. The unsaturated carbon chain structure can 
be easily oxidized in air.
In common with most sesquiterpenes, the formation of (£)-p-famesene catalysed by 
EBFS was proposed to be initiated by loss of the diphosphate group, leaving an allylic 
carbocation with positive charge delocalized between Cl and C3 (775). The reaction 
is then terminated by proton abstraction from the C l5 methyl group to yield 
(£)-P~famesene (Scheme 1.18).
OPP
(iO-P-famesene (57)
OPP
FDP (5)
Scheme 1.18: Proposed catalytic mechanism for (E)-/3-farnesene synthase.
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During the last 15 years, cDNAs encoding EBFS have been isolated from Mentha x 
piperita (115), Citrus junos (126), Artemisia annua (127), Pseudotuga menziesii (128), 
Zea mays (129). The enzymes from Citrus junos, Artemisia annua and Pseudotuga 
menziesii generate essentially one product from FDP, while the enzyme from Mentha 
x piperita generates (£)-p-famesene (65) (~85%) along with (Z)-P~famesene (97) 
(8 %), 6 -cadinene (79) (5%) and another three unidentified minor products and the 
maize (Zea mays) enzyme produces (F)-(3-famesene (-50%), (£)-a-bergamotene (98) 
(-30%) and the other four minor products (94, 99, 100 and 101) (Figure 1.17). 
Formation of multiple products by a single enzyme is a common feature of terpenoid 
synthases and this fact may be caused by the typical electrophilic reaction mechanism. 
A number of highly reactive carbocationic intermediates were generated during 
enzymatic reaction, which would increase the chance of side reactions to produce 
minor products (78).
(£)-a-ber|arnotene sesquisabinene (99) zingibereue (100) p-bisaboleue (94) sesquiphellandrene (101)
Figure 1.17: Structure o f  hydrocarbons generated by EBFS from Mentha x piperita (A) and 
Zea mays (B).
Comparison of the amino acid sequence of EBFS from A. annua with EBFSs from 
other sources reveals an identity/similarity between 21/39% and 42/61%. However, 
the amino acid sequence of EBFS from A. annua shows considerably high similarity 
to other sesquiterpene synthases from the same plant (the four Artemisia
A
(£)-P-famesene (65) (Z)-P-famesene (97) 5-cadinene (79)
B
sesquiterpene synthases show an identity/similarity between 47/65% and 59/78% 
(727)). This fact suggests that the level of amino acid sequence similarity between the 
sesquiterpene synthases containing identical catalytic specificities from different 
species can be lower than the similarity between sesquiterpene synthases catalysing 
completely different reactions but from the same plant.
The cDNA encoding EBFS from peppermint (Mentha x piperita) was utilized in our 
studies. The 1653 bp open reading frame encodes a protein of 550 amino acids with 
deduced molecular mass of 63829. Like most other known class I terpenoid synthases, 
the magnesium-binding aspartate-rich (D301DXXD305) and N ^ S 4 4 ^ 452 motifs are 
present (57).
The deduced amino acid sequence of EBFS is quite similar to some other plant 
sesquiterpene synthases (see Appendix). The primary structure of EBFS is most 
similar to that of e/?z'-aristolochene synthase from tobacco (exhibiting 
identity/similarity of 49/62%). It also closely resembles three other angiosperm 
sesquiterpene synthases: vetispiradiene synthase from Hyoscyamus muticus, 
6 -cadinene synthase from cotton and germacrene C synthase from tomato (showing 
an identity/similarity between 34/57% and 40/63%) (775).
Interestingly, peppermint EBFS exhibits a comparable degree of similarity to both 
angiosperm and gymnosperm terpenoid synthases. For example, peppermint EBFS 
shows an identity/similarity of 30/51% with limonene synthase from spearmint and 
29/50% with sabinene synthase from culinary sage. It also resembles terpenoid 
synthases from the gymnosperm Abies grandis with identity/similarity of 28/49% for 
monoterpene synthases, 29/53% for sesquiterpene synthases and 28/51% for diterpene 
synthases (775). These amino acid sequence-based relationships indicate a bifurcation 
in the evolution of the monoterpene synthases from the higher terpenoid synthases 
that is as ancient as the separation between the angiosperms and gymnosperms.
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1.4.5 Diterpene synthases
Diterpene synthases catalyze the cyclization of geranylgeranyl diphosphate (C20) to 
form a variety of cyclic and polycyclic products. Plant diterpene synthases are 
triple-domain enzymes, which makes them the largest terpenoid synthases (800-900 
residues) (130). The three domains have been suggested to be formed by fusion of 
single-domain and double-domain bacterial diterpene synthases (131).
The first crystal structure of diterpene synthase was solved for taxadiene synthase 
from Taxus brevifolia in 2011 (130). Taxadiene synthase contains three a-helical 
domains including both class I and class II terpenoid synthase folds (Figure 1.18). The 
conserved motifs (DDXXD and (N,D)XX(S,T)XXXE) were identified in the 
C-terminal domain, suggesting that it functions as a class I terpenoid synthase. The 
N-terminal domain (M107-I135 and S349-Q552) together with the insertion domain 
(S136-Y348) adopt the class II terpenoid synthase fold with the unique double 
a-barrel fold tertiary structures, but the conserved DXDD motif among class II 
terpenoid synthases was absent in taxadiene synthase. The unique insertion domain 
was found in most plant diterpene synthases with conserved amino acid sequence and 
position (132). However, the absence of the characteristic DXDD motif and an active 
site cavity makes it a non-functional domain. On the other hand, the C-terminal 
domain was determined to be the functional active domain and the analysis of 
N-terminal truncation variants showed an essential role for the N-terminal domain in 
catalysis too (133).
5 0
N-terminus
Active site
C-terminus
Figure 1.18: Cartoon representation o f taxadiene synthase (PDB 
3P5R). The C-terminal domain is coloured green, the N-terminal 
domain is coloured cyan and the insertion domain is coloured orange.
Investigations with different substrate analogues suggest a cyclization mechanism 
(133-135), in which the C14-C15 double bond, the C10-C11 double bond and the 
diphosphate leaving group are optimally aligned for departure o f the diphosphate 
group before the formation o f a verticillen-12-yl carbocation intermediate (102). 
Subsequent modification steps involve a proton transfer and a ring closure, followed 
by a deprotonation terminating step to yield taxa-4(5),l l(12)-diene (105) (Scheme 
1.19).
51
GGDP (6)
OPP
verticillen-12-yl cation (102)
H
taxa-4,11-diene (105)
B
taxen-4-yl cation (104) verticillen-8-yl cation (103)
Scheme 1.19: Biosynthesis o f taxa-4,11-diene from GGDP.
The crystal structure of taxadiene synthase complexed with the substrate analogue 
2-fluoro-geranylgeranyl diphosphate reveals a similar magnesium cluster-diphosphate 
moiety binding fashion as other class I terpenoid synthases (Figure 1.19) (130). 
Asp613 and Asp617 (the first and the last aspartate residues from DDXXD motif) 
coordinate with M g2+A and M g2+c; M g2+B ion is chelated by N757, T761 and E765 
from the other magnesium binding motif on the opposite side of the active site. The 
diphosphate moiety can also form a hydrogen bond with R754 and makes 
water-mediated hydrogen bonds with Y688, E691, Y835, S713, R768 and Q770, 
which would possibly further stabilize the diphosphate group upon binding in the 
active site. In addition, the conformational change initiated by ligand binding that has 
been observed for the other class I terpenoid synthases is also proposed for the active 
site conformation of taxadiene synthase (130). The active site volume of taxadiene 
synthase is determined to be larger than the volume of the product taxadiene and this 
could explain the promiscuity of the enzyme since the shape of the active site contour 
should be more product-like for high fidelity terpenoid synthases.
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Figure 1.19: Cartoon representation o f  the active site o f  taxadiene 
synthase complexed with three magnesium ions (shown as green 
spheres) and substrate analogue 2-fluoro-geranylgeranyl diphosphate 
(2F-GGDP) (PDB 3P5R). Residues from the two magnesium binding 
motifs are shown as sticks.
The structure o f taxadiene synthase could generally illustrate the structure-function 
relationships in other diterpene synthases that contain catalytically active class II 
terpenoid synthase domains. For example, the bifunctional diterpene synthase 
abietadiene synthase from the grand fir tree is constructed from both class I and class 
II terpenoid synthase functional domains (136). The cyclization of GGDP is first 
carried out in the class II terpenoid synthase domain by protonation to form 
(+)-copalyl diphosphate as an intermediate and the class I terpenoid synthase can then 
catalyze the ionization dependent cyclization o f (+)-copalyl diphosphate to generate 
abietadiene (137) (Scheme 1.20). In another diterpene synthase, copalyl diphosphate 
synthase, only the class II terpenoid synthase is functional; the class I terpenoid 
synthase domain has even lost the signature metal ion binding motifs (138).
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(+)-copalyl diphosphate (106)
abietadiene (107)
'OPP 'OPP
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neoabietadiene (109)
Scheme 1.20: Biosynthesis o f (+)-copalyl diphosphate and abietadiene from GGDP.
1.4.6 Triterpene synthases
Triterpene synthases catalyze the cyclization of the linear C30 substrates squalene or
2,3-oxidosqualene to generate various fused-ring compounds (139, 140). The 
triterpene synthases are defined as class II terpenoid synthases due to their unique 
double a-barrel fold tertiary structures, which are distinct from the characteristic 
a-helical fold of class I terpenoid synthases (92). The reaction cascade was initiated 
by protonation of a carbon-carbon double bond in squalene or by epoxide protonation 
and ring opening in squalene oxide (57). Although triterpene synthases catalyse
cyclisations by employing a longer substrate than monoterpene synthases and 
sesquiterpene synthases, they can also generate products with high structural and 
stereochemical precision. A key structure among triterpene synthases is the 
aspartate-rich motif (DXDD), which does not chelate metal ions as for class I 
terpenoid synthase, but functions as the proton donor to initiate the cyclization. For 
example, squalene-hopene synthase catalyses the cyclization of squalene (7) to form 
the pentacyclic hydrocarbon hopene (110) (Scheme 1.21).
Squalene-hopene
synthase
Hopene (110)Squalene (7)
Scheme 1.21: Biosynthesis o f hopene from squalene.
The crystal structure of squalene-hopene synthase from Alicyclobacillus 
acidocaldarius reveals a dimeric enzyme and each subunit contains two domains 
(Figure 1.20) (141). Domain 1 adopts a double ot6-barrel fold with helices within each 
barrel parallel to each other. Domain 2 contains a similar a -a  barrel fold but each 
layer arranges in an irregular pattern. Some long loops from the inner barrels of both 
domains form a small (3 structure and enclose a central hydrophobic active site cavity 
(141). Eight QW-sequence motifs were discovered from the amino acid sequence of 
squalene-hopene synthase, in which seven of the eight motifs assume virtually 
identical polypeptide conformations. The side chains of the Q and W sequences can 
form hydrogen bonds with the amino end group of the adjacent outer barrel helix and 
with the carbonyl end moiety of the preceding outer barrel helix respectively, thus 
stabilizing the whole protein (142).
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C-terminu! N-terminus
Domain 1
Active site-
Domain 2
Figure 1.20: Cartoon representation o f  squalene-hopene synthase (PDB 
2SQC). The external barrel helices are coloured red, the internal barrel 
helices are coloured green, the ^-sheets are coloured yellow and the 
QW-motifs are coloured blue.
The active site o f squalene-hopene synthase contains a variety o f hydrophobic and 
aromatic residues, defining a hydrophobic active site template. The crystal structure 
o f the enzyme complex with the nonreactive substrate analogue 
3,6,9,12-tetraoxaicosan-l-ol showed a product-like binding, suggesting the active site 
template is able to enforce the pre-catalytically productive conformation of the large, 
flexible substrate squalene (Figure 1.21) (143). The aspartate motif (DXDD) has been 
identified at the polar top o f the active site cavity. The catalytic function of this motif 
in squalene-hopene synthase has been established by site-directed mutagenesis studies, 
in which Asp376 (the second aspartate residue o f the motif) seems to help protonate 
the C3 atom o f substrate squalene. The mutation D376E reduces the catalytic activity 
by 10-fold and the D376G and D376R mutants are inactive (144).
Since the pKa o f the aspartate side chain is around 4 and the enzymatic reaction was 
performed in the sodium citrate buffer system (pH 6), the Asp374, Asp376 and 
Asp377 were expected to be in their deprotonated form. However, in the crystal
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structure o f squalene-hopene synthase, Asp374 and Asp377 are hydrogen-bonded (2.6 
A distance) and this structure is close to another hydrogen-bonded pair (Asp376 and 
His 451). It was proposed that the Asp374:Asp377 hydrogen bonded pair carries a 
negative charge that stabilises the positive charge on the Asp376:His451 hydrogen 
bonded pair and thus the Asp376 could be stabilised in its protonated form (141).
3,6,9,12-tetraoxaico san-1
Figure 1.21: Cartoon representation o f  the active site o f
squalene-hopene synthase complexed with substrate analogue 
3,6,9,12-tetraoxaicosan-l-ol (shown as sticks) (PDB 2SQC). Residues 
from the aspartate-rich motif are shown as sticks.
Notably, the amino acid residues in the upper region o f the active site (i.e., the polar 
Asp376 region) are more conserved than the ones in the lower region compared to 
other triterpene synthases. This suggests that the protonation step common to squalene 
and oxidosqualene synthases occurs in the conserved region o f the cavity. The 
divergence o f amino acid composition in the lower region o f the active site cavity 
among triterpene cyclases will thus determine the divergent biosynthetic reactions 
(141).
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1.4.7 Genomic organization of plant terpenoid synthase
It has been suggested that the precursors and pathways for the generation of natural 
products most likely arose from mutations of enzymes involved in the synthesis of 
primary metabolites (145). The natural products evolved to increase the survival 
fitness of the producing organism under the pressure of natural selection (146). 
However, it is hard to address the evolutionary origins of natural products and their 
complex biosynthetic pathway due to the remarkable diversity of compounds, lack of 
relevant biosynthetic enzymes and the inability to distinguish between compounds 
involved in primary and secondary metabolism based on structure alone.
The evolution of the terpenoid synthase gene family can serve as an instructive model 
to present the origins of natural products since terpenoids are the largest class of 
natural products and play a variety of roles in primary and secondary metabolism. A 
study based on 21 terpenoid synthases gene proposed that the ancestral terpenoid 
synthase contains 12-14 introns and 13-15 exons (Figure 1.22) (145). It was also 
pointed out that the plant terpene synthases involved in secondary metabolism have a 
common ancestral origin from a terpenoid synthase involved in primary metabolism 
and terpenoid synthases went through gene duplication and divergence several times 
to create enzymes of both primary and secondary metabolism. The structural variation 
among the terpenoid synthase genes is consistent with an experimentally 
demonstrated process of concerted intron loss, thus providing a possible explanation 
for the derivation of terpenoid synthases of natural products biosynthesis from those 
of primary metabolism (147).
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Figure 1.22: General structure o f  plant terpene synthase genes (145). Introns 1-14 (Roman 
numerals in figure) are represented by black vertical bars and exons 1-15 are depicted by 
coloured boxes.
Repeated duplication o f the ancestral gene and divergence by functional and structural 
specialization have been proposed as the common evolutionary process for the 
derivation o f large gene families (148, 149). In addition, it seems most reasonable to 
assume that the precursors and pathways for the generation o f secondary metablic 
products arose from mutations o f enzymes involved in the synthesis o f primary 
metabolites (148). Under the pressure o f natural selection, secondary metabolic 
products evolved as compounds with important ecological functions, which increased 
the chance o f survival o f the organism. This assumption provides an explanation for 
the mechanism o f the origin and evolutionary relationship o f plant terpenoid synthase 
genes and their encoded enzymes.
In addition, the analysis suggests that the genes encoding terpenoid synthases from 
both gymnosperms and angiosperms derive from a common ancestor (145). The 
subsequent ancestral gene products diverged in function under the pressure o f natural 
selection to generate the large family o f terpenoid synthases involved in both primary 
and secondary metabolic pathways. Although speculative, it is plausible that the early 
terpenoid synthase ancestors were designed to be less specific enzymes, able to utilize 
different sized prenyl diphosphate substrates for the production o f multiple products. 
The subfamilies o f terpenoid synthases such as monoterpene synthases, sesquiterpene 
synthases and diterpene synthases were developed much later during evolution. In
1 T ‘  1fl I T b 10 11 12 | l 3 |  14 1 151
DDXXD
motif
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summary, the gene organization may have played an essential role in divergence of 
terpenoid structures and the ecological interactions that they mediate. Although the 
evolutionary connections are unclear, the absence of the conifer diterpene internal 
sequence domain in the angiosperm and gymnosperm monoterpene and sesquiterpene 
synthase could be significant for terpene structural diversification. Further more, the 
genetic changes are closely related with an important structural aspect of the terpene 
synthases. Thus, considerable genetic variation occurs in the N-terminal region (with 
no known function) of the terpene synthase genes, whereas the C-terminal region 
(formation of the active site) remains highly conserved in organization and catalytic 
function.
Phylogenetic analysis of the deduced amino acid sequences of 33 terpenoid synthases 
from both angiosperms and gymnosperms allows subdivision of the terpenoid 
synthase (Tps) gene family into six subfamilies, designated Tpsa through Tpsf, each 
distinguished by sharing a minimum of 40% identity among members (132). The 
majority of terpene synthases analysed produce secondary metabolites, including 
members of subfamilies Tpsa (sesquiterpene and diterpene synthases from 
angiosperms), Tpsb (monoterpene synthases from angiosperms of the Lamiaceae), 
Tpsd (11 gymnosperm monoterpene, sesquiterepene and diterpene synthases) and the 
distant and possibly ancient Tpsf branch containing linalool synthase. The other three 
subfamilies, Tpsc, Tpse and Tpsf, are represented by the single angiosperm terpene 
synthase types copalyl diphosphate synthase, kaurene synthase and linalool synthase, 
respectively. The first two subfamilies are diterpene synthases involved in early steps 
of gibberellin biosynthesis. These two are grouped into a single clade and are 
involved in primary metabolism.
1.5 Aims
Comparison of the deduced amino acid sequences of the isolated plant sesquiterpene
synthases reveals significant conservation among them, which can be explained by the
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conserved exon organization observed between their genes. The derivation of this 
large gene family was proposed to be related to functional mutations that had been 
retained during gene duplication by natural selection. This proposal provides a 
reasonable explanation for the mechanism of origin and evolutionary relationship of 
plant sesquiterpene synthase genes and their encoded enzymes.
This project consisted of three parts. The first part of the study focused on DCS, 
which was aimed to ascribe functional roles for particular amino acid positions and 
subdomains encoded by conserved exons. A homology model of DCS based on the 
crystal structure of epi-aristolochene synthase (PDB 5EAT) was created using the 
SWISS-MODEL automated homology modelling server. The mutagenesis studies 
mainly relied on this model because the crystal structure of DCS was solved two years 
after this work had been started (114). Mutational replacement of variable residues 
within and surrounding the active site between DCS and germacrene C synthase (GCS) 
was intended to provide an insight into the relationship between the chemical 
environment of the active site and the product outcome. The role of the DDXXD 
motif was also investigated by site-directed mutagenesis studies. In addition, the 
critical structural elements in defining product outcome were to be determined by 
domain swap experiments.
The second part of the project was aimed at examining the influence of the active site 
volume of EBFS on the product outcome. A homology model of EBFS based on the 
crystal structure of DCS (PDB 3G4F) was created using the SWISS-MODEL 
automated homology modelling server and the mutagenesis studies mainly relied on 
this model. Mutants with enlarged or refined active site were designed to try to 
facilitate cyclization reactions in the modified active site pocket. The active site cavity 
was further modified by swapping residues from the active site of EBFS with 
corresponding ones from DCS to demonstrate the importance of active site volume.
The final part of the project was aimed to investigate the function of N-terminal
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domains of EBFS and DCS, which were previously defined as non-catalytic domains. 
Truncated mutants, chimeras and site-directed mutants were designed to determine 
the role of N-terminal domain in catalysis.
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Chapter 2: Materials and Methods
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2.1 Materials
All chemicals were purchased from Sigma-Aldrich UK, Fisher Scientific Ltd or 
Melford, unless otherwise stated. FDP (150% 2F-FDP (112% 2F-GDP (151) and 
(J£)-p-2-fluoro-famesene (112,135) were synthesised by Dr. Juan A. Faraldos and Dr. 
David J. Miller (Cardiff University). [1-3H]-FDP (20 Ci/mmol) was purchased from 
American Radiolabeled Chemicals, Inc. DEAE anion exchange resins were purchased 
from GE Healthcase. Amicon YM30 membranes were purchased from Millipore. 
EcoScint scintillation fluid was purchased from National Diagnostics. All restriction 
enzymes were purchased from New England Biolabs or Promega. All chemicals were 
used in accordance with their material safety data sheets, COSHH and risk 
assessments. All oligonucleotides were purchased from Operon Technologies 
(Cologne, Germany). The wild type gene encoding 8-cadinene synthase was obtained 
from Dr. Xiao-Ya Chen (100) and subcloned into pET21d by Dr. Susan E. Taylor 
(University of Birmingham). The wild type cDNA of (£)-p-famesene synthase was 
obtained from Dr Linda M. Field (Rothamsted Research, UK) and subcloned into 
pET32b by Dr. Athina Deligeorgopoulou (University of Birmingham).
2.2 M edia
2.2.1 Luria-Bertani medium
LB medium was prepared by dissolving 10 g tryptone, 10 g NaCl, 5 g bacto-yeast 
extract in 1L deionised water and adjusted the pH. to 7. The solution was sterilised in 
an autoclave at 121 °C, 15 lb.(sq. in)'1 for 20min.
2.2.2 LB agar
LB agar plates were made up by mixing 7.5 g of agar with 500 mL of LB media. The 
solution was autoclaved and cooled to under 50 °C and 100 mg of ampicillin was 
added. The mixture was then divided into Petri dishes (around 20 mL per dish) and 
left to solidify. The plates were stored at 4 °C.
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2.3 Sterile solutions
2.3.1 Antibiotics
Ampicillin was dissolved in ethanol (50% v/v) to a concentration of 100 mg/mL. The 
solution was sterilised using a 0.2 pm syringe filter, aliquoted and stored at -20 °C. A 
working concentration of 0.1 mg/mL was used.
2.3.2 Isopropyl-f3-D-l-thiogalactopyranoside (IPTG)
IPTG (360 mg) was dissolved in 1 mL of deionised water for use at a working 
concentration of 0.12 mg/mL. The solution was sterilised using a 0.2 pm syringe filter, 
aliquoted and stored at -20 °C.
2.3.3 Ethylenediaminetetraacetic acid (EDTA)
EDTA (1.46 g) was added to 450 mL deionised water. The solid was dissolved by 
adjusting the pH to 8.0 with 5 M sodium hydroxide and the total volume taken to 500 
mL with deionised water. The solution was sterilised using a 0.2 pm syringe filter and 
stored at room temperature. Stock and working concentrations were 10 mM and 0.1 
mM respectively for enzyme storage.
2.3.4 Dithiothreitol (DTT)
DTT (154 mg) was dissolved in 100 mL deionised water to give a stock concentration 
of 10 mM. The solution was sterilised using a 0.2 pm syringe filter and stored at 4 °C. 
The working concentration was 1 mM for enzyme storage.
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2.3.5 Competent cell solutions
2.3.5.1 Rubidium chloride preparation o f competent cells
Rubidium chloride solution 1 (Rbl) was prepared by dissolving potassium acetate 
(294 mg, 30 mM), rubidium chloride (1.21 g, 100 mM), calcium chloride (110.98 mg, 
10 mM), manganese chloride (692 mg, 55 mM) and glycerol (15% v/v) in 80 mL of 
deionised water. The pH was adjusted to 5.8 with dilute acetic acid and the total 
volume adjusted to 100 mL with deionised water. The solution was sterilised using a 
0.2 pm syringe filter and stored at 4 °C.
Rubidium chloride solution 2 (Rb2) was prepared by dissolving 3-(N-morpholino) 
propanesulfonic acid (MOPS) (209 mg, 10 mM), rubidium chloride (121 mg, 1 mM), 
calcium chloride (832 mg, 7.5 mM) and glycerol (15% v/v) in 80 mL of deionised 
water. The pH was adjusted to 6.5 with dilute sodium hydroxide and the total volume 
adjusted to 100 mL with deionised water. The solution was sterilised using a 0.2 pm 
syringe filter and stored at 4 °C.
2.4 Non-sterile solutions
2.4.1 dNTPs
Stock solutions of each dNTP were purchased 
were diluted to a working concentration of 10 
and stored at -20 °C.
2.4.2 Ethidium bromide
8.1 g of ethidium bromide was dissolved in 100 mL of deionised water to make a 25 
pM stock solution and stored in the dark at 4 °C. Immediately prior to gel staining, a 
working concentration of 6 pM was prepared by diluting 48 pL of stock solution into 
200 mL of deionised water.
at a concentration of 100 mM. These 
mM using deionised water, aliquoted
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2.4.3 lOx DNA loading dye
Bromophenol blue (2.5 mg) and sucrose (400 mg) were dissolved in 1 mL of 
deionised water and store at room temperature. This gave stock concentrations of 3.7 
mM and 1.2 mM respectively. The dye was diluted 1:9 with each DNA sample 
immediately prior to use.
2.4.4 TAE buffer stock (50x) for agarose gels
0.5 M EDTA solution was prepared by dissolving 14.61 g EDTA in 80 mL of 
deionised water. The pH was adjusted to 8.0 with 5 M NaOH and the total volume 
was adjusted to 100 mL.
Tris base (242 g, 2 M), glacial acetic acid (57.1 mL, 7.5 M) and 0.5 M EDTA solution 
(100 mL) were mixed with 800 mL of deionised water. The total volume was adjusted 
to 1 L with deionised water after the entire Tris base was completely dissolved. The 
solution was stored at room temperature and was diluted 50 fold with deionised water 
prior to use.
2.4.5 SDS stacking buffer
Tris base (6 g, 0.5 M) was dissolved in 80 mL of deionised water and the pH adjusted 
to 6.8 with 6 M HC1. The total volume was adjusted to 100 mL with deionised water 
and stored at 4 °C.
2.4.6 SDS resolving buffer
Tris base (27.23 g, 1.5 M) was dissolved in 100 mL of deionised water and the pH 
adjusted to 8.8 with 6 M HC1. The total volume was adjusted to 150 mL with 
deionised water and stored at 4 °C.
6 7
2.4.7 10% (w/v) Sodium dodecyl sulfate (SDS)
Sodium dodecyl sulfate (10 g) was dissolved in 90 mL of deionised water. After the 
solid was fully dissolved, the total volume was adjusted to 100 mL and the solution 
was stored at room temperature.
2.4.8 10% (w/v) Ammonium persulfate
Ammonium persulfate (100 mg) was dissolved in 1 mL of deionised water. The 
solution was stored at 4 °C.
2.4.9 SDS electrode running buffer (lOx)
Tris base (30.3 g, 250 mM), glycine (150 g, 2 M) and sodium dodecyl sulfate (10.0 g) 
were fully dissolved in 900 mL of deionised water. The total volume was adjusted to 
1 L and stored at 4 °C. The concentrated solution was diluted 10 fold prior to use with 
deionised water.
2.4.10 SDS gel stain solution
Coomassie brilliant blue (0.25 mL) and glacial acetic acid (10 mL) were fully 
dissolved with 40 mL deionised water and 45 mL ethanol. The total volume was 
adjusted to 100 mL with deionised water and the solution was stored at room 
temperature.
2.4.11 SDS gel destain solution
Glacial acetic acid (100 ml) and isopropanol (120 ml) were mixed with 750 mL 
deionised water. The total volume was adjusted to 1 L and stored at room 
temperature.
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2.4.12 Protein purification lysis buffers
The lysis buffer for purification of wild-type DCS was prepared by adding Tris base 
(2.42 g, 20 mM), EDTA (1.75 g, 6 mM) and |3-mercaptoethanol (350 pL) to 900 mL 
deionised water. The pH was adjusted to 8 with 5 M NaOH and the total volume 
adjusted to 1 L with deionised water.
The lysis buffer for purification of wild-type EBFS was prepared by adding MOPS 
(4.2 g, 20 mmol), EDTA (1.75 g, 6 mM) and p-mercaptoethanol (350 pL) to 900 mL 
deionised water. The pH was adjusted to 7.2 with 5 M NaOH and the total volume 
adjusted to 1 L with deionised water.
Both lysis buffers were degassed via vacuum pumping (Vacuubrand GmbH +CO KG, 
MD4C, Wertheim, Germany) and stored at room temperature.
2.4.13 Protein dialysis buffer
For wild-type DCS, Tris-base (4.8 g, 10 mM) and p-mercaptoethanol (1.4 mL) were 
added to 3.8 L deionised water. The pH was adjusted to 7.5 with 5 M NaOH and the 
total volume adjusted to 4 L with deionised water.
For wild-type EBFS, MOPS (8.4 g, 10 mM) and (3-mercaptoethanol (1.4 mL) were 
added to 3.8 L deionised water. The pH was adjusted to 7.2 with 5 M NaOH and the 
total volume adjusted to 4 L with deionised water.
Both dialysis buffers were prepared fresh each time and dialysis was performed at 
4 °C.
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2.4.14 DNA miniprep buffers
2.4.14.1 Buffer PI (suspension buffer)
Tris-HCl (157.6 mg 50 mM), EDTA (58.448 mg, 10 mM) and RNase A (50 p,g/mL 
final concentration) were dissolved in 15 mL of deionised water. The pH was adjusted 
to 8.0 and the total volume adjusted to 20 mL with deionsed water. The solution was 
stored at 4 °C.
2.4.14.2 Buffer P2 (lysis buffer)
NaOH (4 g, 0.4 M) and SDS (5 g, 2% w/v) were dissolved separately in 200 mL of 
deionised water. Both solutions were combined and the total volume was adjusted to 
500 mL. The solution was stored at room temperature.
2.4.14.3 Buffer N3 (neutralization and binding buffer)
Guanidine hydrochloride (7.6 g, 4 M) and potassium acetate (981.4 mg, 0.5 M) were 
dissolved in 15 mL of deionised water. The pH was adjusted to 4.2 and the total 
volume was adjusted to 20 mL with deionised water and the solution was stored at 
room temperature.
2.4.14.4 Buffer PB (wash buffer)
Guanidine hydrochloride (9.5 g, 5M), Tris-HCl (63.0 mg, 20 mM) and ethanol (7.6 
mL, 38% v/v) were added to 8 mL of deionised water. The pH was adjusted to 6.6 and 
the total volume was adjusted to 20 mL with deionised water. The solution was stored 
at room temperature.
2.4.14.5 Buffer PE (wash buffer)
NaCl (23.4 mg, 20 mM), Tris-HCl (6.3 mg, 2 mM) and ethanol (16 mL, 80% v/v) 
were added to 2 mL of deionised water. The pH was adjusted to 7.5 and the total
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volume was adjusted to 20 mL with deionised water. The solution was stored at room 
temperature.
2.4.14.6 Buffer EB (Elution buffer)
Tris-HCl (32 mg, 10 mM) was dissolved in 15 mL of deionised water. The pH was 
adjusted to 8.5 and the total volume was adjusted to 20 mL with deionised water. The 
solution was stored at room temperature.
2.4.15 Agarose gel DNA isolation buffers
2.4.15.1 Buffer QG (gel solubilisation buffer)
Guanidine thiocyanate (13 g, 5.5 M) and Tris-HCl (6.3 mg, 20 mM) were dissolved in 
15 mL of deionised water. The pH was adjusted to 6.6 and the total volume was 
adjusted to 20 mL with deionised water. The solution was stored at room temperature.
2.4.15.2 Buffer PE (wash buffer)
NaCl (23.4 mg, 20 mM), Tris-HCl (6.3 mg, 2 mM) and ethanol (16 mL, 80% v/v) 
were added to 2 mL of deionised water. The pH was adjusted to 7.5 and the total 
volume was adjusted to 20 mL with deionised water. The solution was stored at room 
temperature.
2.4.15.3 Buffer EB (Elution buffer)
Tris-HCl (32 mg, 10 mM) was dissolved in 15 mL of deionised water. The pH was 
adjusted to 8.5 and the total volume was adjusted to 20 mL with deionised water. The 
solution was stored at room temperature.
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2.5 E. coli strains and their preparation
2.5.1 Cloning strain
XL 1-Blue competent cells (Stratagene, CA, USA) with genotype (recAl endAl 
gyrA96 thi-1 hsdR17 supE44 relAl lac [F' proAB lacIqZAM15 TnlO (Tetr)]) were 
used for routine cloning purposes, such as following site-directed mutagenesis. High 
quality miniprep DNA could also be produced from this strain for sequencing 
purposes.
2.5.2 Expression strains
BL21(DE3) competent cells (Stratagene, CA, USA) with genotype (E. coli B F' dcm 
ompT hsdS(rB' mB’) gal A,(DE3)) were used for expression of wild-type DCS, whilst 
BL21-CodonPlus(DE3)-RP competent cells (Stratagene, CA, USA) with genotype (E. 
coli B F' ompT hsdS(rB‘ mB') dcm+ Tetr gal X,(DE3) endA Hte [argU proL Camr]) 
were used for expression of wild-type EBFS. BL21-CodonPlus(DE3)-RIL competent 
cells (Stratagene, CA, USA) with genotype (E. coli B F' ompT hsdS(rB' mB') dcm+ 
Tetr E. coli gal X (DE3) endA Hte [argU ileY leuW Camr]) were used for expression 
of N-terminal region chimera D24AAE. All strains contain the XDE3 lysogen that 
carries the gene encoding T7 RNA polymerase under the control of the lacUV5 
promoter.
2.5.3 Preparation of competent cells
Competent cells were streaked on a non-selective plate by a wire loop. The same 
competent cells were also streaked on an ampicillin plate as a negative control. Both 
plates were incubated at 37 °C overnight. 5 mL of LB medium without antibiotics was 
inoculated with a single colony from the non-selective plate and incubated at 37 °C 
until an optical density at 600 nm of 0.6 was reached. The cultures were then cooled 
down on ice for 15 min. Cells were harvested in a Thermo IEC 243 Centra CL3R 
centrifuge (Thermo Fisher Scientific Inc, USA) at 4000 RPM and 4 °C for 10 min and
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the supernatant discarded. The cell pellet was resuspended in 5 mL Rbl solution 
(Section 2.3.2), incubated on ice for 20 min and the centrifugation step repeated. The 
resulting cell pellet was resuspended with 6 mL Rb2 solution, aliquoted (50 pL) into 
sterile Eppendorf tubes and flash frozen in liquid nitrogen for storage at -80 °C.
2.5.4 Transformation protocol and controls
The frozen competent cells were allowed to thaw on ice for about 5 min. 2 pL of 
ice-cold DNA solution was mixed with the competent cells using a pipette tip under 
sterile conditions. The cell/DNA mixture was incubated on ice for 20 min, heat 
shocked at 42 °C in a water bath for 40 s and returned to ice for a minimum of 2 min. 
500 pL of LB medium without antibiotics was added to the cell/DNA mixture and 
incubated at 37 °C for 1 hr. Cells were harvested by centrifugation for 1 min at 15,700 
RPM (Eppendorf centrifuge 5415) and the supernatant discarded. The cell pellet was 
resuspended in 100 pL of LB medium, plated on agar plates containing the 
appropriate antibiotic and incubated at 37 °C overnight. A negative control was 
always included by replacing the DNA solution with sterile water. A positive control 
was also included by transforming cells with wild-type DNA.
2.6 DNA manipulation
2.6.1 Polymerase chain reaction (PCR)
The gene amplification and site-directed mutagenesis work was carried out by 
employing the Polymerase Chain Reaction (PCR) using short oligonucleotide primers. 
For all cloning work described here, Pfu polymerase from the bacterium Pyrococcus 
furiosus was used at 72 °C. This enzyme has a 3’ to 5’ proofreading activity and 
produces blunt-ended PCR products. The low error rate of this polymerase in PCR is 
roughly 106 per base pair duplicated (152).
The double stranded template DNA (dsDNA) was first denatured at 95 °C to form
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two single stranded DNA (ssDNA) molecules. The temperature was then lowered to 
between 45-65 °C to allow primers to anneal to the template ssDNA. DNA 
polymerases synthesised new DNA strands complementary to the template DNA by 
adding dNTPs that were complementary to the template in a 5’ to 3’ fashion. The 
primers would be extended along the whole length of the DNA template and a 
‘daughter’ DNA duplex was formed and the cycle could start again. A final 
elongation step was applied after the last cycle to finish synthesis of any partially 
completed fragments.
The primers were designed according to the instruction manual of the 
QuikChangeTM Site-Directed Mutagenesis Kit. Both primers (forward and reverse) 
must contain the desired mutation and anneal to the same sequence on complementary 
strands of the DNA. The primers should contain between 25 and 45 bases and the 
desired mutation should be in the middle of the primer. The percentage of GC should 
be at least 40%.
To amplify genes of interest and to make site mutations, a general PCR recipe was 
used (Tables 2.1 and 2.2).
Table 2.1: Components o f the PCR reaction.
Component Volume (pL)
dNTPs (40 mM total, 10 mM each NTP) 1
Forwards primer (100 pM) 4
Backwards primer (100 pM) 4
Template dsDNA (-0.01 pmol) 1
lOx Pfu buffer 5
MgSC>4 (50 mM stock, 1.0 mM working concentration) 1
Pfu polymerase (2-3U/pL) 1
Deionised water 33
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Table 2.2: Temperature and duration o f the PCR cycles.
PCR cycles Temperature (°C) Time (min)
Initial denaturation 95 2
Denaturation 95 1
Annealing -55 0.5
Primer extension 72 2 min per kilobase
Final extension 72 5
Dpnl restriction enzyme (target sequence: 5’-GATC-3’ with methylated alanine) was 
used to digest template DNA following site directed mutagenesis, ensuring only 
mutated DNA was left intact. The digestion was performed immediately after site 
directed mutagenesis at 37 °C for 1 hr.
2.6.2 Restriction digestion of DNA and controls
For each restriction digest, the manufacturer’s guidelines were followed with regard 
to operating buffers, temperatures and denaturation steps. £coRI and Sacl were used 
sequentially for excision of the aristolochene synthase gene from pET21 vector when 
required. Both restriction endonucleases were incubated at the same temperature 
(37 °C) for 6 hours and then were heated inactivated at 65 °C for 20 minutes. NheI 
and BamHl were used sequentially for excision of the C-terminal EBFS gene from 
pET32 vector when required. Both restriction endonucleases were incubated at the 
same temperature (37 °C) for 6 hours and then were heated inactivated at 65 °C for 20 
minutes.
2.6.3 DNA visualisation, isolation and purification
Agarose gels were prepared by w/v ratio (usually 1%) with lxTAE buffer (Section 
2.4.3). Agarose gel electrophoresis was run at a constant electric current of 100 mA 
for 60 min and stained in diluted ethidium bromide solution for 10 min. DNA bands
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were visualised using a Syngene GeneFlash UV light box (Syngene, UK). The size of 
sample bands was estimated by comparison to a lkb DNA ladder. For agarose gel 
purification, the appropriate bands were excised from the gel using a clean scalpel 
blade and stored in a sterile eppendorf tube. DNA extraction was performed using the 
QIAquick gel extraction kit (QIAGEN, UK) according to the manufacturer’s 
instructions and stored at -20 °C.
For the determination of the concentration of DNA, a UV/VIS spectrophotometer was 
used. Nucleic acid, has a strong ultraviolet absorption at 280 nm, however absorbs 
much more strongly at 260 nm. Most proteins exhibit a characteristic ultraviolet light 
absorption at 280 nm due to the presence of tyrosine and tryptophan. An A260nm 
value of 1.0 indicates an approximate concentration of 50 pg ml-1 double stranded 
DNA, 40pg ml-1 single stranded DNA or 20pg ml-1 single stranded oligonucleotides. 
The ratio OD260nm / OD280nm is indicative of the purity of the DNA sample. Thus, 
when this ratio takes values between 1.8 and 2.0, the sample is pure, whilst lower 
values indicate contamination with proteins and/or lipids.
2.6.4 Constructions of DNA hybrids and truncated mutants
2.6.4.1 DCS-hybridl
The construct of DCS-hybridl was prepared by replacing the native GGT codon of 
G276 with TTC by site-directed mutagenesis. Together with the codon GAA that 
encodes amino acid E275, this mutation creates an £coRI restriction site. Another 
Sad  restriction site located after the stop codon was also employed to form the hybrid 
construct. The gene encoding aristolochene synthase was amplified from the genomic 
DNA via PCR using short complementary oligonucleotide primers designed to flank 
the gene of interest and provide overhanging EcoRl and Sad  restriction sites at the 5’ 
and 3’ end respectively. The restriction sites were introduced immediately prior to the 
start codon and immediately after the stop codon. The gene fragment that encodes the 
C-terminal domain of DCS was removed from the mutated plasmid by a double
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digestion with EcoBl and Sacl restriction enzymes. The opened plasmid was then 
ligated with the newly formed DNA fragment encoding aristolochene synthase, 
creating a plasmid containing the gene encoding DCS-hybridl.
2.6.4.2 DCS-hybrid2
The gene of DCS-hybrid2 was constructed using two native Sad  restriction sites 
identified in the plasmid containing the gene encoding DCS; one Sad  restriction site 
sequence encodes amino acids E318 and L319 and the other Sad  restriction site is 
located after the stop codon. A synthetic DNA fragment was designed to encode the 
amino acid sequence from E311 to the stop codon of GCS, with Sad  restriction sites 
at both the 5’ and 3’ end. The plasmid containing the gene encoding DCS was 
digested with Sad  restriction enzyme, dephosphorylated with Calf Intestinal Alkaline 
Phosphatase (CIP) and the longer DNA fragment was purified by agarose gel 
electrophoresis. The longer opened plasmid was then ligated with the synthetic DNA 
fragment encoding the 3’-terminal portion of the GCS gene.
2.6.4.3 EBFS active site hybrid
The construct of the hybrid was created by mutating the native codon TAT that 
encodes amino acid Y271 to AGC; together with the codon GCT that encodes amino 
acid A270, this mutation creates a NheI restriction site. A synthetic DNA fragment 
was designed to encode the amino acid sequence after V272 of EBFS with all the 
chosen mutations and constructed with Nhel and BamHl restriction sites at the 5’ and 
3’ end respectively. Double digestion of the mutated plasmid with Nhel and BamHl 
restriction enzymes and subsequent ligation with the synthetic DNA fragment formed 
a plasmid containing the gene encoding the hybrid.
2.6.4.4EBFSA14
The full-length cDNA for EBFS (1.6 kb) was initially cloned into the vector pET32b 
(5.9 kb) with an Ncol restriction site at the 5’ end. To construct the gene of EBFS A14,
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another Ncol restriction site was introduced into the DNA sequence of the wild-type 
enzyme. The foreign Ncol restriction site was formed by replacing the DNA fragment 
S’-GTAAGGCCA^’ that encodes Vail 4, Argl5 and Pro 16, with 
5’-GCCATGGCA-3’ using site-directed mutagenesis. The mutated plasmid was then 
treated with Ncol and the resulting large DNA fragment was intramolecularly ligated 
to give the desired plasmid.
2.6.4.5 EBFSA24
This mutant was prepared following a similar method to that used for constructing 
EBFSA14, by introducing an Ncol restriction site into the DNA sequence of the 
wild-type EBFS. The mutated plasmid was then treated with Ncol and the resulting 
large DNA fragment was intramolecularly ligated to give the desired plasmid.
2.6.4.6 D24AAE
The cDNA of D24AAE was created by ligation of the DNA encoding EBFSA24 
following Ncol digestion with a DNA fragment encoding the chosen amino acids 
from DCS. The smaller DNA fragment was designed to anneal with Ncol restriction 
sites at both ends.
2.6.4.7 E24AAD
The cDNA of E24AAD was prepared by ligation of the DNA encoding DCSA30 
(constructed by Dr. Veronica Gonzalez in our group) following Ncol digestion with a 
DNA fragment encoding the first 24 amino acids of EBFS. The insert DNA fragment 
was designed to anneal with the Ncol restriction sites at both ends.
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2.6.5 Plasmid purification
5 mL of ampicillin selective LB medium was inoculated by a single colony that was 
picked from an ampicillin selective plate containing the appropriate transformed cells. 
The mixture was incubated at 37 °C overnight, whilst shaking at 150 rpm in an 
Innova® 43 shaker (New Brunswick Scientific, UK). Cells were harvested by 
centrifugation for 10 min at 5000 RPM (Eppendorf centrifuge 5415R). Isolation of 
pure plasmid was performed using the QIAprep spin miniprep kit (QIAGEN, UK), 
following the manufacturer’s instructions.
2.6.6 DNA sequencing
Usually, the standard plasmid purification procedure described in Section 2.6.3 will 
give pure DNA at a concentration of ~50 pg/pL. DNA sequencing of plasmid 
constructs and site-directed mutagenesis products was performed by Lark 
Technologies (Cogenics, UK) and in the School of Biosciences, Cardiff University.
2.7 Protein production and purification
2.7.1 Small scale test expression
Prior to large scale production of any protein (Section 2.7.2), a small scale test 
expression was performed to ensure cells could be brought to an optical density of 0.6 
AU at 600 nm and the expression could be induced by IPTG. 100 mL of ampicillin 
selective LB medium was inoculated with 1 mL of overnight culture and allowed to 
grow at 37 °C to an optical density of 0.6 AU at 600 nm. IPTG (0.5 mM) was used to 
induce gene expression, which was allowed to grow at optimised temperature. Protein 
production was monitored by taking a 200 pL sample every hour for SDS-PAGE 
analysis (Section 2.7.8).
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2.7.2 Large scale expression
For protein production, the selected strain of competent cells (Section 2.5.2) were 
transformed with the appropriate DNA solution and incubated overnight on ampicillin 
selective agar plates at 37 °C. A single colony was picked and used to inoculate 100 
mL of ampicillin selective LB medium by incubating at 37 °C overnight whilst 
shaking at 150 rpm in an Innova® 43 shaker (New Brunswick Scientific, UK). The 
overnight pre-culture was used to inoculate ampicillin selective LB medium (5 mL 
per 500 mL final culture) and incubated at 37 °C whilst shaking as previously 
described until an optical density of 0.6 AU at 600 nm was reached. IPTG (0.5 mM) 
was then added into cells culture. For the expression of wild-type DCS, the cell 
culture was allowed to grow for another 4 hr at 37 °C. For the expression of wild-type 
EBFS, the cell culture was allowed to grow for another 7 hr at 16 °C.
Large scale protein production used 1.5 L of culture. Cells were harvested by 
centrifugation in a Sorvall RC5C Plus centrifuge (Thermo Fisher Scientific, USA) 
using an SLA-3000 rotor at 9000 RPM for 10 min and stored at -20 °C.
2.7.3 Glycerol stocks
0.8 ml of an overnight culture containing the plasmid of interest was aseptically 
transferred to a sterile 1.5 ml eppendorf. 0.15 ml of sterile glycerol was added and the 
resultant mixture was vortexed briefly and stored at -  80 ° C. Prior to use, the 
glycerol stock should be defrosted on ice and by the use of a sterile inoculating loop 
the sample was streaked on an agar plate containing proper antibiotics.
2.7.4 Base extraction
Frozen cell pellets (-10 g per 1.5 L culture) (See section 2.7.2) were allowed to thaw
on ice. Cells were resuspended in -100 ml protein purification lysis buffer (Section
2.4.9) and lysed by sonication on ice (3 sec sonication period followed by a 3 sec rest
period, repeated for a total of 5 min). The lysate was centrifuged at 12,000 RPM
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(Sorvall RC5C Plus centrifuge, Thermo Fisher Scientific Inc, USA, using an SS-34 
rotor) for 30 min and the supernatant solution discarded. The pellets were 
resuspended in 150 mL of fresh lysis buffer and titrated on ice with 5 M NaOH until 
the solution became clear (about pH 12). After stirring on ice for 30 min, the pH was 
lowered to 7.2 with 1 M HC1 and (3-mercaptoethanol was added to a final 
concentration of 5 mM. The resulting solution was stirred for 30 min on ice and 
centrifuged at 12,000 RPM (Sorvall RC5C Plus centrifuge, Thermo Fisher Scientific, 
Inc, USA, using an SS-34 rotor) for 30 min at 4 °C, after which the protein was found 
in the supernatant solution.
2.7.S Anion exchange chromatography
Ion-exchange chromatography, which separates compounds based on their net surface 
charge, is often used in protein purification. The stationary phase contains charged 
functional groups, of which there are four main types: strong acidic (e.g. sulfonic acid 
groups), strong basic (e.g. quaternary amino groups), weak acid (e.g. carboxylic acid 
groups) and weak basic (e.g. primary, secondary and/or tertiary amino groups).
The crude cell extract is prepared in a buffer of pH at least one unit above (for anion 
exchange) or below (for cation exchange) its isoelectric point (pi) and passed over the 
stationary phase resin. The desired protein and other molecules of appropriate charge 
are retained on the resin, while other molecules are eluted. After all the non-binding 
molecules have been washed through, the buffer conditions are changed in order to 
elute the target protein. The buffer conditions can be modified by adjusting the pH or 
the ionic strength. For this work, diethylaminoethyl (DEAE), a weakly basic 
anion-exchange resin that remains charged in a range of pH 3-9, was used.
The protein solution was loaded onto a diethylaminoethyl (DEAE) anion exchange 
column (column volume (CV) ~75 ml). The column was washed for at least 2 CV
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until baseline absorbance was reached and the flow-through was collected. A 
two-stage NaCl gradient was applied to the column, from 0-0.5 M NaCl over 4 CV, 
followed by 0.5-1 M NaCl over 1 CV. The column was then washed by another 1 CV 
lysis buffer with 1 M NaCl solution. The absorbance was monitored at 280 nm. To 
remove the NaCl used to elute the protein, the solution was dialyzed using MediCell 
membranes Size 3500/2 (cut-off of 3500) against buffer that contained 10 mM Tris 
and 5 mM p-mercaptoethanol at pH 7.5, without NaCl.
2.7.6 Concentration of the dialysed protein using Amicon ultrafiltration
The dialysate was transferred to a 50 ml Amicon™ ultracentrifugation apparatus 
containing a 44.5 mm Millipore 30 kDa cutoff ultrafiltration membrane and 
concentrated at a pressure of 1.5 bar at 4 °C.
2.7.7 Size exclusion chromatography
The apparent molecular weight of the wild-type EBFS was determined by size 
exclusion chromatography. Typical commercially available resins for sizing column 
include crosslinked compounds such as dextran and epichlorohydrin (e.g. sepharose), 
dextran covalently bound to agarose (e.g. superdex), highly crosslinked agarose (e.g. 
superose) and Zu's-acrylamide/detran copolymers (e.g. sephacryl). The packed resin in 
the sizing column would retard different proteins in the mixture to different degrees 
whilst passing through the column based on their molecular size. Larger molecules 
will be retarded much less than the smaller ones due to their inability to enter the 
small pores of the particles in the gel matrix. Smaller molecules will be trapped in the 
pores while diffusion happens between the stationary and mobile phase, which leads 
to a longer retention time. Therefore, the separation is dependent on the length and 
density of the column, the type of resin used, the sample volume and the flow rate 
applied.
8 2
1 mL of concentrated protein solution was applied to a Superdex™ 200 size exclusion 
column (CV ~24 mL), which had been previously equilibrated with 2 CV of protein 
purification lysis buffer with 150 mM NaCl. The column was then washed with 
another 2 CV of the equilibration buffer. The absorbance was monitored at 280 nm 
and the fractions were analysed by SDS-PAGE.
2.7.8 Determination of protein concentration
Sodium phosphate buffer (5 mM, pH 7) in the presence of 50 mM sodium sulfate was 
filtered and degassed using a vacuum pump (MD4C, Vacuubrand GMBH + CO KG, 
Germany) prior to use in protein concentration determination. Purified protein was 
dialysed against dialysis buffer (4L) overnight before the measurement. The 
spectrometer was blanked with 1 mL of buffer. Then, 10 pL of the dialysed protein 
sample was mixed with 1 mL of phosphate buffer and a blank sample was prepared 
by mixing 1 - 10 j^L of the dialysis buffer with 1 mL of phosphate buffer. Both 
samples were prepared immediately before use by gently pipetting several times. The 
increase in absorption at 205 nm was noted once the readings were stable. This 
process was then repeated at 280 nm using a 10 times more concentrated sample. To 
ensure the accuracy of measurements, the abosorbance was kept down to no more 
than 0.5. The extinction coefficient at 205 nm was calculated by the formula:
S  2056 mL' -  27 + 120 x (A280/A205)
where: e = extinction coefficient, A = absorbance at given wavelength
The Beer-Lambert law was used to calculate the concentration (mg/mL) of the protein 
solution.
A = sxcxl and therefore c = Axdf/exl
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where: e = extinction coefficient, A = absorbance at given wavelength, c = sample 
concentration in mg/mL and 1 = pathlength of cuvette in cm and df is the dilution
factor. The calculated protein concentration can be used to recalculate the E™ and the
value of this S™ can be used to determine the concentration of the same protein 
sample next time.
2.7.9 SDS-PAGE protocol
Monomer solutions were prepared by mixing reagents as described in Table 2.3. The 
gels were cast between two glass plates. 100 pL- of 10% APS and 10 pL of 
NJVJP JST -tetramethylenediamine (TEMED) were added to both resolving and 
stacking gels immediately prior to pouring the gel. Solutions were mixed gently by 
pipetting to initiate polymerization. The resolving gel solution was covered with a 
layer of isopropanol when it was poured and allowed to polymerize. Isopropanol was 
removed with blotting paper once the resolving gel was set. The stacking gel solution 
was poured and a comb was inserted to create wells for sample loading. Typically, a 
9% stacking and 13% resolving gel were used in my experiments.
Table 2.3: SDS-PAGE monomer solutions.
Gel (%) dH20  (mL) 30% Degassed 
Acrylamide-Bis (mL)
Gel Buffer 
(mL)
10% (w/v) 
SDS (mL)
6 5.4 2.0 2.5 0.1
7 5.1 2.3 2.5 0.1
8 4.7 2.7 2.5 0.1
9 4.4 3.0 2.5 0.1
10 4.1 3.3 2.5 0.1
11 3.7 3.7 2.5 0.1
12 3.4 4.0 2.5 0.1
13 3.1 4.3 2.5 0.1
14 2.7 4.7 2.5 0.1
15 2.4 5.0 2.5 0.1
16 2.1 5.3 2.5 0.1
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2.8 Enzyme characterization
2.8.1 Enzyme kinetics
Enzyme kinetics is the study of the chemical reactions that are catalysed by enzymes. 
In enzyme kinetics, the reaction rate is measured and the effects of varying the 
conditions of the reaction are investigated as well. Studying an enzymes’s kinetics can 
reveal the catalytic mechanism of this enzyme.
In biochemistry, Michaelis-Menten kinetics is one of the most frequently used model 
of enzyme kinetics. Most of the biochemical reactions are bimolecular reactions 
involving two reactants, substrate ‘S’ and enzyme ‘E’. In all enzymatic reactions, the 
enzyme is recycled and not consumed in the reactions. Before proceeding the in vitro 
experiments, some conditions must be met to ensure the resulting data is valid. As 
long as initial velocity is considered, the concentration of product can be neglected 
(compared to that of the substrate) and the concentration of substrate is in large excess 
over that of the enzyme. Here is a simple model of enzyme reaction:
k l  k c a t
E  +  S  < > E S  -----------> E  +  P
k - i
In this model, the substrate S reversibly associates with the enzyme E in a first step 
and some of the resulting complex ES is allowed to break down and yield the product 
P and the free enzyme back. Michaelis-Menten made three assumptions to derive and 
explain the kinetics of an enzyme reaction.
Assumption 1: reaction is in equilibrium.
In the above reaction once the product is formed, it does not go back to substrate, the 
reaction is in equilibrium.
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Assumption 2: Steady-state assumption.
In a steady state, the concentration of the intermediates [ES] is constant even if the 
concentration [S] and [P] are changing. This steady state occurs when the rate of 
formation and breakdown of ES complex are equal.
Assumption 3:
Maximal rate is obtained when the catalytic sites on the enzyme are saturated with the 
substrate.
2.8.1.1 Buffers for kinetics
Kinetic parameters of DCS based proteins were determined in 20 mM Tris buffer 
containing 1 mM DTT and 5 mM MgCk at pH 7.5. Kinetic parameters of EBFS based 
proteins were determined in 20 mM MOPS buffer containing 1 mM DTT and 5 mM 
MgCb at pH 7.2. Buffers were made freshly for each experiment.
2.8.1.2 Activity assays o f column fractions
The aim of this assay was to quantify the product formed by the enzyme from 
different fractions of the chromatography column, when incubated with [1-3H] FDP. 
The substrate remained in the aqueous phase while the cyclic products went into the 
organic solvent (hexane) used for the extraction. Constant amounts of substrate were 
incubated at 22 °C with constant amounts of enzyme eluted at different times from the 
chromatography column in activity buffer. The final volume for the reaction was 250 
pi. The reaction was quenched by the addition of 100ml EDTA (100 mM). Products 
were extracted with 3x700 pL hexane. The organic solution was then passed through 
a small silica column (typically containing 500 mg of silica) and mixed with 15 mL
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EcoScint™ (National Diagnostics) scintillation fluid before analysis on a scintillation 
counter (Packard 2500 TR™) in 3H mode for 4 min per sample. The percentage 
conversion of [1- H] FDP to radioactive hexane extractable products was determined 
by comparing the observed radioactivity with a known concentration of [1-3H]FDP 
and with control samples with no enzyme.
2.8.1.3 Steady state kinetics
Steady state kinetics were performed by radioactive assays using tritiated FDP ([1-3H] 
FDP) as substrate. Reactions (250 pL) were initiated by addition increasing 
concentrations of labeled FDP to a constant concentration of enzyme solution. The 
highest concentration of FDP should reach the saturation state for each enzyme. The 
reaction time and enzyme concentration were optimized to ensure the reaction was in 
the initial linear phase and was not reaching saturation during the experiment. The 
incubation temperature was 22 °C for all measurements. The reactions were quenched 
by addition of 100 pL of 100 mM EDTA. Products were extracted with 3x700 pL 
hexane. The organic solution was then passed through a small silica column (typically 
containing 500 mg of silica) and mixed with 15 mL EcoScint™ (National Diagnostics) 
scintillation fluid before analysis on a scintillation counter (Packard 2500 TR™) in 3H 
mode for 4 min per sample. The percentage conversion of tritiated FDP to radioactive 
hexane extractable products was determined by comparing the observed radioactivity 
level with a known concentration of tritiated FDP without enzyme in scintillation 
fluid. Data were fitted to the Michaelis-Menten equation,
V — ( v  max [SJ)/(Km + [S]) 
using Systat SigmaPlot 10. kcm was calculated by the formula:
kcat ~  V m a x / ( A  X  t X  [E] )
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where: A is the specifici activity of substrate (counts per min corresponding to 1 pM 
FDP). t is the reaction time (s). [E] is the enzyme concentration (pM).
2.8.2 GC-MS
Product profiles were determined by incubating 10 pM of purified enzyme with 1 mM 
(£,£)-FDP in the present of 5 mM Mg2+. Reactions were overlaid with 700 pL HPLC 
grade pentane and typically left over two nights. Sesquiterpene products were 
extracted using 3x700 pL pentane (HPLC grade) and pentane extracts were passed 
through a small silica column (containing approximately 500 mg silica). According to 
the previously reported methods (114), the resulting solutions were then analysed by 
GC-MS using a Hewlett-packard 6890 gas chromatography fitted with a J&W 
Scientific DB-5MS column and a Micromass GCT Premiere detecting in the range of 
m/z 50-800 in EI+ mode.
‘Relative abundance’ of GC or MS readings was defined as the ion current. The 
presented data has been normalized to that the maximum value displayed equals 100.
2.8.3 Circular dichroism spectroscopy
All circular dichroism spectroscopy was performed on a Chirascan™ 
spectrophotometer (Applied Photophysics Ltd, UK). Potassium phosphate buffer (10 
mM, pH 7) was used for all the measurements. A scan of the buffer alone was taken 
before every actual run as a blank. In the experiment, the appropriate amount of 
enzyme was mixed with the potassium phosphate buffer to give a final enzyme 
concentration of 10 pM.
Converting the signal obtained from CD experiments into mean residue ellipticity 
(MRE) was performed by the formula:
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© m r e  = 0/lOxnxcxl
where: 0  = CD signal in millidegree, n = number of backbone peptide bond, c = 
molar concentration of sample and 1 = path length of cuvette used in cm.
Typically, a 0.1 cm path length cuvette was used and the CD spectrum was recorded 
usually from 190-400 nm.
2.8.4 Errors and their propagation
2.8.4.1 Standard deviation and standard error o f the mean
The errors in this work are described as the standard error of the mean ( o s e m )  that is 
defined as the standard deviation (a) of the values in the sample divided by the square 
root of the sample size.
where: X = each value measured in the sample, M = mean of the sample, n = sample 
size.
2.8.4.2 Propagation o f errors
The propagation of the errors for kcJK u  was calculated as follow,
a
o SEM -
Z = X/Y
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where X and Y represent independent values directly measured experimentally, AX 
and AY are their errors, Z is the calculated value and AZ is its propagated error.
2.9 Amino acid sequence(s) alignment
Program ClustalX was used for two or multiple amino acid sequence(s) alignment. 
Sequences (and profiles) are input using the FILE menu. Invalid options will be 
disabled. All sequences must be in 1 file, one after another. 7 formats are 
automatically recognised: NBRF/PIR, EMBL/SWISSPROT, Pearson (Fasta), Clustal 
(*.aln), GCG/MSF (Pileup), GCG9 RSF and GDE flat file. All non-alphabetic 
characters (spaces, digits, punctuation marks) are ignored except which is used to 
indicate a GAP ("." in MSF/RSF).
Table 2.4: Default parameters for protein sequence(s) alignment.
Fast pairwise alignment parameters
K-tuple (word) size 1
Window size 5
Scoring method percentage
Number of top diagonals 5
Multiple alignment parameters
Wight matrix blosum
Gap opening penalty 10.0
Gap extension penalty 0.05
Hydrophilic gaps on
Hydrophilic residues GPSNDQERK
Residue-specific gap penalties on
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Chapter 3: 6-Cadinene Synthase
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3.1 Characterisation of the wild-type 6-cadinene synthase (WT-DCS)
As described in Section 1.5, a considerable amount o f work has previously been 
devoted to investigating both the mechanistic and the structural characteristic of DCS 
(104-110 , 114). To provide a benchmark for our mutagenesis and cloning studies, 
some basic experiments were repeated to characterize DCS from Gossypium  
arboreum  (tree cotton).
3.1.1 Purification o f W T-D C S
A cDNA o f W T-DCS (Gossypium arboreum ) was previously subcloned into the 
expression vector pET21d by Dr. S. Taylor. E. coli BL21(DE3) cells transformed with 
the resulting plasmid were used for protein production. After cell lysis, the protein 
was isolated from the insoluble fraction and refolded using the base extraction 
protocol (Section 2.7.3) (Figure 3.1).
1 2 3 4 5 6 Pronin
marker
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25.0 k 
18.4 k
Figure 3.1: 13% SDS-PAGE analysis o f  DCS purification from BL21(DE3) cells. Lane 1: 
supernatant solution after sonication and centrifugation. Lane 2: pellet after sonication and 
centrifugation. Lane 3: protein markers. Lane 4: supernatant solution after base extraction and 
centrifugation. Lane 5: pellet after base extraction and centrifugation. Lane 6: DCS fractions 
after concentration by Amicon.
The refolded protein mixture was loaded onto a DEAE column and a 0-1 M NaCl 
gradient was applied to elute the bound proteins. Two peaks could be identified from
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the FPL chromatogram (Figure 3.2A). Based on the SDS-PAGE analysis of the 
purified protein, the first peak contained the majority of the protein with the correct 
molecular weight representing DCS (Figure 3.2B). The fractions that contained pure 
protein were pooled and dialyzed against 4 L dialysis buffer overnight. The dialysate 
was concentrated to approximately 5 ml using an Amicon™ ultrafiltration apparatus 
(Figure 3.1).
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Figure 3.2: (A) Chromatogram for DEAE purification o f wild-type DCS.
(B) 13% SDS-PAGE analysis o f the purified protein. Lane 1 to 6: eluent 
fractions from the first peak. Lane 7 and 8: eluent fractions from the second 
peak. Lane M: protein marker.
3.1.2 Structural characterisation of WT-DCS by CD spectroscopy
The studies of the crystal structure of WT-DCS revealed an overall a-helical fold 
(114) and this was confirmed by the circular dichroism spectrum of the protein with 
two minima at 208 and 222 nm (Figure 3.3). The a-helicity was calculated to be 44% 
at 20 °C using K2d software (753).
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Figure 3.3: CD spectrum o f  DCS at 20 °C in potassium phosphate buffer (10 mM, pH  7).
3.1.3 Analysis of the hexane extractable products and kinetic studies
In agreement with a previous study (59), incubation o f purified DCS with FDP in the 
presence o f  cofactor M g2+ gave only the bicyclic compound S-cadinene (Figure 3.4). 
The identity o f the product was confirmed by comparing the mass spectrum with the 
Wiley database available on the mass spectrometer software (154).
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Most of the compounds formed by sesquiterpene synthases from FDP are 
hydrophobic. Saturation of these compounds in the reaction buffer will reduce the rate 
of release of newly formed products from the active site. To determine the optimal 
reaction time, incubations were carried out using 0.2 pM wild-type enzyme with 5 
|xM [1-3H]FDP (0.1 Ci/mmol) in 20 mM Tris, 5 mM Mg2+ and 1 mM DTT at pH 7.5 
for variable amounts of time (Figure 3.5). A reaction time of 20 min was chosen from 
the initial linear region.
1 2 0 0 0
8000
6000
4000
2000
0 10 30 40 50 6020
Time / min
Figure 3.5: Plot o f radioactivity level in hexane-extracted 
products formed by 0.2 pM  wild-type DCS versus reaction 
time.
Some sesquiterpene synthases aggregate at high concentrations. This situation has 
been shown to lower the activity of the enzymes, as exemplified by studies with 
aristolochene synthase (95). In order to find the optimal enzyme concentration for 
measuring the kinetic parameters of DCS, the radioactivity level in the products was 
determined at variable enzyme concentrations. A concentration of 0.26 pM was found 
as the optimal concentration from the initial linear region (Figure 3.6).
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Figure 3.6: Plot o f radioactivity level in products formed in 20 min 
by wild-type DCS versus enzyme concentration.
Kinetic assays were subsequently carried out by incubating 0.26 pM WT-DCS with 
variable concentrations of [1-3H]FDP (from 1 to 40 pM) (Figure 3.7). Km and vmax 
values for each individual run were calculated using the program SigmaPlot 10 by 
fitting to the Michaelis-Menten equation, v = (v™* [S])/(KM + [S]).
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Figure 3.7: Michaelis-Menten plot for o f wild-type DCS, incubation of 
0.26 pM  enzyme with different concentrations o f [1-HJFDP in the 
presence o f 5 mMMg2+.
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Based on five individual kinetic runs, the KM value was calculated to be 9.82 ± 0.33 
piM and the A^at value 0.0155 ± 0.0005 s'1 (based on the equation, kcat = 
vmax/(AxTx[E]), (section 2.8.1.2)). Both kc&t and Km value are comparable to the 
published data (7 pM for KM and 0.039 s’1 for kc&t) (100).
3.2 Mutagenesis studies of DCS
3.2.1 Introduction
Promiscuous enzyme activities are believed to have divergently evolved to acquire 
higher specificity and activity (755). This process is usually carried out by a small 
number of amino acid substitutions (156). Some studies have reported the importance 
of contributions from residues within and surrounding the active site (84, 157-159). 
For example, Deligeorgopoulou et al. observed that a single amino acid substitution 
within the active site of aristolochene synthase was sufficient to change the product 
spcificity more towards the acyclic sesquiterpene (7s)-P-famesene (84). Active site 
saturation mutagenesis of y-humulene synthase, a promiscuous sesquiterpene synthase 
generating more than 50 products, created mutants that generated alternative 
predominant products by substitution of only three to five active site residues at a time 
(155).
Recently, Greenhagen et al. accomplished a systematic interconversion of Nicotiana 
tabacum 5 -epi-aristolochene synthase (TEAS) and Hyoscyamus muticus 
premnaspirodiene synthase (HPS) activities, which established a minimal set of 
residues responsible for the divergent biosynthetic properties in these two enzymes 
(160). Molecular comparisons of TEAS and HPS, two plant sesquiterpene synthases 
that share 72% amino acid identity and similar enzymatic mechanism (Scheme 3.1), 
have shown to be useful in identifying structural elements for determining product 
specificity (161).
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H
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Scheme 3.1: Proposed catalytic mechanisms for TEAS and HPS via the common eudesmyl 
cation as intermediate.
To have a more systematic investigation of identifying functional residues, a contact 
mapping strategy was developed by using three-dimensional coordinates of TEAS 
complexed with an unreactive FDP analogue, famesylhydroxy-phosphonate (FHP). 
This strategy created concentric tiers of amino acid residues that have contact with 
each carbon atom of FHP (Figure 3.8). The first tier of the active site of TEAS was 
defined as the residues within van der Waals radii (3.5 A) of FHP and ten residues 
were identified in this tier. The second tier was constructed by the next 18-residues 
shell of contact. A three-dimensional model of HPS was created based on the TEAS 
template structure. By comparing the amino acid composition of both enzymes, the 
first tier residues of TEAS and HPS are identical, while only 4 different residues were 
spotted in the second tier. Experiments by mutating these residues of TEAS to the 
corresponding ones of HPS resulted in a growth of premnaspirodiene production, but 
not a full transmutation of activity. In this case, another five residues differing 
between TEAS and HPS within 12.5 A of the active site center that may have 
potential to contribute to the reaction were targeted for further analysis. Sequential 
mutagenesis at these five positions on the previously obtained quadruple mutant
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showed a gradual growth of premnaspirodiene production. The mutant with all nine 
amino acids mutated catalyses the formation of 75% premnaspirodiene and the 
catalytic efficiency of this mutant is comparable to the wild type HPS. Since all of the 
sesquiterpene synthases share the same class I terpenoid fold, this successful 
interconversion could serve as a model for sesquiterpene synthases to identify amino 
acids within and surrounding the active site that make direct and indirect contributions 
to catalysis.
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Figure 3.8: Identity and spatial relationships o f residues that 
distinguish TEAS and HPS activitys. FHP and selected residues are 
shown as sticks.
The aim of our mutagenesis work was to convert DCS to germacrene C synthase 
(GCS) by analogy. The amino acid sequence of DCS (from Gossypium arboretum) 
shows 68% similarity and 50% identity with that of GCS (from Lycopersicon 
esculentum), which is the closest homologue of DCS (59). Thus, GCS would be the 
most suitable target to perform the transmutation of activity from DCS and hence to 
identify structural elements underlying the evolution of product selectivity.
A homology model of DCS based on the crystal structure of epi-aristolochene 
synthase (PDB 5EAT) was created using the SWISS-MODEL automated homology 
modelling server. The mutagenesis studies mainly relied on this model because the
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crystal structure of DCS was solved two years after this work had been started {114). 
The tertiary structure alignment between the homology model and the crystal 
structure reveals very little difference in the overall conformation (Figure 3.9), 
demonstrating that the structural rationale behind all of the mutagenesis studies 
performed here was robust.
Figure 3.9: Cartoon representation of the tertiary structure 
alignment between the homology model generated for this work 
(coloured yellow) and the x-ray crystal structure o f DCS (coloured 
green) (PDB 3G4F{114)).
The substrate FDP was docked into the active site by the program FlexX and the 
residues within and surrounding the active site of DCS were defined here as the ones 
that in the first tier {i.e. within van der Waals radii (about 3.5 A) of the substrate 
carbon atoms) and second tier {i.e. within van der Waals radii of the first tier residues) 
of the active site sequence alignment to identify the corresponding residues was 
carried out using ClustalX with the default parameters {162). The proposed active site 
residues of DCS were then compared with corresponding ones of GCS and 7 different 
residues between DCS and GCS were identified, which potentially have the ability to 
affect the enzymatic reaction (Table 3.1). The contribution of these residues to the 
proposed active site was later confirmed by the crystal structure of DCS {114); the
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tertiary structure alignment revealed that these residues were positioned in a similar 
fashion in both homology model and crystal structure (Figure 3.10).
Table 3.1: Comparison o f wild-type DCS active site contact residues with corresponding 
residues from GCS. Residue differences between DCS and GCS are shown as bold characters.
X 2nd 1st 2nd 2nd 1st 1st 1st 2ncl 2nd 2nd
\ tier tier tier tier tier tier tier tier tier tier
DCS F27 R270 R272 G276 W279 V283 1300 S304 D308 L378
GCS F15 R263 R265 C269 W272 V276 L293 S297 D301 L371
X 2nd 1st 2nd nd 1st 1st 2nd 2nd 1st 2 nd
x ^ tier tier tier tier tier tier tier tier tier tier
DCS Y382 E385 T407 C408 Y410 L413 S443 1446 R448 E455
GCS Y275 E378 S401 A402 Y404 1407 S437 1440 R442 G449
1st tier 2nd tier 2nd tier 1st tier 1st tier 1st tier 1st tier
DCS L519 V522 M523 L526 Y527 D531 Y533
GCS L513 V516 A517 L520 Y521 D525 Y527
E455
C408,
'  >
M523
h f
i j 407
BOO 
-
*  f
L413 G276
Figure 3.10: Cartoon representation for the comparison o f active site contact residues (shown 
as sticks) between the homology model (coloured yellow) and the x-ray crystal structure 
(coloured green) (PDB 3G4F (714)).
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Substitution of DCS active site residues to the corresponding residues in GCS was 
performed to identify the essential set of residues responsible for divergent 
biosynthetic properties in DCS.
3.2.2 Expression and purification of active site mutants
Active site mutations were constructed by site-directed mutagenesis. The native and 
the substituted codons for each mutation are listed in Table 3.2. The presence of the 
mutations was verified by DNA sequencing.
Table 3.2: Comparison of native codons from wild-type DCS with substituted codons for the 
active site contact residues.
G276C BOOL T407S C408A L413I E455G M523A
Native
codon
GGT ATA ACT TGT CTT GAA ATG
Substituted
codon
TGT AAT AGT GCT ATT GGA GCG
Stepwise mutagenesis of the active site of DCS started from the first tier residues. 
L413 of DCS, located deep in the middle of the active site, was mutated to lie. The 
constructed single mutant DCS-L413I (Ml) was subsequently modified by addition of 
another mutation BOOL to form a double mutant DCS-D00L/L413I (M2). BOO sits 
close to L413 in the active pocket and both residues point toward the centre of the 
active site. Ml and M2 were produced and purified by the same method as the 
wild-type DCS (Figure 3.11). Typically, 12 mg and 35 mg of purified Ml and M2 
were obtained per litre of culture respectively.
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Figure 3.11: Chromatograms for DEAE purification o f Ml (A) and M2 (C) and 13% 
SDS-PAGE analyses o f each purification (B) and (D). Lane 1-6: eluent fractions for Ml. Lane 
7-14: eluent fractions for M2. Lane M: protein marker.
Mutational replacement of the second tier residues of DCS to the corresponding 
residues of GCS was carried out by sequential addition of the other five mutations 
onto the double mutant M2. First, E455 of DCS was mutated to the corresponding Gly 
residue of GCS to form a triple mutant DCS-I300L/L413I/E455G (M3). Next, the 
mutant DCS-I300L/T407S/C408A/L413I/E455G (M5) was constructed by combining 
another two mutations T407S and C408A with M3. As these two residues are adjacent 
to one another, this mutagenesis was performed in a single step and no mutant M4 
was generated. E455, T407 and C408 are located near the entrance of the active site. 
In addition to the contribution of forming active site contour, these residues may also 
involve in stabilizing the magnesium ion and diphosphate moiety. The mutants M3 
and M5 were produced and purified following the same method as wild-type DCS 
(Figure 3.12).
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Figure 3.12: Chromatograms for DEAE purification o f M3 (A) and M5 (C) and 13% 
SDS-PAGE analyses o f each purification (B) and (D). Lane 1-8: eluent fractions for M3. Lane 
9-16: eluent fractions for M5. Lane M: protein marker.
Typically, 25 mg and 30 mg of purified M3 and M5 were obtained from per litre of 
culture respectively. The mutant M5 was subsequently modified by addition with 
another mutation M523A to form a new variant 
DCS-I300L/T407S/C408A/L413I/E455G/M523A (M6). The last mutant
DCS-G276C/I300L/T407S/C408A/L413I/E455G/M523A (M7) was prepared by 
introducing the mutation G276C into the mutant M6. The mutants M6 and M7 were 
produced and purified based on the same method as wild-type DCS (Figure 3.13). 
Typically, 15 mg and 10 mg of purified M6 and M7 were obtained from per litre of 
culture respectively.
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Figure 3.13: Chromatograms for DEAE purification o f M6 (A) and M7 (C) and 13% 
SDS-PAGE analyses o f each purification (B) and (D). Lane 1-7: eluent fractions for M6. Lane 
8-15: eluent fractions for M7. Lane M: protein marker.
3.2.3 Analysis of the sesquiterpene products and kinetic studies
All the in vitro reactions were performed by incubating 10 jiM enzyme and 1 mM 
FDP in 20 mM Tris buffer containing 5 mM Mg2+ and 1 mM DTT at pH 7.5. All the 
kinetic assays were carried out using radiolabelled [1-3H]FDP and the same Tris 
buffer system as for in vitro reactions. The incubation time and the enzyme 
concentration for the kinetic assays were optimized before the actual runs (See section
2.8.1.2 for details).
The mutagenesis studies related to the active site of DCS revealed a totally different 
pattern of the function of active site residues from those previously reported 
mutagenesis studies of other sesquiterpene synthases (e.g. AS, TEAS and y-humulene 
synthase). It has been shown that active site modification by substitutions of active 
site residues of terpene synthases had a significant influence on the product profile 
and/or catalytic efficiency (84, 155,157-159). However, all of the mutants within and 
surrounding the active site of DCS gave 6-cadinene as the exclusive sesquiterpene 
product (Figure 3.14).
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Figure 3.14: Product profiles for incubation o f FDP with M l (A), M2 (B), M3 (C), M5 (D), 
M6 (E) and M7 (F).
In addition to the unchanged product outcome, the mutants that contain modification(s) 
in the first tier of the active site even showed similar kinetic parameters to the 
wild-type enzyme. Kinetic assays revealed a ^at value of 0.0203 ± 0.0009 s'1 and a 
Km value of 13.34 ± 2.56 pM for the mutant Ml (Figure 3.15). The catalytic 
efficiency (k^JKu) of this mutant (1.52 ± 0.31 s'1 mM’1) was very similar to that of 
the wild-type DCS (1.58 ± 0.07 s'1 mM'1).
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Figure 3.15: Kinetic analysis o f  M l. (A) Time course (0.26 pM enzyme, 5 pM FDP); (B) 
Plot o f radioactivity level against enzyme concentration (5 pM FDP, 20 min incubation time); 
(C) Michaelis-Menten plot (incubation o f 0.26 pM enzyme with radiolabelled substrate for 20 
min at 22 °C).
The double mutant M2 was found to be an even more efficient enzyme. A k^i value of 
0.0223 ± 0.0037 s '1 and a Km value of 2.89 ± 0.94 pM were obtained from the assay 
(Figure 3.16). The decrease of the Km value leads to a roughly 5-fold improvement of 
catalytic efficiency comparing to the wild-type DCS.
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Figure 3.16: Kinetic analysis o f  M2. (A) Time course (0.062 pM enzyme, 5 pM FDP); (B) 
Plot o f radioactivity level against enzyme concentration (5 pM FDP, 10 min incubation time); 
(C) Michaelis-Menten plot (incubation o f 0.062 pM enzyme with radiolabelled substrate for 
10 min at 22 °C).
Generally, the mutants containing mutations in both the first and the second tier of the 
active site experienced a reduction in catalytic activity. The t value of M3 was 
determined to be (0.04 ± 0.012) x 10'3 s'1, which was reduced by about 400 fold 
compared to the wild-type enzyme. The Km value was increased to 4.65 ± 1.63 pM 
(Figure 3.17). The catalytic efficiency was therefore reduced by about 200 fold.
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Figure 3.17: Kinetic analysis o f  M3. (A) Time course (1 pM enzyme, 5 pM FDP); (B) Plot of 
radioactivity level against enzyme concentration (5 pM FDP, 20 min incubation time); (C) 
Michaelis-Menten plot (incubation o f 1 pM enzyme with radiolabelled substrate for 20 min at 
22 °C).
The &cat value of M5 was found to be (0.009 ± 0.0008) x 10'3 s '1 which represented the 
lowest catalytic activity among all the mutants. However, this mutant showed a much 
stronger substrate binding affinity compared to wild-type DCS. The Ku value was 
determined to be 0.84 ± 0.04 pM, which was roughly 12 times smaller than that of 
wild-type DCS (Figure 3.18). Overall, the catalytic efficiency was reduced by about 
140 fold compared to the wild-type enzyme.
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Figure 3.18: Kinetic analysis o/M 5. (A) Time course (2 pM enzyme, 5 pM FDP); (B) Plot of 
radioactivity level against enzyme concentration (5 pM FDP, 60 min incubation time); (C) 
Michaelis-Menten plot (incubation of 2 pM enzyme with radiolabelled substrate for 60 min at 
22 °C).
The &cat value of M6 was found to be (0.035 ± 0.0003) x 10'3 s'1 and the Km value was 
1.86 ± 0.31 pM (Figure 3.19). The catalytic efficiency of this mutant (0.019 ± 0.003 
s'1 mM'1) is comparable to that of the mutants M3 (0.009 ± 0.004 s'1 mM'1) and M5 
(0.011 ±0.004) s '1 mM"1).
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Figure 3.19: Kinetic analysis ofM 6. (A) Time course (2 pM enzyme, 5 pM FDP); (B) Plot of 
radioactivity level against enzyme concentration (5 pM FDP, 60 min incubation time); (C) 
Michaelis-Menten plot (incubation o f 2 pM enzyme with radiolabelled substrate for 60 min at 
22 °C).
The mutant M7, containing all seven chosen mutations, showed a &cat value of (0.030 
± 0.006) x 10'3 s '1 and a Km value of 0.52 ± 0.07 pM (Figure 3.20). Compared to the 
wild-type enzyme, the catalytic efficiency of this mutant is only reduced 27 fold.
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Figure 3.20: Kinetic analysis ofM 7. (A) Time course (1 pM enzyme, 5 pM FDP); (B) Plot of 
radioactivity level against enzyme concentration (5 pM FDP, 60 min incubation time); (C) 
Michaelis-Menten plot (incubation o f 1 pM enzyme with radiolabelled substrate for 60 min at 
22 °C).
The residues identified from the proposed active site of DCS were based on the 
crystal structure of epi-aristolochene synthase. However, modification of the active 
site surface showed no influence on the product specificity, leading to a speculation 
that the enzymatic reaction catalysed by DCS may not take place in the proposed 
active site. The recently solved crystal structure of DCS (114) provides some 
indications to support this assumption. An obviously different orientation of the 
famesyl chain moiety can be identified by comparing the binding conformations of 
the substrate analogue 2F-FDP in DCS and famesyl hydroxyl phosphonate (FHP) in
1 0 9
epi-aristolochene synthase (91,114) (Figure 3.21).
Figure 3.21: Cartoon representation for the comparison of 2F-FDP (shown as magenta sticks) 
bound in the crystal structure of DCS (coloured green) (PDB 3G4F, Chain A; (114)) and 
famesyl hydroxyl phosphonate (shown as orange sticks) bound in the crystal structure of 5-epi 
aristolochene synthase (coloured cyan) (PDB 5EAT; (91)). Tertiary structures of DCS and 
5-epi aristolochene synthase were aligned using the Pymol program.
For epi-aristolochene synthase, the famesyl chain of FHP is docked deeply into the 
active site pocket, adopting a conformation conductive to the cyclization between Cl 
and CIO. This kind of productive substrate binding fashion can be found in most of 
the crystal structures that have been solved including monoterpene, sesquiterpene and 
diterpene synthases (57, 130). However, the famesyl chain of the substrate analogue 
2F-FDP was observed binding more towards the entrance of the active site in the 
crystal structure of DCS. The actual initial binding conformation of substrate FDP 
may be different from the observed conformation for 2F-FDP because the distal 
double bond of 2F-FDP is not in close proximity to Cl, therefore precluding the 
proposed Cl-CIO ring closure. Nevertheless, it suggests that the native substrate FDP 
may not be docked deeply into the active site as observed for 5-epi aristolochene 
synthase.
The kinetic data (summarized in Table 3.3) also provide some support for this
n o
argument. According to the crystal structure of DCS, residues 1300 and L413 are 
found in the middle of the active site and the hydrophobic side chains are positioned 
toward the centre of the active site cavity. They are proposed to be in a close 
proximity to the substrate and contribute directly to the active site surface. However, 
the catalytic activity of both Ml and M2 were comparable to wild-type DCS, 
suggesting a considerable distance between the substrate and these residues.
Table 3.3: Summary o f kinetic data for the active site mutants o f DCS.
Protein Jfcc/lOr3 *-1 KmI pM kcat/Km / s'1 mRf1
WT-DCS 15.5 ± 0 .5 9.82 ± 0.33 1.58 ±0.07
M l (DCS-L413I) 20.3 ± 0.9 13.34 ± 2 .56 1.52 ±0.31
M2 (M1-I300L) 22.3 ± 3 .7 2.89 ± 0.94 7.7 ±2 .8
M3 (M2-E455G) 0.04 ±0.012 4.65 ±1.63 0.009±0.004
M5 (M3-T407S/C408A) 0.009 ± 0.0008 0.84 ± 0.04 0.011±0.004
M6 (M5-M523A) 0.035 ± 0.0003 1.86 ±0.31 0.019±0.003
M7 (M6-G276C) 0.03 ± 0.006 0.52 ± 0.07 0.058±0.014
E455 of DCS was defined to be outside of active site. The triple mutant M3, 
constructed by introducing mutation E455G into the double mutant M2, leads to a 
huge catalytic activity reduction. This is because the E455 is part of the second 
magnesium binding motif. This mutation could directly compromise the magnesium 
ion binding affinity, which may also lead to the mispositioning of the famesyl chain 
and thus affect catalytic activity. The role of E455 related to the magnesium ion 
binding has been explained in the crystal study of DCS and the E455A single mutant 
also shows a significant catalytic activity reduction (114).
T407 and C408 of DCS are two residues that also form unique structures in the crystal 
structure of DCS. T407 makes a water-mediated hydrogen bond with the diphosphate 
moiety, which would further stabilize the diphosphate group upon binding in the
in
active site (114). C408 and C477 were observed to form a disulfide linkage in the 
crystal structure of DCS between helices G and H (114). The function of this disulfide 
linkage has not been identified, but this bond could possibly stabilize the two helices 
and so help to form a well-defined active site contour. These two structures were both 
compromised in the mutant M5. The changes did not allow any new sesquiterpene 
hydrocarbons to be formed. In addition, it led to a further four-fold reduction in 
catalytic activity compared to M3.
G276 and M523 of DCS are found in the middle of the active site pocket. Similar to 
the function of residues 1300 and L413, these two residues may also contribute to the 
overall active site shape and volume. The catalytic activities of mutants M6 and M7 
were better than that of M5 and this was most likely because the modified active site 
could serve as a better template to direct substrate binding into a suitable 
conformation for catalysis. On the other hand, the catalytic activities of mutants M6 
and M7 were similar to that of M3, suggesting the activity loss caused by disturbance 
of magnesium binding area cannot be re-established by manipulating the structure of 
the active site contour.
Generally, the major catalytic activity loss among the mutants was caused by the 
mutation E455G. Other modifications to the proposed active site did not make an 
obvious difference in terms of catalytic activity. In addition, the KM values were 
found to be smaller in most of the mutants compared to the wild-type DCS. This 
suggests the overall structure change allowed the mutants to have better binding 
affinity towards substrate FDP.
Similar results have been reported by manipulating active site residues of
amorphadiene synthase (163). In this study, the author compared the active site amino
acid composition between amorphadiene synthase and TEAS. The only different
residue in the active site pocket of the two enzymes was F525 in amorphadiene
synthase that corresponds to Y527 in TEAS. In addition, the modelling study revealed
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a different positioning of the W271 of amorphadiene synthase in comparison to the 
corresponding W273 of TEAS and this residue may be essential for positioning of the 
substrate FDP in the active site of amorphadiene synthase. The different conformation 
of this tryptophane residue can be caused by the surrounding structures, including 
residues F514 and Q518 from amorphadiene synthase. Mutagenesis studies toward 
F514, Q518 and F525 of amorphadiene synthase were carried out, but the 
substitutions replacing the original amino acid for the corresponding amino acid from 
TEAS did not lead to any new sesquiterpene product. Only reductions or complete 
losses of activities were observed among those mutants. These results are in 
agreement with our findings, suggesting the differences in product specificity of 
amorphadiene synthase and DCS are not only determined by the core of active sites. 
To find out the essential component that controls the product specificity of DCS, four 
chimeras were designed and analysed in the following experiments.
3.3 Domain-swapping studies
Generally, the functional domain of a terpenoid synthase could provide a template 
that binds flexible isoprenoid substrate(s) with proper orientation and conformation, 
especially for high-fidelity enzymes. Thus, the closed active site cavity could enforce 
the generation of reactive carbocations and specific intermolecular or intramolecular 
carbon-carbon bond forming reactions.
The proposed active site for DCS is in the C-terminal domain. However, mutagenesis 
studies by sequential substitution of the active site surface showed an unchanged 
product profile for all the mutants (Section 3.2.3). These results may lead to two 
hypotheses. One possibility is that the enzymatic reaction catalysed by DCS does not 
take place in the proposed active site. In this case, the mutations that were introduced 
into the enzyme may only bring some minor influence to the conformation of the real 
reaction cavity rather than affecting the substrate or intermediates directly. This could 
explain the observed activity loss from mutants. The other possibility is that the
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product specificity of DCS is determined by an unidentified structure rather than the 
proposed active site contour if the C-terminal domain is the catalytically active 
domain. Domain-swapping studies were therefore performed to clarify the functional 
domain of DCS and the residues or subdomain responsible for determining the 
product specificity.
3.3.1 N-Terminal domain hybrid
The first speculation that arose from the unexpected mutagenesis results was that the 
N-terminal domain of DCS might catalyse the enzymatic reaction. It has been shown 
that class I and class II terpenoid synthase folds can be combined in multidomain 
terpenoid synthases to form larger active site cavities or even bifunctional enzymes 
(7). For example, squalene-hopene synthase is formed by joining two class II domains 
together in ‘face-to-face’ fashion, which form a large active site pocket to 
accommodate the C30 substrate (141). The plant sesquiterpene synthase 5-epi 
aristolochene synthase contains a catalytically active class I terpenoid synthase 
domain and an inactive class II terpenoid synthase domain (91), while the plant 
diterpene synthase abietadiene synthase, which is structurally homologous to 5-epi 
aristolochene synthase and taxadiene synthase, is constructed with both domains 
showing catalytic activity and catalysing tandem cyclization reactions (57).
To characterize the function of the N-terminal domain of DCS, a hybrid (hybrid 1) 
was prepared by substitution of the C-terminal domain of DCS with that of the fungal 
sesquiterpene synthase aristolochene synthase (from Penicillium roqueforti) (Figure 
3.22). Aristolochene synthase is active as a single domain, which is homologous to 
the C-terminal domain of DCS (164). Therefore, if the N-terminal domain of DCS is 
catalytically active, the product profile of this hybrid should give both 6-cadinene and 
aristolochene as enzymatic products.
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Figure 3.22: Schematic diagram o f the N-terminal domain-swapping test (A) and cartoon 
representation o f homology model o f d-cadinene synthase (B), crystal structure o f 
aristolochene synthase (C) and homology model o f hybridl (D). Line drawings depict 
composite diagrams for wild-type DCS (the insert of DCS is coloured white and the vector 
part is coloured gray), wild-type aristolochene synthase (coloured black) and hybrid 1 genes. 
The N-terminal domain of DCS is coloured cyan and the C-terminal is green. The structure of 
AS is coloured orange.
The construct of hybrid 1 was prepared by replacing the native GGT codon of G276 
with TTC by site-directed mutagenesis. Together with the codon GAA that encodes 
amino acid E275, this mutation creates an EcoRl restriction site. Another Sacl 
restriction site located after the stop codon was also employed to form the hybrid 
construct. The gene encoding aristolochene synthase was amplified from the genomic 
DNA via PCR using short complementary oligonucleotide primers designed to flank 
the gene of interest and provide overhanging EcoRl and Sacl restriction sites at the 5’
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and 3’ end respectively. The restriction sites were introduced immediately prior to the 
start codon and immediately after the stop codon (Figure 3.23).
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Figure 3.23: 1% Agarose gel analyses o f  the hybrid 1 cDNA construct preparation. Lane 1 
and 6: Plasmid encoding the mutated gene encoding DCS after double digestion by both 
iscoRI and Sacl restriction enzymes. Lane 2 and 5: The mutated insert gene after digestion by 
EcoRl restriction enzyme. Lane 3: Aristolochene synthase 3’ PCR product. Lane 4: Gene 
encoding hybrid 1 after digestion by iscoRI restriction enzyme. Lane M: 1 kb DNA ladder.
The gene fragment that encodes the C-terminal domain o f DCS was removed from the 
mutated plasm id by a double digestion with iscoRI and Sacl restriction enzymes. The 
opened plasmid was then ligated with the newly formed DNA fragment encoding 
aristolochene synthase, creating a plasmid containing the gene that encodes hybrid 1. 
Formation o f the constructed plasmid was checked by a single digestion with iscoRI 
(Figure 3.23) and the correct construct was confirmed by DNA sequencing.
Hybrid 1 was produced and purified in the same manner as wild-type DCS (Figure 
3.24), typically yielding 20 mg o f purified enzyme per litre o f culture. The in vitro 
assay was carried out by incubating 10 pM of purified enzyme with 1 mM of FDP in 
the same buffer system used for wild-type DCS. GC-MS analysis of the hexane 
extractable products showed a nearly identical product profile to wild-type 
aristolochene synthase and no S-cadinene was observed (Figure 3.25).
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Figure 3.24: (A) Chromatogram for DEAE purification of hybrid 1. (B) 13% 
SDS-PAGE analysis. Lane 1-7: eluent fractions. Lane M: protein marker.
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Figure 3.25: Product profiles for incubation of FDP with wild-type aristolochene synthase (A) 
and hybrid 1 (B).
The study of hybrid 1 showed that the N-terminal domain of DCS is unlikely to be 
responsible for the conversion of FDP to 6-cadinene. The C-terminal domain of DCS 
must therefore be the catalytically active domain. In this case, it is very likely that the 
previously proposed active site contour is not the key component for determining the 
product specificity of DCS. Further experiments were therefore performed to aid 
identification of the essential component that controls the specific formation of
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S-cadinene by DCS.
3.3.2 C-Terminal domain hybrid
Comparison of a number of fungal and plant genes encoding terpene synthases reveals 
a nearly identical intron/exon organization of genomic DNA for all plant 
sesquiterpene synthases, while very little similarity is observed between DNA 
sequences of the fungal and plant sesquiterpene synthases (145,164). One implication 
of the conserved exon organization observed among plant sesquiterpene synthase 
genes is that these conserved exon regions may correspond to functional subdomains 
that may determine the product specificity. The relationship between functional 
subdomains and product specificities was demonstrated by swapping regions 
approximating exons between a 5-epi aristolochene synthase gene and a 
vetispiradiene synthase gene (161). The results from characterization of the resulting 
hybrids showed that exon 4 of 5-epi aristolochene synthase gene conferred specificity 
for the production of 5-epi aristolochene, while exon 6 of vetispiradiene synthase 
gene conferred specificity for the production of vetispiadiene.
Based on the domain swapping studies of 5-epi aristolochene synthase and 
vetispiradiene synthase, a similar experiment was prepared for DCS to identify the 
functional domain responsible for product specificity. The gene encoding the chimeric 
protein (hybrid 2) was designed by substituting the gene regions of DCS that 
approximate exons 5, 6 and 7 with the corresponding gene regions for GCS (Figure
3.26).
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Figure 3.26: Genomic organization o f DCS gene (145).
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The gene of hybrid 2 was constructed using two native Sacl restriction sites (Figure
3.26) identified in the plasmid containing the gene encoding DCS; one Sacl restriction 
site sequence encodes amino acids E318 and L319 and the other Sacl restriction site is 
located after the stop codon. A synthetic DNA fragment was designed to encode the 
amino acid sequence from E311 to the stop codon of GCS, with Sacl restriction sites 
at both the 5’ and 3’ end (Figure 3.27).
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F ig u re  3 .2 7 : Schematic diagram o f  the C-terminal domain-swapping tests. L ine drawings 
depict co m p o site  d iagram s for w ild -ty p e  D C S  (co lou red  w h ite), the synthetic gen e fragm ent 
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The plasmid containing the gene encoding DCS was digested with Sacl restriction 
enzyme, dephosphorylated with Calf Intestinal Alkaline Phosphatase (CIP) and the 
longer DNA fragment was purified by agarose gel electrophoresis (Figure 3.28). The 
longer opened plasmid was then ligated with the synthetic DNA fragment encoding 
the 3’-terminal portion of the GCS gene. Formation of the constructed plasmids were 
checked by a single digestion with Clal restriction enzyme, which cuts the resulting 
plasmid only once (Figure 3.28).
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Figure 3.28: 1% Agarose gel analyses o f  the hybrid2 and hybrid3 cDNA construct 
preparation. Lane 1: The plasmid containing the gene encoding DCS after digestion by Sacl 
restriction enzyme. Lane 2 and 3: The ligation products after digestion by Clal restriction 
enzyme. Lane M: 1 kb DNA ladder.
Since both 5 ’ and 3 ’ restriction sites employed the same Sacl site, the synthetic DNA 
fragment can be ligated into the open insert gene in two different manners (Figure
3.27). The desired gene construct for hybrid 2 was confirmed by DNA sequencing. 
The other construct was also identified, in which the synthetic DNA fragment was 
ligated into the insert vector in a reverse pattern. The gene sequence o f this chimeric 
protein (hybrid 3) contains a stop codon after that encoding N329 amino acids, 
truncating the protein at that position.
Hybrid 2 was produced and purified by the same method as wild-type DCS (Figure
3.29). Typically, 15 mg o f purified protein can be obtained per litre o f culture. The in 
vitro  assay was carried out by incubating 10 pM  purified enzyme with 1 mM FDP in 
the same buffer system used for wild-type DCS. GC-MS analysis o f the hexane 
extractable products revealed 6-cadinene as the sole sesquiterpene product (Figure
3.30).
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Figure 3.29: (A) Chromatogram for DEAE purification of hybrid 2. 
(B) 13% SDS-PAGE analysis. Lane 1-9: eluent fractions. Lane M: 
protein marker.
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Figure 3.30: GC trace representing product profile for incubation o f FDP with hybrid 2.
For the kinetic study of hybrid 2, the reaction time and the enzyme concentration were 
optimized to be 1 hr and 1 pM respectively before the actual run. A &cat value of 
(0.025 ± 0.002) x 10'3 s '1 and a KM value of 0.44 ± 0.04 pM were obtained from the
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kinetic assay (Figure 3.31). In order to get a valid Km value for an enzyme using 
Michaelis-Menten, the enzyme concentration used in the reaction must be much lower 
than the actural KM value (ATm/[E]>10). In this case, the Km value for the hybrid2 was 
approximated.
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Figure 3.31: Kinetic analysis o f  hybrid 2. (A) Time course (1 pM enzyme, 10 pM FDP); (B) 
Plot o f radioactivity level against enzyme concentration (10 pM FDP, 60 min incubation 
time); (C) Michaelis-Menten plot (Incubation o f 1 pM enzyme with radiolabelled substrate 
for 60 min at 22 °C).
In hybrid 2, roughly 2/3 of the functional C-terminal domain structure of DCS has 
been swapped with the corresponding structure of GCS, in which the original second 
magnesium binding motif (D451DXXE455) has been substituted with an unusual 
^450q 454£458 motif The unchanged product profile revealed the protein structure 
encoded by exon 5, 6 and 7 is not related to product specificity. In addition, the 
observed kinetic parameters for hybrid 2 were comparable to the mutants that contain 
mutations in the second magnesium binding motif (Section 3.2.3). Thus, it seems the 
loss of catalytic efficiency of the hybrid 2 could be mainly due to the alteration of the 
second magnesium binding motif rather than the overall structural change.
It has been shown in hybrid 1 that the N-terminal domain of DCS, encoded by exon 1, 
2 and most of exon 3, does not contribute to the product specificity. The result from 
hybrid 2 indicates that amino acids from E318 to L554 of DCS, corresponding to 
exons 5, 6 and 7, do not determine the product specificity either. These results 
strongly suggest that exon 4 of the DCS gene confers specificity for the production of
S-cadinene.
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Hybrid 3 was produced and purified by the same method as wild-type DCS (Figure 
3.32A). The protein with a molecular weight around 38,000 Da was identified by the 
SDS-PAGE analysis (Figure 3.32B). Typically, 15 mg of purified protein can be 
obtained per litre of culture.
Figure 3.32: (A) Chromatogram for DEAE purification o f hybrid 3. (B)
13% SDS-PAGE analysis. Lane 1-9: eluent fractions. Lane M: protein 
marker.
Hybrid 3 can be defined as a truncated mutant of DCS; roughly 2/3 of the C-terminal 
domain has been removed from the original protein structure, resulting in a protein 
that encoded by exons 1 to 4. This mutant was expected to be inactive because the 
truncated active site is very likely exposed to the solvent and unable to protect the 
cationic intermediates. Surprisingly, the in vitro assays of this mutant with FDP 
suggest a different story. In total, eight individual protein productions and 
purifications were performed for hybrid 3. Half of these purifications yielded enzyme 
that showed catalytic activity towards FDP, with 6-cadinene as the only product 
according to GC-MS analysis (Figure 3.33); while half of the time, the hybrid 3 was
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inactive.
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Figure 3.33: Product profiles for incubation o f FDP with hybrid 3.
Hybrid 3 from batches that showed activity toward FDP was employed in the 
subsequent kinetic experiments. An optimised incubation time of 1 hr and an enzyme 
concentration of 1 pM were determined to meet the requirements for 
Michaelis-Menten kinetic assay before the actual run (Figure 3.34). The £cat and Km 
were determined to be (0.073 ± 0.013) x 10'3 s"1 and 0.43 ±0.13 pM respectively. 
Again, since the enzyme concentration value used in this reaction is bigger than the 
calculated Km value, the calculated KM value is only approximated here.
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Figure 3.34: Kinetic analysis o f hybrid 3. (A) Time course (1 pM enzyme, 10 pM FDP); (B) 
Plot o f radioactivity level against enzyme concentration (10 pM FDP, 60 min incubation 
time); (C) Michaelis-Menten plot (Incubation o f 1 pM enzyme with radiolabelled substrate 
for 60 min at 22 °C).
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The approximate Km value was reduced by roughly 20 fold than that of wild-type 
DCS and the &cat value was 3 times greater than that of the hybrid 2, indicating the 
activity observed from hybrid 3 was not due to the contamination either from 
wild-type enzyme or the hybrid 2. The unpredictable catalytic activity of hybrid 3 
may be because of the unstable tertiary structure. The remaining C-terminal domain 
and the N-terminal domain may adjust their orientations to form an enclosed space 
that could catalyze the cyclization from FDP to 6-cadinene. On the other hand, the 
formation of the active conformation of hybrid 3 may not be easily achieved, thus the 
mutant sometimes behaves as an inactive enzyme probably due to the inappropriate 
tertiary structure. In any case, the active form of hybrid 3 provides further evidence to 
support the theory that exon 4 of the DCS gene confers specificity for the production 
of S-cadinene. However, more truncated mutants could be designed to verify this 
result conclusively.
3.4 Mutagenesis o f the first aspartate rich motif
The gene sequence encoding the aspartate rich D307DTYD311 motif was identified in
^  I ^  j
the exon 4 and this motif was proposed to interact with the putative Mg A and Mg c 
ions (57, 145). To further probe the role of this magnesium binding motif, three 
aspartate residues were substituted with alanine respectively.
All the three mutants D307A, D308A and D311A were prepared by substitution of the 
native codon that encodes the relevant Asp residue with a GCG codon of Ala by 
site-directed mutagenesis. These mutants were produced and purified in the same way 
as wild-type DCS (Figure 3.35). Typically, 20 mg of purified protein was obtained per 
litre of culture for each mutant. The in vitro assays followed the standard method in 
that 10 pM of the purified mutant was incubated with 1 mM FDP overnight.
6-Cadinene was identified as the sole hexane extractable product for all three mutants 
by GC-MS analysis (Figure 3.36).
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Figure 3.35: Chromatograms for DEAE purification o f DCS-D307A (A), DCS-D308A (C) and DCS-D311A (E) and 13% SDS-PAGE analyses o f each 
purification (B), (D) and (E). Lane 1-5: eluent fractions for DCS-D307A. Lane 7-12: eluent fractions for DCS-D308A. Lane 14-19: eluent fractions for 
DCS-D311A. Lane 6, 13 and 20: wild-type DCS sample.
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Figure 3.36: Product profiles for incubation o f FDP with DCS-D307A (A), DCS-D308A (B) 
and DCS-D311A (C).
The D307A and D311A mutants were found to be much less active than the wild-type 
DCS but all produced 6-cadinene as the only product. The steady-state kinetic 
parameters for catalysis by DCS-D307A and DCS-D311A could not be measured 
accurately. The rate of radiolabelled 6-cadinene production was so low that it was 
beyond the capacity of the kinetic assays to be measured. The huge catalytic activity 
loss that determined for D307A and D311A substitutions is consistent with the 
observation in the crystal structure that residues D307 and D311 coordinate with 
Mg2+A and Mg2+c {114). The kinetic assay for the other mutant DCS-D308A was 
carried out by Dr. Veronica Gonzalez from our group. A A^at value of 0.012 ± 0.002 s'1 
and a KM value of 43 ± 16 pM were obtained from the kinetic assay {114). The 
unaffected suggests the residue D308 contributes very little to metal ion binding, 
while it may have some influence on the active site contour, as reflected by the 
decreased substrate binding affinity. The crystal structure of DCS also confirmed that 
D308 is not involved in the interactions that chelate the magnesium ions {114).
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3.5 Conclusions
Wild-type DCS from Gossypium arboretum was shown to be constructed with an 
overall a-helical fold by CD spectroscopy and confirmed to be a high-fidelity enzyme 
by producing 6-cadinene as the sole product. The relationship between the product 
specificity and the protein structure was investigated first by mutagenesis studies 
based on the sequence alignment and homology modelling. Seven residues from the 
proposed active site were chosen to be substituted by the corresponding residues of 
GCS and to study a possible enzyme activity interconversion between DCS and GCS 
for this study. However, the product profiles displayed by all the variants were the 
same as WT-DCS, suggesting that the active site contour was not the key component 
for determining the product specificity of DCS.
In addition, the determined kinetic constants for the mutants suggest most of these 
mutations did not make obvious contributions to catalysis. The catalytic activities of 
mutants Ml and M2 were comparable to wild-type DCS. Mutant M3 showed a 
significant catalytic activity reduction of three orders of magnitude compared to 
wild-type DCS. The observed activity loss of M3 was caused by the newly introduced 
mutation E455G. This mutation would greatly compromise the interaction between 
the second magnesium binding motif and the Mg2+B. A further catalytic activity 
reduction was observed in the mutant M5, probably due to the additional mutation 
T407S. This mutation may compromise the potential water-mediated hydrogen bond 
between T407 and the diphosphate moiety. The mutants M6 and M7 contain 
additional modifications in the proposed active site, while the catalytic activities of 
both mutants are comparable to that of M3.
Generally, the mutations were sequentially introduced into the wild-type DCS, but the 
mutations are non-additive in terms of &cat- The major activity loss was caused by 
alteration of the magnesium binding motif rather than amino acid substitution of the
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proposed active site surface. These results suggest that the product specificity of DCS 
is possibly determined by an unidentified structure rather than the immediate active 
site contour.
The possibility that the N-terminal domain of DCS is the major catalytically active 
domain was ruled out by characterising the function of hybrid 1. Hybrid 1 contains 
the C-terminal domain from aristolochene synthase and the N-terminal domain from 
DCS. The product profile of hybrid 1 is identical to that of aristolochene synthase, 
indicating the enzymatic reaction of DCS should take place in the C-terminal domain. 
Nevertheless, it is still possible that the N-terminal domain of DCS could catalyse the 
conversion from FDP to 6-cadinene, but in a very slow rate.
As the above studies showed that either the active site contour or the N-terminal 
domain could not affect the product specificity of DCS; thus, the product specificity 
was expected to be related to a specific region from the C-terminal domain. The study 
of hybrid 2 suggested that the structure of amino acid sequence from E318 to L554 of 
DCS did not contribute in regard to product specificity, since hybrid 2 was 
constructed by substitution of this region with the corresponding region of GCS and 
the mutant converted FDP into 6-cadinene exclusively. The C-terminal domain is 
mainly encoded by exons 4 to 7 and the examined region from E318 to L554 of DCS 
is encoded by exons 5, 6 and 7. Therefore, the exon 4 of DCS gene most likely 
confers the specificity for the production of 6-cadinene. This assumption was 
supported by the result from hybrid 3 which was a truncated mutant encoded only by 
exons 1 to 4. This mutant was able to convert FDP into 6-cadinene, indicating that 
either the protein structure encoded by exon 4 was the key component for controlling 
specificity, or this partial C-terminal domain combining with the whole N-terminal 
domain could form a new active site, which also possesses the catalytic activity to 
convert FDP into 6-cadinene.
The role of the first aspartate rich motif was confirmed by alanine substitutions. The
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significantly catalytic activity loss of D307A and D311A mutants indicated the 
reactions between these two residues with magnesium ions. This is consistent with the 
observation in the crystal structure that residues D307 and D311 coordinate with 
Mg2+A and Mg2+c. The unaffected catalytic activity of D308A suggests that Mg2+A 
and Mg2+c are only chelated by D307 and D311, which is also confirmed in the 
crystal structure.
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Chapter 4: (£)-p-Farnesene Synthase
1 3 1
4.1 C haracterisation of the wild-type (£)-p-farnesene synthase 
(WT-EBFS)
This chapter aim ed at exam ining the influence o f  the active site volume of EBFS on 
the product outcome. M utants w ith enlarged or refined active site were designed to try 
to facilitate cyclization reactions in the modified active site pocket. The active site 
cavity was further m odified by swapping residues from the active site of EBFS with 
corresponding ones from  DCS to demonstrate the importance o f active site volume.
4.1.1 Expression and purification of WT-EBFS
The cDNA clone o f  W T-EBFS was previously subcloned into the expression vector 
pET32b by Dr A thina D eligeorgopoulou with Nco\ and BamWl restriction sites at the 
5’ and 3’ ends. The gene was expressed in BL21-CodonPlus(DE3)-RP cells. To 
optimise the expression conditions, different expression temperatures were 
investigated. Cells w ere grown at 37 °C to an OD6oo o f 0.6 before expression was 
induced by addition o f  IPTG (0.1 mg/ml) at 16 °C and 37 °C, respectively (Figure 
4.1). As indicated from  the SDS gel, very little WT-EBFS was observed at 37 °C until 
7 hr, but a large am ount o f  the protein was produced at 16 °C after 7 hr.
Protein
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Figure 4.1: 13% SDS-PAGE analysis o f  wild-type EBFS production in comparison to total 
protein production in E. coli BL21-CodonPlus(DE3)-RP at 16 and 37 °C respectively. Lanes 
1 to 3: 2, 4 and 7 hr at 16 °C after induction of expression. Lanes 4 and 5: 37 °C immediately 
prior to induction of expression. Lane 6 and 7: 2 and 7 hr at 37 °C after induction of 
expression.
132
The inclusion bodies that formed during protein production were pelleted by 
centrifigation. Refolding of inclusion body proteins followed the same base extraction 
protocol as described for wild-type DCS (Section 2.7.3). The refolded protein was 
purified on a DEAE column. Three peaks can be identified from the FPL 
chromatogram (Figure 4.2A). According to the SDS gel, the first two peaks contained 
the majority of the enzyme with the correct molecular weight (Figure 4.2C).
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Figure 4.2: (A) Chromatogram for DEAE purification of wild-type EBFS. (B) Activity of 
fractions from DEAE purification of wild-type EBFS. (C) 13% SDS-PAGE analyses of the 
purified protein. Lane 6 to 14: eluent fractions from the first peak. Lane 15 to 30: eluent 
fractions from the second peak. Lane 37 and 38: eluent fractions from the third peak. Lane M: 
protein marker.
Monitoring the enzymatic activity of the eluted fractions utilizing [1-3H]FDP (Figure 
4.2B) revealed that, while the first and the third peak turned over FDP slowly, the 
second peak contained most of the active protein. To remove NaCl, the protein 
solution from the second peak was combined and dialyzed using MediCell 
membranes Size 3500/2 (cut-off of 0-3500) against buffer that contained 10 mM 
MOPS and 5 mM (3-mercaptoethanol at pH 7.2. The dialysate was concentrated to
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approximately 5 ml using an Amicon™  ultrafiltration apparatus containing a 
Millipore 30 k cutoff membrane, at a pressure o f 1.5 bar at 4 °C (Figure 4.3).
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Figure 4.3: 13% SDS-PAGE analysis o f  EBFS purification. S: supernatant solution after 
sonication. PI: pellet after sonication. R: supernatant solution after base. P2: pellet after base 
extraction. M: protein marker. FI: flow-through from the DEAE column after injection of 
EBFS. A: EBFS fractions after concentration by Amicon. F2: flow-through from Amicon. C: 
protein after further concentration by spin column.
4.1.2 Structural characterisation of WT-EBFS by CD spectroscopy
Based on amino acid sequences homology and the crystal structures o f several 
sesquiterpene synthases (57, 93, 114, 165), EBFS was predicted to have an overall 
a-helical fold like all other sesquiterpene synthases. The circular dichroism (CD) 
spectrum o f the protein confirm ed a typical a-helical spectrum with two minima at 
208 and 222 nm (Figure 4.4). The a-helicity was calculated to be 34% at 20 °C using 
K2d software (753).
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Figure 4.4: CD spectrum o f  EBFS at 20 °C in potassium phosphate buffer 
(10 mM, p H  7).
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4.1.3 Determination of the apparent molecular mass of WT-EBFS
The apparent molecular weight of the wild-type enzyme was determined by size 
exclusion chromatography, which is commonly used as a final step in a series of 
chromatographic procedures. The retention times of protein standards (Bio-Rad) 
thyroglobulin, bovine gamma-globulin, chicken ovalbumin and equine myoglobin on 
a Superdex™ 200 column were determined in 20 mM MOPS buffer with 150 mM 
NaCl at pH 7.2 by monitoring the absorption of the eluent at 280 nm (Figure 4.5, 
Table 4.1). The dependence of the log of the molecular mass on a retention time was 
determined by linear regression (Figure 4.6).
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Figure 4.5: Chromatogram for elution of molecular mass standards (50 ill) from a 
Superdex™ 200 size exclusion column at 20 °C in MOPS buffer (20 mM MOPS, 150 mM 
NaCl, pH 7.2). (A) thyroglobulin (20 pM). (B) bovine gamma-globulin (80 pM). (C) chicken 
ovalbumin (300 pM). (D) equine myoglobin (400 pM).
Table 4.1: Retention times of molecular weight standards on a Superdex™ 200 column in 20 
mM MOPS buffer with 150 mM NaCl at pH 7.2.
MW-Standard MW logjo MW 'R (ml)
(A) Thyroglobulin 670000 5.826 9.49
(B) Bovine gamma-globulin 158000 5.199 12.71
(C) Chicken ovalbumin 44000 4.643 15.1
(D) Equine myoglobin 17000 4.23 16.87
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Figure 4.6: Retention times (in ml) of molecular weight standards and EBFS on a
Superdex™ 200 column in 20 mM MOPS buffer with 150 mM NaCl at pH 7.2. (A) 
thyroglobulin. (B) bovine gamma-globulin. (C) chicken ovalbumin. (D) equine myoglobin.
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Figure 4.7: (A) Chromatogram for Superdex™ 200 purification of wild-type 
EBFS. (B) 13% SDS-PAGE analysis of the purified protein. Lane 8 to 20: 
fractions from 8 to 20 (1 ml per fraction). Lane M: protein marker.
Figure 4.7 showed the purification of EBFS when 100 pi of 250 pM enzyme was 
loaded onto the size exclusion column. Different concentrations (20, 40, 250 and 600
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|*M) of EBFS all showed the same retention time of 14.56 ml and eluted as a single 
major peak. This retention time corresponds to a molecular weight of 56781 for EBFS. 
Since the monomeric molecular weight of EBFS determined from the amino acid 
sequence is 63830, EBFS apparently is a monomer at 20 °C in 20 mM MOPS buffer 
with 150 mM NaCl at pH 7.2 as expected.
4.1.4 Analysis of the hexane extractable products
Incubation of purified EBFS with FDP in the presence of 5 mM Mg2+ gave 
(£)-P-famesene (65, 95%) as the dominant product, along with a small amount of 
three other acyclic sesquiterpenes, (Z)-p-famesene (97, 1.5%), (3Z, 67s)-a-famesene 
(112, 1.3%) and (3£,6£)-a-famesene (113, 0.2%) (Figure 4.8 and 4.9). The identity 
of the peaks for (£)-p-famesene, (3Z, 67T)-a-famesene and (37s, 67s)-a-famesene were 
confirmed by comparing the retention times in the GC and the MS spectra with 
chemically synthetic samples (Figure 4.10 and 4.11) that were synthesized from 
famesyl acetate by Dr Juan Faraldos (86). (Z)-p-Famesene was identified by 
comparing the mass spectrum with the Wiley database available on the mass 
spectrometer software. Another 5 sesquiterpene products (<2% in total) were also 
detected by GC-MS (Figure 4.9), but the MS spectra of these compounds could not 
match any standard provided by the Wiley database (Table 4.2). Nevertheless, these 
unidentified sesquiterpene structures are very likely to be cyclic products, since all the 
acyclic sesquiterpene products had been identified. The observed product profile is 
different to that published for partially purified EBFS, which yielded (7s)-j3-famesene 
(97, 85%), (Z)-(3-famesene (112, 8%) and 6-cadinene (79, 5%), as well as three other 
minor cadinene-type products (less than 1% each) based on mass spectrometry (MS) 
(775).
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Figure 4.8: Acyclic sesquiterpene products generated by WT-EBFS from substrate FDP.
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Figure 4.9: GC trace for hexane-extractable products following incubation of 
10 pM WT-EBFS with 1 mM FDP in the presence of 5 mM Mg2+. Peaks 1 to 5: 
5 unknown sesquiterpene products.
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Figure 4.10: Overlay of the chromatograms for wild-type EBFS incubation 
products (blue) with chemically synthetic (E)-f-farnesene, 
(3Z,6E)-a-farnesene and (3E,6E)-a-famesene samples (red).
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Figure 4.11: El-mass spectrum o f  (E)-f-farnesene from incubation (A) and standard (B). 
El-mass spectrum o f  (3Z,6E)-a-farnesene from  incubation (C) and standard (D). El-mass 
spectrum o f  (3E,6E)-a-farnesene from  incubation (E) and standard (F).
EBFS has been reported to catalyze the conversion o f GDP to several monoterpene 
olefins. According to the previous research (115), major products were the cyclic 
monoterpenes limonene (49, 48%), terpinolene (117, 15%) and the acyclic 
monoterpene m yrcene (45, 15%). The other minor products were y-terpinene (116, 
7%), (Z)-ocimene (46, 6%), (£)-ocim ene (114, 7%) and sabinene (115, 3%) (Figure 
4.12). This observation is dramatically different from our result. As expected, mainly 
acyclic monoterpenes were confirm ed as products (Figure 4.13). Myrcene (45, 38.3%),
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as the main product, together with (Z)-ocimene (46, 18.9%) and (£)-ocimene (114, 
29.4%) were determined to make up to more than 87% of total product. Lesser 
amounts of cyclic monoterpenes were identified, limonene (49, 7.2%), y-terpinene 
(116, 1.1%), terpinolene (117, 3%), a-terpinene (118, 0.9%) and another unknown 
monoterpene (Figure 4.12). Monoterpene products (Table 4.3) were confirmed by 
comparing the retention times of GC and MS spectrum with authentic samples that 
were purchased from Sigma-Aldrich, Alfa Aesar, Fluka and TCI Europe.
OPP
GDP (4) myrcene (45) (Z)-ocimene (46) limonene (49) (£>ocimene (114)
sabinene (115) y-terpinene (116) terpinolene (117) a-terpinene (118) 
Figure 4.12: M onoterpene products generated by WT-EBFS from  substrate GDP.
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Figure 4.13: GC trace fo r  the hexane extractable products following incubation 
o f  10 m M  EB F S with 1 m M  GDP. All monoterpene products have been labeled.
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Table 4.2: GC-MS analysis o f  the sesquiterpene products from the incubation of wild-type 
EBFS with FDP.
Retention time / min Product Percentage %
23.24 unknown-1 trace
23.54 (Z)-|3-famesene (97) 1.5
24.34 (£)-p-famesene (65) 95
25.22 unknown-2 trace
25.50 (3Z, 6£)-a-fam esene (112) 1.3
25.79 unknown-3 trace
25.91 (3£'J6^)-a-famesene (113) 0.2
26.10 unknown-4 trace
26.37 unknown-5 trace
Table 4.3: GC-MS analysis o f  the sesquiterpene products from the incubation of wild-type 
EBFS with GDP.
Retention time / min Product Percentage %
8.32 unknown 1.2
8.86 Myrcene (45) 38.3
9.69 a-terpinene (118) 0.9
10.08 limonene (49) 7.2
10.41 (Z)-ocimene (46) 18.9
10.76 (£)-ocimene (114) 29.4
11.12 Y-terpinene (116) 1.1
12.14 terpinolene (117) 3
4.1.5 Kinetic studies of WT-EBFS
All the kinetic assays were carried out using radiolabelled [1-3H]FDP and MOPS 
buffer system (20 mM MOPS, 5 mM MgCl2 and 5 mM P-mercaptoethanol at pH 7.2).
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To determine the optimal incubation time, the reaction was carried out by incubating 
0.06 pM wild-type enzyme with 10 pM [1-3H]FDP for variable amounts of time 
(Figure 4.14A). A reaction time of 15 min was chosen for the actual kinetic runs since 
it is in the initial region of the graph and a relatively good radioactivity level was 
obtained in this time. The optimal enzyme concentration was determined by plotting 
variable enzyme concentrations against radioactivity level of product formation. As a 
result, the concentration of 0.06 pM was defined as the optimal concentration from 
the initial linear region (Figure 4.14B) and this result also confirmed that the time 
course was carried out with the optimised enzyme concentration conditions.
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Figure 4.14: Plots o f radioactivity level in products formed by 0.06 pM  WT-EBFS versus 
incubation time (A) and in 15 min versus concentration o f WT-EBFS (B).
Previous studies showed a slight substrate inhibition when the substrate concentration 
went over 10 pM (775). To make sure the inhibition was not caused by the cofactor 
(Mg2+) or the inorganic diphosphate released during reaction (as the aqueous solution 
was covered by hexane during reaction, most of the organic products would go into 
the organic phase and diphosphate is therefore the only product that could accumulate 
in the aqueous phase), a set of kinetic assays were carried out in the presence of 
variable MgCk and diphosphate concentrations (Figure 4.15). No inhibition was 
observed up to Mg2+ concentration of 200 mM or for diphosphate concentrations of 
up to 400 pM.
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Figure 4.15: Plots o f  radioactivity level in products formed in 15 min formed by 0.06 mM 
WT-EBFS and 10 mM [1-H ]F D P  against Mg2+ (A) and inorganic diphosphate (B) 
concentration.
Kinetic assays were subsequently carried out by incubating 0.06 pM wild-type EBFS 
with variable concentrations of radiolabelled FDP (from 0.1 to 120 pM) (Figure 4.16). 
Km and £cat values for each individual run were calculated using the programme 
SigmaPlot 10 by fitting the data to the Michaelis-Menten equation, v = (vmax [S])/(Km
+ [S]).
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Figure 4.16: Michaelis-Menten profile o f WT-EBFS, incubation of 
0.06 pM  enzyme with different concentrations o f radiolabelled FDP 
in the presence o f  5 mM Mg2+.
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Based on five individual kinetic runs, the Km value was calculated to be 6.4 ±1.7 pM 
and the &cat value 0.015 ± 0.004 s '1. The Km value was higher than the previously 
reported value of 0.6 pM (115) but very close to the value of 5 pM that was 
determined for the EBFS from maritime pine (166). The kcat value (calculated based 
on the equation, kcat = vmax/(AxTx[E]), (section 2.8.1.2)) obtained here is in the 
normal range for plant sesquiterpene synthases (167).
4.1.6 Investigation of the reaction mechanism using the substrate analogues 
2F-FDP and 2F-GDP
Previous research into EBFS has proposed an enzymatic reaction mechanism via the 
ionization of trans-trans-famQsyl diphosphate and formation of (E)-p-famesene (65) 
(Scheme 1.18) (115). 2F-FDP (8 6 ) should be a good inhibitor for producing both 
products because the fluorine at C2 position can greatly inhibit the formation of allylic 
cation (Scheme 4.1).
It has recently been shown that 2F-FDP (8 6 ) is an inhibitor of DCS and the crystal 
structure of the complex of DCS with 2F-FDP has been solved (114). In contrast, 8 6  
is a very good substrate for EBFS. The product, (is)-p-2F-famesene (119) (Figure
4.17), was confirmed by comparing retention time and MS spectrum with an authentic 
sample that was synthesized by Dr Juan Faraldos (112, 135). Under identical 
conditions (10 pM enzyme, 1 mM substrate, 5 mM Mg2+), EBFS produces 
approximately twice as much (£)-p-famesene as (£)-|3-2F-famesene based on the 
peak intensity in the GC-MS spectrum (Figure 4.17).
©OPP
2F-FDP (86)
Scheme 4.1: Inhibition step o f  forming 2F-transoid allylic cation.
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The proposed mechanism of forming both 6 -cadinene and (7s)-p-famesene goes 
through the same intermediate, transoid allylic cation (54) (775). To form 6 -cadinene, 
this cation is converted to NDP and then to the bicyclic product (114). The C2 
fluorine can strongly inhibit the formation of transoid allylic cation through an 
inductive electron withdrawing effect. In this case, 1, 6  ring closure can hardly happen 
and therefore, 6 -cadinene is unlikely to be formed. The fact that EBFS converts 
2F-FDP into (£)-|3-2F-famesene strongly suggests that the transoid allylic cation is 
not an intermediate in (7s)-p-famesene formation and therefore implies a concerted 
elimination mechanism rather than the two steps El elimination.
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The yield of (£)-p-2F-famesene is slightly lower than that of (£)-p-famesene itself, 
probably because the fluorine at C2 position increases the transition state energy of 
diphosphate group release. The concerted elimination mechanism requires 
involvement of an active site base. These are usually histidine residues and the 
diphosphate group (57, 167). In the case of EBFS, there are no histidine residues 
around the active site pocket, suggesting that the diphosphate group would most likely 
be the active site base. Here, we proposed a syn-elimination mechanism for the 
enzymatic reaction catalysed by EBFS (Scheme 4.2). In agreement, the diphosphate 
group was also proposed as the catalytic base in the enzymatic reactions catalysed by 
isoprene synthase, famesyl diphosphate synthase and aristolochene synthase (62, 72, 
93), which provides another hint for the described enzymatic strategy of EBFS.
OPP
FDP (5)
2’0 ,P0
l l H 19
11AX19
C o ® ? ,o .? ? o e
II IIo o
B
ppi
(£')-P-faraesene (57)
Scheme 4.2: Proposed mechanism for the formation o f (E)-/3farnesene from an 
intramolecular reaction o f  FDP via either pathway A or pathway B.
Since the structures of those cyclic products have not been identified, it is hard to 
explain the details about the mechanism of enzymatic conversion of FDP to cyclic 
product by EBFS. Nevertheless, it suggests that the first ring closure of this catalytic 
mechanism goes through a concerted fashion as decribed for aristolochene synthase 
(81, 82)
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4.2 Mutagenesis studies of (£>p-farnesene synthase
4.2.1 Introduction
The deduced amino acid sequence of wild-type (£)-p-famesene synthase has a 
significant level of similarity with other plant sesquiterpene synthases. It is most 
similar to e/?/-aristolochene synthase from tobacco (62% similarity and 4 9 % identity) 
(168) and also closely resembles 6 -cadinene synthase from tree cotton with 60% 
similarity and 37% identity (59) and the germacrene C synthase from tomato (57% 
similarity and 34% identity) (169).
Several liganded and unliganded crystal structures of sesquiterpene synthases from 
both fungi and plants have been solved, revealing a conformational change triggered 
by Mg2+3-FDP complex binding to the enzymes (81, 90, 93, 170). Several loop 
regions participate in this movement upon ligand binding, forming a sequestered 
active site cavity with the proper conformation for terpenoid production. It has also 
been suggested that the active site cavity could enforce the substrate to dock into the 
enzyme with a product-like conformation for high fidelity sesquiterpene synthases, 
whereas the promiscuous synthases contain a larger active site pocket that allows 
different substrate binding conformations, leading to mutiple reaction products (1). 
Based on the above discussion, it is reasonable to assume that altering the active site 
volume would lead to a different product outcome.
A homology model for EBFS was created based on the crystal structure of 6 -cadinene 
synthase using the SWISS-MODEL automated homology modelling server (Figure
4.18). Sequence alignment with other plant terpene synthases was carried out with 
ClustalX using default parameters (162). Residues in the first tier of the active site (i.e. 
within van der Waals radii (about 3.5 A) of the substrate (160)) have been listed in 
Table 4.4.
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Figure 4.18: Cartoon representations of the EBFS homology model and the expansion of the 
active site. FDP (red sticks) was docked into the active site by the program FlexX.
Table 4.4: Comparison of wild-type EBFS active site contact residues with other plant 
sesquiterpene synthases. GAS: germacrene A synthase from Crepidiastrum sonchifolium 
(ABB00361.1); GCS: germacrene C synthase from Solanum lycopersicum (AAC39432.1); 
TEAS: 5-e/n-aristolochene synthase from Nicotiana tabacum (AAA19216.1); DCS: 
6-cadinene synthase from Gossypium arboretum (AAA93064.1); EBFS: (F)-(3-famesene 
synthase from Mentha x piperita, L. (AAB95209.1).
Enzyme Active site contact residues
GAS R275 W284 V288 T305 L308 V309 D312 T412
GCS R263 W272 V276 L293 T296 S297 D300 S401
TEAS R264 W273 V277 1294 1297 S298 D301 T401
DCS R270 W279 V283 1300 A303 S304 D307 T407
EBFS R264 W273 Y277 V294 C297 G298 D301 T401
Enzyme Active site contact residues
GAS S413 A414 Y415 1418 R453 D456 L524
GCS A402 G403 Y404 1407 R442 N445 L513
TEAS T402 T403 Y404 L407 R441 D444 L512
DCS C408 G409 Y410 L413 R448 D451 L519
EBFS S402 C403 1404 M407 R441 N444 Y514
Y277 and Y514 from the bottom of active site of EBFS were revealed by the amino 
acid sequence alignment to be conserved in the other four enzymes as smaller size 
hydrophobic residues; and 1404 from the side face of the active site was replaced by 
aromatic residues in the analogous position of the other four enzymes. Mutants 
containing these three residues were prepared to investigate if the volume change 
could bring a new function to the active site pocket. In addition, there are two cysteine 
residues that had been observed to form a potential disulfide linkage. The 
corresponding residues from EBFS were mutated to cysteine residues to see if the 
changes could affect the product outcome. Finally, a hybrid was constructed by 
swapping all the active site residues of EBFS with the corresponding ones of DCS.
4.2.2 EBFS-Y514L
Y514 of EBFS that sits at the bottom of the active site pocket has been found to be a 
conserved Leu in the four other sesquiterpene synthases (Figure 4.19). The reason 
EBFS forms mainly acyclic products may be that the distal isoprene unit is 
mispositioned in the active site due to steric hindrance, attenuating the efficiency of 
cyclisation. The mutant EBFS-Y514L could release some free space around the 
bottom of the active site, which might allow the substrate to fold into a different 
conformation.
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Figure 4.19: Cartoon representation o f the active site o f the EBFS 
homology model. FDP (shown as red sticks) was docked into the active 
site by the program Flex X. Residue Y514 was shown as orange sticks.
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The mutant was made by substitution of the native TAC codon of Tyr with CTG of 
Leu by site-directed mutagenesis. EBFS-Y514L was purified in the same way as 
WT-EBFS (Figure 4.20). Typically, 15 mg of EBFS-Y514L was obtained per litre of 
culture. 10 pM of the purified mutant was incubated with 1 mM FDP overnight and 
the hexane extractable products were analysed by GC-MS. The product outcome was 
not significantly affected (Figure 4.21). The mutant generates (E)-(3-famesene as the 
main product (95%) and another four minor products, (Z)-(3-famesene (0.7%), 
(3Z,6£)-a-famesene (1%), QE, 6FT)-a-famesene (1.6%) (structures are confirmed by 
comparing GC-MS results of wild-type EBFS) and an unknown sesquiterpene with 
the retention time of 25.22 min (1.7%).
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Figure 4.20: (A) Chromatogram for DEAE purification o f EBFS-Y514L. (B) 
13% SDS-PAGE analysis. Lane 1-3: fractions from the first peak. Lane 4-12: 
fractions from the second peak. Lane M: protein marker.
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Figure 4.21: GC frace for incubation of 10 p.M EBFS- Y514L with 1 
mM FDP in the presence of 5 mMMg2+.
The reaction time and enzyme concentration were optimised to ensure the reaction 
was in the initial linear region and was not reaching saturation during the experiment. 
An incubation time of 30 min and an enzyme concentration of 0.4 pM were chosen 
from the linear part of both curves to meet the requirements for Michaelis-Menten 
kinetic assay. After three replicates, a kCdX of (5.5 ± 1.9) xlO4 s' 1 and a ATm of 23 ± 8  
pM were obtained from the assays (Figure 4.22).
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Figure 4.22: Kinetic analysis of EBFS-Y514L. (A) Time course (0.125 pM enzyme, 10 pM 
FDP); (B) Plot of velocity against enzyme concentration (10 pM FDP, 30 min incubation 
time); (C) Michaelis-Menten plot (incubation of 0.4 pM enzyme with radiolabelled substrate 
for 30 min at 22 °C).
Although the product outcome was not affected, the &cat was reduced 27-fold and the
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Km was 4 times greater than that of the wild-type enzyme, suggesting the volume 
increase does affect the substrate binding, but not in the way of generating any other 
new structures. In contrast, this change may compromise the orbital alignment 
between the electron lone pair of nucleophile and empty s-obital of the proton by 
increasing the mobility of the famesyl chain in the active site.
4.2.3 EBFS-I404Y
1404 of EBFS is in helix G and the side chain of 1404 points to helice H in close 
proximity (Figure 4.23). The corresponding residue was found to be a conserved Tyr 
in the other four sesquiterpene synthases. Different residues at this position may either 
affect the conformation of helices G and H, or directly influence the plasticity of 
active site surface.
Helix (
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Figure 4.23: Cartoon representation for the active site o f EBFS 
homology model. FDP (shown as red stick) was docked into the active 
site by the program Flex X. Residue 1404 was shown as orange sticks.
The gene of mutant EBFS-I404Y was prepared by replacing the native lie codon ATT 
with a Tyr codon of TAT using site-directed mutagenesis. The mutant was purified in 
the same manner as the wild-type EBFS (Figure 4.24). Typically, 20 mg of 
EBFS-I404Y was obtained per litre of culture. The in vitro assay was carried out by 
incubating 10 pM of purified mutant protein with 1 mM of FDP in a total volume of 
500 pi reaction solution at room temperature overnight and the hexane extractable 
products were analysed by GC-MS. Rather than producing another 8 minor products 
(as seen for the wild type), in addition to the predominant (£)-(3-famesene only a
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small amount o f the unknown sesquiterpene at the retention time of 25.22 min was 
detected (Figure 4.25).
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Figure 4.24: (A) Chromatogram for DEAE purification o f EBFS-I404Y. (B) 13% 
SDS-PAGE analysis. Lane 1-13: eluent fractions. Lane M: protein marker.
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Figure 4.25: GC trace fo r incubation o f 10 pM EBFS-I404Y with 1 mM 
FDP in the presence o f 5 mM Mg2+.
E B F S -I4 0 4 Y  w a s  a lso  fo u n d  to  b e  a  le s s  a c t iv e  en z y m e  com p ared  to the w ild -typ e  
E B F S . T h e in cu b a tio n  t im e  an d  th e  e n z y m e  con cen tra tion  for the k inetic assay  w ere  
o p tim ised  to  b e  3 0  m in  an d  0 .2  p M  r e sp e c tiv e ly . A fter  three rep licates, a Km o f  2 9  ±  
12 p M  an d  a kcaLt o f  0 .0 0 3 7  ±  0 .0 0 1 6  s '1 w e r e  ob ta in ed  from  the k in etic  assays (Figure  
4 .2 6 ). O v era ll th e ca ta ly tic  e f f ic ie n c y  w a s  red u ced  1 8 -fo ld . T h e fact that the m utant 
co u ld  n o t p ro d u c e  th e  o th er three a c y c lic  p rod ucts ((Z)-(3-fam esen e , 
( 3 Z ,6 £ ) -a - fa m e s e n e  an d  (3E, 6E )- a - f a m e s e n e )  su g g ests  the substrate b inds into the  
active  s ite  o f  th is  m u tan t in  a  d ifferen t co n fo rm a tio n  com p ared  to the b ind ing  
con form ation  in  th e  w ild -ty p e  E B F S , su ch  that o n ly  the p roton  at C l 5 can  be  
ap proach ed  b y  th e  a c t iv e  s ite  b a se  an d  th u s co m p le te  the d ep rotonation  step.
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Figure 4.26: Kinetic analysis o f  EBFS-I404Y. (A) Time course (0.2 pM enzyme, 10 pM 
FDP); (B) Plot of velocity against enzyme concentration (10 pM FDP, 30 min incubation 
time); (C) Michaelis-Menten plot (incubation of 0.2 pM enzyme with radiolabelled substrate 
for 30 min at 22 °C).
4.2.4 EBFS-Y277V
A cco rd in g  to  th e  h o m o lo g y  m o d e l, Y 2 7 7  is  an oth er arom atic resid ue that sits in  the 
b ottom  o f  th e a c t iv e  s ite  (F ig u re  4 .2 7 ) . It h as b e e n  fou n d  to  b e  a con served  V a l in  the 
four o ther se sq u iter p e n e  sy n th a ses  and th e  in crea sin g  s iz e  o f  th is residue in  E B F S  
m ay b e  im portan t for  th e o v e r a ll sh ap e o f  th e a c tiv e  site  ca v ity . In addition, it m ay  
a lso  h elp  to  iso la te  th e su b strate fro m  th e so lv en t.
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Figure 4.27: Cartoon representation for the active site of 
EBFS homology model. FDP (shown as red stick) was 
docked into the active site by the program Flex X. Residue 
Y277 was shown as orange stick.
The corresponding residues from the other four sesquiterpene synthases are found to 
be a conserved Val. Thus, the mutant EBFS-Y277V was designed to check if the 
modified active site cavity would affect the product selectivity and catalytic activity. 
The native Tyr codon TAC was substituted by a Val codon GTG using site-directed 
mutagenesis. The mutant was produced and purified by the same method for the 
wild-type enzyme (Figure 4.28). Typically, 13 mg of EBFS-Y277V was obtained per 
litre of culture. GC-MS analysis following overnight incubation of EBFS-Y277V (10 
jxM) with FDP (1 mM) showed an unchanged product profile from the wild-type 
enzyme (Figure 4.29).
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Figure 4.28: (A) Chromatogram for DEAE purification o f EBFS-Y277V. (B) 13% 
SDS-PAGE analysis. Lane 1-14: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
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Figure 4.29: GC trace for incubation o f 10 pM EBFS-Y277V 
with 1 mM FDP in the presence o f 5 mM Mg2+.
T he k in e tic  p aram eters o f  th is  m u tan t co m p a ra b le  to  that ob ta in ed  from  the w ild -typ e  
en zy m e . T h e  kcat w a s  fo u n d  to  b e  0 .0 1 7  ±  0 .0 0 9  s '1 and the Km w a s  18 ±  7 pM  (Figure  
4 .3 0 ). T h u s, c h a n g in g  th e  v o lu m e  b a se d  o n  th is  T yr resid u e  d o es  n ot appear to a ffect 
the e n z y m e  fu n ctio n a lity  at a ll, su g g e s t in g  a con sid erab le  d istance b etw een  the  
b in d in g  su bstrate F D P  an d  th e  T yr re s id u e  at 2 7 7  p o sitio n .
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Figure 4.30: Kinetic analysis o f  EBFS-Y277V. (A) Time course (0.0375 pM enzyme, 10 pM 
FDP); (B) Plot of velocity against enzyme concentration (10 pM FDP, 20 min incubation 
time); (C) Michaelis-Menten plot (incubation of 0.375 pM enzyme with radiolabelled 
substrate for 20 min at 22 °C).
4.2.5 EBFS-I404Y/Y514L
In order to  g e t  a  further u n d erstan d in g  o f  th e re la tion sh ip  b e tw e en  active  site  v o lu m e  
and e n z y m e  fu n ctio n a lity , th e  m u tan ts in v estig a ted  ab o v e  w ere com b ined . First, a  
d ou b le  m u tan t E B F S -I 4 0 4 Y /Y 5 1 4 L  w a s  prepared, w h ic h  con ta in s m od ifica tion s to  
the s id e  and  b o tto m  o f  th e  a c t iv e  s ite . T h e d o u b le  m utant w a s  p rod uced  and purified  
in  the sa m e m a n n er  a s  th e w ild -ty p e  e n z y m e  (F igure 4 .3 1 ). T yp ica lly , 2 0  m g  o f  
E B F S -I4 0 4 Y /Y 5 1 4 L  w a s  o b ta in ed  p er litre o f  cu lture. In cu bation  o f  10 pM  purified  
e n zy m e w ith  1 m M  F D P  g a v e  n o  G C -M S  d etec ta b le  product (F igure 4 .3 2 ).
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Figure 4.31: (A) Chromatogram for DEAE purification o f EBFS-I404Y/Y514L. 
(B) 13% SDS-PAGE analysis. Lane 1-11: eluent fractions. Lane M: protein 
marker.
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Figure 4.32: GC trace for incubation o f 10 pM EBFS-1404Y/Y514L 
with 1 mM FDP in the presence o f 5 mMMg2+.
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The observed activity loss of the double mutant indicates a significant change of the 
active site conformation. The modified active site cavity may not be able to complex 
with FDP anymore, or FDP is docked into the active site with a conformation that is 
highly unfavored for any reaction to take place. Another three triple mutants were 
designed based on EBFS-I404Y/Y514L, trying to restore the catalytic activity of this 
enzyme against FDP. These mutants with additional alteration were also expected to 
be constructed with different functions.
4.2.6 EBFS-Y277V/I404Y/Y514L
The substitution Y277V was first introduced into the double mutant 
EBFS-I404Y/Y5 14L to confer the active site with more free space at the bottom 
(Figure 4.27). This triple mutant was overexpressed and purified by the same method 
as wild-type enzyme (Figure 4.33). Typically, 17 mg of EBFS-Y277V/I404Y/Y514L 
was obtained per litre o f culture.
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Figure 4.33: (A) Chromatogram for DEAE purification o f
EBFS-Y277V/I404Y/Y514L. (B) 13% SDS-PAGE analysis. Lane 1-12: eluent 
fractions. Lane M: protein marker. Lane C: concentrated protein.
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Although the mutation Y277V did not change either product selectivity or catalytic 
activity compared to wild-type EBFS, it restored the activity of the double mutant 
EBFS-I404Y/Y514L. In addition, the triple mutant showed an obviously different 
product distribution. (iT)-|3-Famesene is still the main product but it only makes up 
83% of the total sesquiterpenes and an increasing amount of (3Z,6E)-a-famesene 
(2.5%) and (3£’,6E)-a-famesene (11.5%) was observed by GC-MS (Figure 4.34). 
Besides, a newly formed peak at the retention time of 23.95 min was identified. 
Comparing the mass fragmentation pattern of this compound with data from the 
Wiley database available on the mass spectrometer software suggests a cyclic 
sesquiterpene structure. However, the actual structure of this compound cannot be 
assigned solely by it mass spectrum because the mass spectra of cyclic sesquiterpenes 
are very similar. An activity test was carried out by incubation of 0.5 [iM purified 
mutant with 60 (iM radiolabelled FDP for 30 min and the activity of enzyme reaction 
was roughly at the same level as the enzyme-free control. Thus, the catalytic activity 
was defined as too low to be measured reliably by the kinetic assay using 
radiolabelled substrate.
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Figure 4.34: (A) Sesquiterpene product profile o f EBFS-Y277V/I404Y/Y514L. Peak 1: 
unknown sesquiterpene product. Peak 2: (£)-|3-famesene. Peak 3: (3Z,6£>a-famesene. Peak 
4: (3£, 6E)-a-famesene. (B) EI-MS o f the peak 1.
In summary, all the mutants studied with the aim of manipulating the active site 
volume suggest that the bound famesyl chain is close to the side formed by helices H 
and G since the mutations (1404Y and Y514L) on this side significantly reduce the
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en zy m e  a c t iv ity  an d  th e d o u b le  m utant e v e n  lo s t  ca ta ly tic  activ ity , p o ss ib ly  due to  
im paired  su bstrate b in d in g . A fte r  r e le a s in g  so m e  m ore sp ace on  the other sid e o f  
a ctiv e  s ite  b y  th e  m u ta tio n  Y 2 7 7 V  in  th e trip le  m utant, the substrate m ay have b een  
forced  to  b in d  m o re  to w a rd s th e  o p p o s ite  s id e  o f  h e lic e s  H  and G  w ith  a d ifferent 
con form ation , a l lo w in g  a  n e w  c y c lic  p rod u ct to  form . H o w ev er , the orig inal active  
site  co n to u r  is  p r e c is e ly  d e f in e d  fo r  th e o p tim ise d  reaction  con d ition s, thus the 
m o d ific a tio n  le a d s  to  a  h u g e  red u ctio n  o f  e n z y m e  a ctiv ity .
4 .2 .7  N 4 4 4 D
T h e w o rk  so  far w a s  fo c u s s e d  o n  m a n ip u la tin g  the sp ace in sid e  the active  site  p ocket. 
O n the o th er h an d , th e  co n fo rm a tio n  o f  the substrate b in d in g  area is  a lso  crucial for  
the p rod u ct s e le c t iv ity  an d  a c t iv ity  an d  m u ta tion s in  th e M g 2+ b ind in g  m o tif  cou ld  
ch an ge b o th  th e  e n z y m e  a c t iv ity  and  p rod u ct p ro file  (95, 170-172). A ccord in g  to the  
h o m o lo g y  m o d e l an d  th e  se q u e n c e s  a lig n m en t, N 4 4 4  w a s  id en tified  as part o f  the  
seco n d  M g 2+ b in d in g  m o t i f  N ^ D T S S Q L R E  (eq u iv a len t p o sitio n  to  other plant 
sesq u iterp en e sy n th a se s )  an d  it w a s  fo u n d  to  b e  an  A sp  in  the corresp ond ing  p osition  
am on g  so m e  o th er  p la n t se sq u iterp en e  syn th ases . P rev iou s stud ies sh o w ed  that the  
corresp on d in g  m u ta tio n  N 2 4 4 D  in  the P. roqueforti a risto loch en e syn th ases altered  
the p rod u ct s e le c t iv ity  fro m  94%  a r isto lo ch en e  to  80%  germ acrene A  and redu ced  the  
cata ly tic  e f f ic ie n c y  b y  6 6 0 0 - fo ld  (9 5 ) . T h erefore, the m utation  E B F S -N 4 4 4 D  w a s  
co n stru cted  in  b o th  th e  w ild -ty p e  e n z y m e  and th e m utant E B F S -I4 0 4 Y /Y 5 1 4 L  to  
in v estig a te  i f  th is  ch a n g e  c o u ld  b rin g  n e w  fu n ction  to th e a ctiv e  sites w ith  d ifferent  
v o lu m e s.
B oth  m u tants w e r e  p u r ified  b y  th e sa m e m eth o d  as w ild -ty p e  E B F S  (F igure 4 .3 5 ).
T y p ic a lly , 2 0  m g  o f  E B F S -N 4 4 4 D  an d  10 m g  o f  E B F S -I4 0 4 Y /N 4 4 4 D /Y 5 1 4 L  w as
ob ta in ed  p er  litre  o f  cu ltu re. In cu b ation  o f  E B F S -N 4 4 4 D  w ith  F D P  g a v e  n o G C -M S
d etectab le  se sq u iter p e n e  p rod u ct (F igu re  4 .3 6 ) . T h e ob serv ed  lo ss  o f  w ild -typ e
en zy m e a c t iv ity  re su ltin g  fro m  th is  m u tation  in  the M g 2+ b in d in g  m o tif  is  probably
due to  d istu rb an ce  o f  th e  p r e c ise  b in d in g  con form ation  o f  the substrate b y
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compromising the enzyme:Mg2+:FDP tertiary complex. It also suggests a precise 
active site template, which is only defined for certain substrate binding conformation. 
EBFS-I404Y/N444D/Y514L showed very weak enzyme activity; only three small 
peaks (barely higher than the noise level) representing (£}-(3-famesene, 
(3Z,6£)-a-famesene and P E ^i^-a-fam esene were identified by GC-MS analysis 
after a typical overnight incubation (Figure 4.36). Although the misfolded substrate in 
the modified active site of the triple mutant did not lead to a total loss of activity, the 
catalytic efficiency was lowered to a negligible level.
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Figure 4.35: Chromatograms for DEAE purification o f EBFS-N444D (A) and EBFS- 
1404Y/N444D/Y514L (B) and 13% SDS-PAGE analyses o f each purification (C) and (D). 
Lane 1-11: eluent fractions for EBFS-N444D. Lane 12-22: eluent fractions for 
EBFS-I404Y/N444D/Y514L. Lane M: protein marker. Lane C: concentrated protein.
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Figure 4.36: Product profiles fo r incubation o f FDP with EBFS- N444D (A) and EBFS- 
I404Y/N444D/Y514L (B).
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4.2.8 EBFS-I404Y/Y514L/A529Y
Another substitution that was introduced into the double mutant EBFS-I404Y/Y514L 
was A529Y. The residue A529 belongs to the J-K loop, which is located near the 
entrance of the active site and has been shown to be involved in the movement upon 
ligand binding, capping the active site pocket during catalysis (7). This residue was 
proposed to be close to the Mg2+-PPi complex. The corresponding residues to A529 
are either Tyr or Phe among the other four sesquiterpene synthases (Figure 4.37). The 
aromatic group could provide negative or positive electrostatic potential to the local 
area and this might be related to adjusting the orientation of the Mg2+ cluster. In 
addition, they might also provide the bulk required for the shape of the active site.
This triple mutant was purified in the same manner as the wild-type enzyme (Figure 
4.38). Typically, 15 mg of EBFS-I404Y/Y514L/A529Y was obtained per litre of 
culture. GC-MS showed three weak signals representing (7s)-|3-famesene (65), 
(3Z,6E)-a-famesene (112) and (37s,67s)-a-famesene (113) respectively following a 
typical overnight incubation (Figure 4.39).
Figure 4.37: Cartoon representation of DCS complexed with three 
magnesium ions and substrate analogue 2F-FDP (PDB 3G4D, chain 
A). Magnesium ions are shown as green spheres and bound 2F-FDP is 
shown as red sticks. Residue Y535 is shown as orange sticks.
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Figure 4.38: (A) Chromatogram for DEAE purification o f EBFS-I404Y/Y514L/A529Y. (B) 
13% SDS-PAGE analysis. Lane 1-6: fractions from the first peak. Lane 7-16: fractions from 
the second peak. Lane M: protein marker. Lane C: concentrated protein.
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Figure 4.39: GC trace for incubation o f 10 pM
EBFS-I404Y/Y514L/A529Y with 1 mM FDP in the presence o f 
5 mM Mg \
Similar to the mutant EBFS-I404Y/N444D/Y514L, EBFS-I404Y/Y514L/A529Y 
seems to affect the precise binding of the substrate, supported by the fact that the
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triple mutant showed weak activity rather than loss of activity seen for the mutant 
EBFS-I404Y/Y514L. However, only acyclic products ((£)-|3-famesene (65), 
(3Z,6ir)-a-famesene (112) and (BE^i^-a-famesene (113)) were formed, which 
suggests the active site of this mutant is still quite rigid and not able to allow the 
formation of cyclic intermediates or products.
4.2.9 EBFS-S402C/G440C
In the crystal structure o f DCS, a disulfide linkage between C408 and C447 was 
identified (Figure 4.40). The specific function of this structure has not been 
discovered; nevertheless this linkage could possibly stabilize helices G and H, leading 
to a better-defined active site template for the precise intermediates and product to 
form.
Helix G
Helix H
Figure 4.40: Cartoon representation o f DCS with substrate analogue 
2F-FDP bond in the active site (PDB 3G4D, chain A). Bound 2F-FDP is 
shown as red sticks. Disulfide linkage is shown as orange sticks.
In the homology model of EBFS, S402 and G440 were found at analogous positions 
to the two cysteine residues from DCS. A double mutant (EBFS-S402C/G440C) was 
designed to introduce the disulfide bridge into the structure of EBFS. To construct the 
cDNA of the double mutant, the native codons AGC for S402 and GGT for G440 
were replaced by Cys codons TGC and TGT, respectively, by site-directed 
mutagenesis. The double mutant was purified in the same way as wild-type enzyme 
(Figure 4.41). Typically, 10 mg of EBFS-S402C/G440C was obtained per litre of
165
culture. Sesquiterpene products profile was obtained by an incubation of 10 pM 
EBFS-S402C/G440C with 1 mM FDP at room temperature overnight. GC-MS 
analysis showed that mainly (iT)-(3-famesene (97) and (3Z, 6£)-a-famesene (112) were 
identified as sesquiterpene products with a roughly 2 to 1 ratio (Figure 4.42). Kinetic 
assay of this mutant was not performed.
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Figure 4.41: (A) Chromatogram for DEAE purification o f EBFS-S402C/G440C. (B) 13% 
SDS-PAGE analysis. Lane 1-20: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
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Figure 4.42: GC trace for incubation o f 10 pM EBFS-S402C/G440C 
with 1 mM FDP in the presence o f 5 mM Mg2+.
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Further investigation of the role of the proposed disulfide linkage was performed by 
employing tris(2-carboxyethyl)phosphine (TCEP) (Figure 4.43). TCEP is a commonly 
used reducing agent for the purpose of breaking disulfide bonds between and within 
proteins {173). Thus, a different product profile was expected after addition of TCEP 
into the reaction solution, if the disturbed product distribution was caused by the 
formation of the disulfide linkage.
O O
F ig u r e  4 .4 3 : The structure o f TCEP.
Six individual incubation tests were carried out by addition of FDP (final 
concentration of 1 mM) to solutions containing 10 pM protein with variable 
concentrations of TCEP (0.1, 1, 3, 8 and 20 mM). GC-MS analysis revealed no 
obvious change of product profile up to 8 mM TCEP (Figure 4.44), while protein 
precipitation was observed when the concentration of TCEP was increased to 20 mM. 
The unchanged product profiles strongly indicate that the two cysteine residues did 
not form the proposed disulfide bond in the tertiary structure of EBFS. Nevertheless, 
both mutations could lead to a change of overall active site contour. According to the 
homology model (Figure 4.18), both S402 and G440 are located in the middle part of 
the active site. The size increase caused by mutation G440C would greatly reduce the 
width of the active site, affecting the substrate binding conformation in the active site. 
Differing from previously prepared mutants that did not affect the product distribution, 
the alterations in the active site of EBFS that introduced two cysteine mutations 
would possibly force the C4 proton to be more accessible to the active site base. This 
was supported by the increased production of (3Z,6£)-a-famesene. In addition, it also 
revealed a critical role for the structure of helices G and H, which could be the 
essential component to determine the product specificity of EBFS.
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F ig u r e  4 .4 4 :  The TCEP concentration dependence o f product profiles. GC  
traces for in cu b ation  o f  10 p M  E B F S -S 4 0 2 C /G 4 4 0 C  w ith  1 m M  FD P  at 
the p resen ce  o f  variab le  T C E P  con centration s.
The enzymatic reaction catalysed by the double cysteine mutant was also performed 
in non-reducing conditions. The mutant protein was purified without the presence of 
any reducing agent. 200 pi of the purified protein (20 pM) was first left in the air at 
room temperature for 12 h and then mixed with 250 pi buffer (20 mM MOPS, 5 mM 
MgCh, pH7.2) and 50 pi FDP (10 mM). The incubation was left at room temperature 
overnight. GC-MS analysis showed an unchanged product profile compared to that 
obtained under reducing conditions (Figure 4.45).
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F ig u r e  4 .4 5 :  GC trace for incubation o f 10 yM  EBFS-S402C/G440C 
with 1 mM FDP in the buffer system without any reducing agent.
4.2.10 EBFS-S402C/G440C/Y514L
The substitution Y514L was first introduced into the double cysteine mutant to test if 
the increasing volume at the bottom of active site pocket would have any particular 
effect on the selectivity of the double cysteine mutant. The triple mutant was 
produced and purified by the same procedure as the wild-type enzyme (Figure 4.46) 
typically yielding 23 mg of EBFS-S402C/G440C/Y514L per litre of culture. 
Incubation of the purified enzyme with FDP showed an unchanged product profile 
from that of the double cysteine mutant (Figure 4.47). Together with the result from 
mutant EBFS-Y514L, the unchanged product profile of this triple mutant suggests the 
residue Y514 has nearly no contribution to the product specificity of EBFS. Kinetic 
assay of this mutant was not performed.
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F igure 4.46: (A) Chromatogram for DEAE purification o f
EBFS-S402C/G440C/Y514L. (B) 13% SDS-PAGE analysis. Lane 1-11: 
eluent fractions. Lane M: protein marker.
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Figure  4.47: GC trace for incubation o f 10 pM
EBFS-S402C/G440C/Y514L with 1 mM FDP in the presence o f 5 
mM Mg2 .
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4.2.11 EBFS-S402C/I404Y/G440C
Another triple mutant was constructed by adding the substitution I404Y into the 
double cysteine mutant. This triple mutant was overexpressed and purified by the 
same manner as wild-type enzyme (Figure 4.48), typically yielding 10 mg of 
EBFS-S402C/I404Y/G440C per litre of culture. GC-MS analysis of the hexane 
extractable products from the incubation of purified mutant with FDP showed no 
obvious sesquiterpene product formation (Figure 4.49).
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Figure 4.48: (A) Chromatogram for DEAE purification of EBFS-S402C/I404Y/G440C. (B) 
13% SDS-PAGE analysis. Lane 1-13: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
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Figure 4.49: GC trace for incubation o f 10 pM  EBFS-S402C/I404Y/G440C 
with 1 mMFDP in the presence o f 5 mMMg2+.
As mentioned before, residue 1404 was found to be positioned in between helices G 
and H in the homology model. Therefore, the substituted Tyr was expected to further 
disturb the active site contour that has been modified by the double cysteine mutant. 
The observed activity loss of this triple mutant indicated a significant effect of the 
active site volume on the enzyme activity. The substituted residues together brought a 
local volume reduction to the side of active site cleft and the substrate might not be 
able to fit into the newly formed active site with a proper conformation for the 
reaction. In addition, this fact supports the assumption that substrate FDP binds more 
closely to the side of the active site formed by helices G and H (see Section 4.2.6) and 
modifications in this area will directly lead to the product promiscuity and the 
reduction of enzyme activity.
4.2.12 EBFS-S402C/I404Y/G440C/Y514L
The mutant EBFS-I404Y/Y514L has been proved to be a non-catalytic enzyme. Here, 
a quadruple mutant was prepared by introducing the double cysteine mutations into 
the mutant EBFS-I404Y/Y514L to check if the further modification to the active site 
would confer the enzyme with ability to make new sesquiterpenoid products. The
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mutant was purified by the same method as wild-type enzyme (Figure 4.50), typically 
yielding 10 mg of EBFS-S402C/I404Y/G440C/Y514L per litre of culture.
Remarkably, the quadruple mutant showed activity towards FDP rather than the 
observed activity loss of double mutant EBFS-I404Y/Y514L and triple mutant 
EBFS-S402C/I404Y/G440C. The product profile of this mutant was very close to the 
one from the double cysteine mutant, consisting of mainly (£)-p-famesene and 
(3Z,6E)-a-famesene with a tiny amount of {3E,6E)-a-famesene (Figure 4.51). A 
slight increase in production of (3Z,6£)-a-famesene was observed from 30% of the 
double cysteine mutant to 40% of the quadruple mutant. These results indicated that 
the modifications further altered the binding orientation of famesyl chain in the active 
site, which made the proton elimination from C l5 became less favoured.
Figure 4.50: (A) Chromatogram for DEAE purification o f EBFS-S402C/I404Y/G440C/Y514. 
(B) 13% SDS-PAGE analysis. Lane 1-13: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
/
B Volume ml
116.0k
66.2 k
45.0 k
35.0 k
173
100 1
s?^
 80 o o
•g 603
3
o 40 • 
>
'■8
S  20 ■
23 24 2 5 26 27
Time / min
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4.2.13 EBFS-Y277V/S402C/I404Y/G440C/Y514L
Another substitution Y277V was introduced into EBFS-S402C/I404Y/G440C/Y514L 
to check if any new product would be formed by creating more free space at the 
bottom of the active site pocket. The mutant was produced and purified by the same 
method as wild-type enzyme (Figure 4.52). Typically, 15 mg of purified protein was 
obtained per litre of culture. Apart from the three acyclic products also produced by 
the previous quadruple mutant, a new product (appeared at 23.95 min) with a mass 
fragmentation pattern suggestive of a cyclic sesquiterpene was also identified by 
GC-MS (Figure 4.53). The m/z of 161.1 most likely represents the fragment of a 10 
member ring structure, which was form by losing the isopropyl group from 
sesquiterpene product. This fragmentation pattern in the mass specta of this 
compound is very similar to that of cadinane type sesquiterpenes and greatly suggests 
that a 1,10-cyclisation is involved in the formation of this compound.
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Figure 4.52: (A) Chromatogram for DEAE purification of
EBFS-Y277V/S402C/I404Y/G440C/Y514. (B) 13% SDS-PAGE analysis. Lane 1-17: eluent 
fractions. Lane M: protein marker. Lane C: concentrated protein.
This product profile is close to that of mutant EBFS-Y277V/I404Y/Y514L, whereas 
the increased amount o f (3Z, 6£)-a-famesene (16%) represents the impact of the 
double cysteine mutant. In addition, the increased amount of the unknown 
sesquiterpene product (7%) supports the previously proposed explanation that 
modifications on the helices G and H forces the substrate to move towards the other 
side of the active site and the enlarged space created by mutation Y277V could 
possibly accommodate substrate in a cyclic form to initiate cyclisation. We speculated 
that the mutant produces mainly acyclic compounds probably because the ic-orbital of 
the distal double bond and the empty p-orbital of Cl could not reach a perfect 
alignment required for the alkylation. Thus, only a small amount of substrate FDP can 
be converted into cyclic product.
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F ig u re  4 .5 3 :  GC trace for incubation o f 10 pM  EBFS-Y277V/S402C/I404Y/G440C/Y514L 
with 1 mMFDP in the presence o f  5 mM Mg2+ (A) and EI-MS o f the peak at 23.95 min.
4.2.14 Active site hybrid
Plant sesquiterpene synthases exhibit a significant degree of similarity at the amino 
acid level and this feature leads to some successful examples of manipulating enzyme 
function through a small amount of amino acid substitutions in the active site (155, 
174). However, in our studies all the attempts to modify the active site volume to 
mimic other plant sesquiterpene synthases failed to alter the function of EBFS from 
generating cyclic sesquiterpene product as major product. To get a better 
understanding of the relationship between active site contour and product selectivity, 
a hybrid was prepared by substitution residues of EBFS that have contact with the 
substrate FDP within 8 A with corresponding ones from DCS (Figure 4.54). The 
whole design was based on the deduced amino acid sequence alignment and the 
homology model of EBFS. In total, 50 residues of EBFS were identified have contact 
with FDP within 8 A, in which 34 residues were different to the corresponding 
residues from DCS (Figure 4.55). Thus, these 34 residues were chosen to be 
substituted.
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Figure 4.54: Cartoon representation o f the EBFS homology model. FDP 
was docked into the active site by the program MOE (red). Selected 
mutations are shown as sticks.
1 MATNGWISCLREVRPPMTKHAPSMWTDTFSNFSLDDKEQQKCSETIEALKQEARGMLMA 
6 1  ATTPLQQMTLIDTLERLGLSFHFETEIEYKIELINAAEDDGFDLFATALRFRLLRQHQRH  
1 2 1  VSCDVFDKFIDKDGKFEESLSNNVEGLLSLYEAAHVGFREERILQEAVNFTRHHLEGAEL 
1 8 1  DQSPLLIREKVKRALEHPLHRDFPIVYARLFISIYEKDDSRDELLLKLSKVNFKFMQNLY  
2 4 1  KEELSQLSRWWNTWNLKSKLPYARDRWEAYVWGVGYHYEPQYSYVRMGLAKGVLICGIM 
3 0 1  DDTYDNYATLNEAQLFTQVLDKWDRDEAERLPEYMKIVYRFILSIYENYERDAAKLGKSF 
3 6 1  AAPYFKETVKQLARAFNEEQKWVMERQLPSFQDYVKNSEKTSCIYTMFASIIPGLKSVTQ 
4 2 1  ETIDWIKSEPTLATSTAMIGRYWNDTSSQLRESKGGEMLTALDFHMKEYGITKEEAASKF 
4 8 1  EGLVEETWKDINKEFIATTNYNVGREIAITFLNYARICEASYSKTDGDAYLDPNVAKANV 
5 4 1  VALFVDAIVF
Figure 4.55: The deduced amino acid sequence ofWT-EBFS. The mutations on the active site 
hybrid are coloured orange.
The construct of the hybrid was created by mutating the native codon TAT which 
encodes amino acid Y271 to AGC; together with the codon GCT that encodes amino 
acid A270, this mutation creates a NheI restriction site. A synthetic DNA fragment 
was designed to encode the amino acid sequence after V272 of EBFS with all the 
chosen mutations and constructed with Nhe I and BamHI restriction sites at the 5’ and 
3’ end respectively. Double digestion of the mutated plasmid with Nhel and BamHl 
restriction enzymes and subsequent ligation with the synthetic DNA fragment formed 
a plasmid containing the gene encoding the hybrid (Figure 4.56). Formation of the
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constructed plasm id was checked by a single digestion with BamHl (Figure 4.57) and 
also confirmed by D N A  sequencing.
EBFS 5’-
NHf
Synthetic gene fragment encoding 
part of DCS with selected mutations
Hybrid 5’-
N H f
Nhel
 I____
i---------
810 bp 
(270 aa)
Nhel
5 - J -
N H f
BamHl
1653 bp 
(550 aa)
BamHl
3’
COO
3’
COO-852 bp 
(281 aa)
Stop codon 
3-
1 COO-1653 bp 
(550 aa)
Figure 4.56: Schematic diagram o f  construction o f  the active site hybrid. Line drawings 
depict composite diagrams for wild-type EBFS (coloured white), synthetic gene fragment 
encoding part of DCS with selected mutations (coloured black) and hybrid gene.
8 . 0  k b  —
6 . 0  k b -
- 8 . 0  k b  
- 6 . 0  k b
Figure 4.57: 1% Agarose gel analyses o f  the active site hybrid cDNA construct preparation. 
Lane 1: The mutated insert gene after double digestion by both Nhe I and BamHl restriction 
enzymes. Lane 2: The mutated insert gene after digestion by BamHl restriction enzyme. Lane 
3: The gene plasmid of the hybrid. Lane 4: The gene of the hybrid after digestion by BamHl 
restriction enzyme. M: 1 kb DNA ladder.
The hybrid w as purified by the same method as wild-type EBFS (Figure 4.58), 
typically yielding 6 m g o f  hybrid per litre o f culture. Surprisingly, the overall active
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site modification leads to a huge reduction in enzyme activity. GC-MS analysis 
showed only two weak signals (barely higher than the noise level) representing 
(£)-(3-famesene and (3Z, 6iT)-a-famesene as products from an overnight incubation of 
10 |xM purified mutant with 1 mM FDP; the expected product 6-cadinene was not 
detected (Figure 4.59). A control experiment by removing FDP from incubation 
solution was carried out to ensure the observed sesquiterpene peaks were coming 
from the enzymatic reaction. This model indicates a well-defined active site volume 
of wild-type EBFS for the acyclic products. Although the chemical environment and 
steric conformation of the active site has been modified to mimic another plant 
sesquiterpene cyclase, the rigid space would not allow any cyclic intermediates or 
products to form.
Volume ml
Figure 4.58: (A) Chromatogram for DEAE purification o f the active site 
hybrid. (B) 13% SDS-PAGE analysis. Lane 1-13: eluent fractions. Lane M: 
protein marker.
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Figure 4.59: GC trace for incubation o f 10 fiM the active site 
hybrid with 1 mM FDP in the presence o f 5 mM Mg2+.
3.3 Conclusions
Wild-type EBFS has been fully purified and determined to be a monomer at pH 7.2. 
An overall a-helical fold was confirmed by CD spectroscopy. The product 
distribution was defined as (£)-|3-famesene (95%), (Z)-|3-famesene (1.5%), 
(3Z, 6£)-a-famesene (1.3%), (3E, 6£)-a-famesene (0.2%) and another 5 unknown 
cyclic products (<2% in total) when Mg2+ was employed as the cofactor. Mechanitic 
studies using the substrate analogue 2F-FDP suggests an concerted syn-elimination 
rather than the previously proposed two step El elimination (115) by forming the 
transoid allylic cation as the intermediate since the C2 fluorine can greatly inhibit the 
forming of this intermediate through an inductive electron withdrawing effect. It was 
believed that the enzymatic formation of sesquiterpenes went through the ionization 
of trans-trans-famesyl diphosphate to the corresponding transoid allylic cation. 
However, the E2 elimination suggests an alternative route to (2i)-|3-famesene. It seems 
that the enzymatic reaction catalysed by EBFS is under kinetic control since the 
predominant product (£)-|3-famesene is not the most stable product. In addition, the 
formation of transoid allylic cation intermediate in sesquiterpene cyclization reactions 
was also reported to be under kinetic rather than thermodynamic control (175).
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Alternatively, purified wild-type EBFS catalyses the conversion of Cio analogue GDP 
to mainly acyclic products (myrcene (38.3%), (£)-ocimene (29.4%) and (Z)-ocimene 
(18.9%)), rather than the previously reported major product limonene (48%) that was 
generated by the partially purified enzyme. The broad distribution towards three 
acyclic products is probably due to the large active site volume which leads to 
different substrate GDP binding conformation, allowing the active site base to 
approach protons from both C4 and CIO.
In terms of the proposed active site volume theory (Section 4.2.1), three single 
mutants (Y277V, 1404Y and Y514L) were prepared to mimic the conformation of this 
region in the other four plant sesquiterpene synthases, but none of them had a 
significant influence on the product outcome, only a 20-100 fold catalytic efficiency 
reduction was observed for mutants 1404Y and Y514L. The observed activity loss in 
the double mutant EBFS-I404Y/Y514L and restored activity of the triple mutant 
EBFS-Y277V/I404Y/Y514L indicate that the position of the famesyl chain in the 
active site of wild-type EBFS should be close to the helices G and H. After 
introducing mutations 1404Y and Y514L, the active site contour could not 
accomodate the famesyl chain in a reactive conformation, leading to activity loss. 
Mutation Y277V brought more space into the active site of the double mutant and the 
substrate can be accommodated into the enlarged active site again but more towards 
the opposite site of helices G and H with a slightly different conformation. The 
modified active site contour plus the possibly different substrate binding conformation 
led to the formation of an unknown cyclic sesquiterpene by the intramolecular attack 
of the 10,11- or 6,7- double bond on Cl.
Mutagenesis studies at the two conserved Mg2+ binding motifs showed the possibility
of altering both the enzyme activity and product profile (95, 170-172). When the
mutation N444D (from the second Mg2+ binding motif N444DTSSQLRE) was
introduced into both wild-type EBFS and the double mutant I404Y/Y514L, only a
huge enzyme activity reduction was observed. The observed activity loss by
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manipulating the Mg2+-binding site suggests a significant disturbance of the precise 
substrate binding conformation. This change did not generate any new product, 
possibly due to the rigid active site pocket, which would barely accommodate any 
kind of cyclic intermediate or product.
The active site contour was also modified by introducing two cysteine substitutions, 
which have been observed to form a disulfide linkage in the crystal structure of DCS. 
However, treatment with TCEP suggested that the newly introduced two cysteine 
residues did not form the proposed disulfide linkage in the tertiary structure of EBFS. 
Nevertheless, the double cysteine mutant alters the product distribution from 
(£)-P-famesene (95%) to 65% (£)-p-famesene, 33% (3Z,6£)-a-famesene and 1% 
(3E, 6£)-a-famesene. The increased production of (3Z, 6£)-a-famesene suggests a 
possible active site volume reduction, which would squeeze the famesyl chain more 
towards the entrance of the pocket, leading the C4 proton to be more accessible to the 
diphosphate group (proposed active site base). This is consistent with the apparent 
function of the two cysteine mutations that could reduce the width of the active site 
pocket. In addition, the alteration of the product distribution by modifications on the 
helices G and H also indicates the structure of helices G and H may be the key 
component that determines the product specificity for the enzyme.
Additional modifications toward manipulating the active site volume did not confer
the enzyme with obvious new function. The activity loss of the triple mutant
EBFS-S402C/I404Y/G440C suggests that the modified active site was not able to
accommodate the substrate with the proper conformation due to the volume reduction
caused by the mutations. This can be supported by the fact that releasing some space
in the active site of the non-catalytic enzyme by mutating the aromatic residue Y514
into a smaller hydrophobic residue Leu restored catalytic ability of the enzyme. The
quintuple mutant EBFS-Y277V/S402C/I404Y/G440C/Y514L even reveals a
combined effect of the mutants EBFS-Y277V/I404Y/Y514L and
EBFS-S402C/G440C by showing an increased production of (3Z,62s)-a-famesene and
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the newly formed unknown sesquiterpene (retention time of 23.95 min) compared to 
the wild-type enzyme.
The observed activity loss of the active site hybrid simply illustrates the importance of 
the active site volume. In other words, the active site of the hybrid does not contain a 
proper cavity to dock cyclic intermediates and products, although it contains a nearly 
identical chemical environment to DCS. In addition, the modification also 
compromises the ability to form (£)-|3-famesene, suggesting either the conformation 
of the Mg2+ binding area has been severely disturbed or the modified active site 
contour cannot accommodate the native substrate FDP.
Table 4.5: Summary o f kinetic data for the mutants o f EBFS.
Protein kcat ! S Km/ \ i M
W T -E B F S 0.015 ± 0 .0 0 4 6.4 ±  1.7
E B F S -Y 5 1 4 L (5.5 ± 1.9) xlO-4 23 ±8
E B F S -I4 0 4 Y 0.0037 ±0.0016 29 ±12
E B F S -Y 2 7 7 V 0.017 ±0.009 18 ± 7
E B F S -I 4 0 4 Y /Y 5 1 4 Y Inactive
E B F S - Y 2 7 7 V /1 4 0 4 Y /Y 5 14 Y P oor actvity
E B F S -N 4 4 4 D Inactive
E B F S -I 4 0 4 Y /N 4 4 4 D /Y  5 1 4 Y Inactive
E B F S -I4 0 4 Y /Y  5 1 4  Y /A 5 2 9 Y Poor actvity
E B F S -S 4 0 2 C /G 4 4 0 C A ctiv e
E B F S -S 4 0 2 C /G 4 4 0 C /Y  5 1 4L A ctiv e
E B F S -S 4 0 2 C /I4 0 4 Y /G 4 4 0 C Inactive
E B F S -S 4 0 2 C /I4 0 4 Y /G 4 4 0 C /Y  5 14L P oor activ ity
E B F S -Y 2 7 7 V /S 4 0 2 C /I4 0 4 Y /G 4 4 0 C /Y  5 1 4L P oor activity
A c t iv e  s ite  hybrid Inactive
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Chapter 5: Dual roles of the N-Terminal 
Region in Catalysis
1 8 4
5.1 In troduction
Sesquiterpene synthases from bacteria and fungi are single-domain enzymes. These 
enzymes contain a class I terpenoid synthase fold domain constructed with several 
a-helices connected by short loops. Plant sesquiterpene synthases usually contain an 
additional N-terminal domain (91). This domain adopts an a-helical fold closely 
related to glycosyl hydrolases and has a structure similar to the N-terminal domain of 
the class II terpenoid synthase fold (92). Recently, the crystal structure of A. grandis 
a-bisabolene synthase (AgBIS) was solved (176), which is the first three-domain plant 
sesquiterpene structure. Unlike the previous structurally characterised plant 
sesquiterpene synthases (TEAS and DCS) that have only two domains, AgBIS 
composes an additional domain (insertion domain), which can be found in diterpene 
synthases such as taxadiene synthase and copalyl diphosphate synthase (130, 138). 
The C-terminal domain of AgBIS contains the class I terpenoid synthase fold and is 
determined to be the functionally active domain. While, the N-terminal domain 
together with the insertion domain of AgBIS exhibits a non-functional class II 
terpenoid synthase fold, since AgBIS lacks the conserved DXDD motif that initiates 
the cyclization of linear isoprenoids. Thus, AgBIS is proposed to be potentially an 
intermediate in the evolutionary transition from diterpene to sesquiterpene synthase 
(176). In this sense, the N-terminal domain of plant sesquiterpene synthase may 
function as part of the class II terpenoid synthase active site for the ancestral origin of 
this enzyme family. However, the function of the N-terminal domain among 
two-domain plant sesquiterpene synthases is still not clear.
It has been proposed (57) that the N-terminal domain of plant sesquiterpene synthase 
plays a role in capping the active site of the C-terminal class I terpenoid synthase 
domain. In the crystal structures of two plant sesquiterpene synthases (TEAS and 
DCS), the N-termini are above the entrance of the active site, which were proposed to 
protect the active site from exposure to the solvent during catalysis (75, 114). Based 
on the crystal structure of TEAS, it has also been suggested that the N-terminal region
1 8 5
may have contact with A-C, D-Dl, J-K and H -H-al loops for the purpose of 
protecting the active site (91). Thus it is tempting to suggest that the N-terminal 
region could have influence on catalysis. Based on the sequence alignment of EBFS 
with other plant sesquiterpene synthases, the initial part (first 14 amino acids) of the 
N-terminal region (M1-K38) shares nearly no similarity, yet the rest part of sequence 
shares a considerable amount o f similarity and identity (Figure 5.1).
GAS 1 KAAVEAKGTLQAKTKTTTEPVR LANT? SVHGDRFMFSI.DKKEI.EGTAKAiiEEPK£ELRRI,::VDSCKDSKKttSX.iySVHiaUSLnLF
GCS 1 M A A SS,,^v~A EK CR LAKTH SW CYHFL8 YT. HEITNQ. EKVEVDETKETIRK LVETCDNSTQKLVLI. AHQRXiGVAIKF
TEAS 1 KASAAVAKXESEZVK VADFS 8 LHGDQFIA F 8 1KWCVAEKYA KE Z EAUtE QC RK tLATGKKIADCU{I.IDTZERX«ZSIKF
DCS 1 KASQVSOKPSSSPLSSKKDEKK KADFQ SZWGDLFUfCPDKHZDAE • CEKRHQQUCEEVRK ZVAFXAKSTQKLATXDSVQHbGVSIKF
EBFS 1 MATKGW:SCLREVRP KTKHA SJWTDTFSKFSLDDKE0QKC3ETZRAUCQEARG XJfAATTP.l£QKrLII»TLERLiGL8FKF
GAS 91  LQEIEA0IAKLFKEFKX/QDYDEVDI.XTT8ZKFQVFRHLGHKLP DVFKRFKDSTSGKFICEXITKDVKSKLGLrESAQLKVRGESILDEAS
GCS 77 DKEIETSIOKIFDASSKOKDKDKKI.rWSLRFRI.VRQOCTntSSDVFKOFTK.ODeiCFKETM’KDVQGLLSMEASHI.RVRKEEIUEEAL
t e a s  84 e k e i d d i l p q i x ^ . ^ ^ OTcirc f tr e g AM y jn ftMMwmAm rtxrm^ TMwrjwAfw/m*ixvuMYWtMuaxu(MU
DCS 90 TKEXEDEIAKXyHKK. .  .KDAEKDX.XTTSZRFRXAREHGYKVS DTFKKFKP ■ EQCKTKS8VTSU VRCLLEI.TQAS YLRVHGEDII^EAZ
EBFS 84 ETKi Kr Ki KLXKAAg ^ ^ ^ v BQCFTafcf ftTf tm F U U I » M V SF*1P UU» 4 * AX
GAS 181  A FTETK UCSW K TlfG K. . .LEEOVMQSUUt FKQGH KVEAKX.XF8. KYTEECATHASLI.KZJUCLHFSYLEIJQQKEEXAZV8QHWKDKE
GCS 1 6 6  TFTTT8XASTVSKLSKKKKSLKVEVGEALTQ ZRKTZ RMGARKXIB. XIEKKDAHHBLU<KFAKU>FHKXaQKFHQREI£DX.TfWKKDI^)
TEAS 169  AFSTZHX^RAAPHXJCSP. .  . LREOVTHALEQCLHKGV KVETRFFESSIXDKEOSKKKVIiRFAKADFIiX&QHUfKQEXAQVBimWKDLD
DCS 1 7 6  SFTTHKLSLAVASXjD H ?. . . LE EVSHALKQSZRRGL KVEARHIIA. VTQDZEBHHKALLEFAKZDFWLQFUCRICEIAEZCIWWKDUS
EBFS 169  KTTRHKLFG^^AEIJXJSPIilREKVKHALEH L.HRDF ZTOARLFXS. ITEKDDSRDEIXLKLSICVKFKrKQKI.YKEEMQIARWKirTtfK
GAS 2 6 7  FQCSV 1 1 RDRV PEIXLHIM LXFE RISLARZZATKZTLrLWLDDTXDAXATZEEZRLLTDAIKRWDISAMEQI E U R  FXKZIXEE
GCS 2 5 5  FAKKT TAKDRLVECIFKXIiGVXFE KTSRARK XTKVLKLTSXZDDTFDAIATFDEI.VTFKDAICRHDANAIDSIQPI R AXQALL -
TEAS 2 5 6  FVTTX. XARDRWECXFMAI2SVXFE QIS-QARV I.VKTZSItZSIVDI»TFDAIGTVKKXeAXTDAIQRWDIKEIDRL DX KZSIKAZLDL
DCS 2 6 2  FQRKL I  ARE1 RWEGXFXXSOVXFE QXSLGRK tTKVTAKASIVDDTXDSIATXEEXrPXTKAIERKDIltCIOEI EX K SIKALU V
EBFS 2 5 6  LKSKX. lARDKWBAXVWGVOXirXE QISXVRMGXAKGVLTCGUtDDTTDKXATUfEAOLrrOVXiMCMDRDEAERL EX KZVXRFZtSZ
GAS 3 5 7  TAEX.£KQLRXEOREK5V:ASJCQAFQD;AKGXZ£EAEtrTKSG.XVATFPETXK]iGLITSAXt>VTSKSAl.V6 GEKVSEBALAKYESH KTL
GCS 3 4 5  I SSMBQVL8KECICLDRVTIAKNE KKX.VRAIFKETXJWLKDCDHT KYEEQVEHAZVSAGIWlZSCTCLTOZEEFZSEETFEWLieiESVIV
TEAS 3 4 6  XKDYEKELSSAGRSHZVCHAZER KEWRKXKVESTVFZEG. XT PVSEIiSIIAIArTCXYXIACTSYI« KS. ATEQDFEXLSKK KIL
DCS 3 5 2  IEEXVQLVAEHGRQYRVEIAKKA ZRXAQSXLVEAKWTLQK. XK SFEEFKAHAAPTCGXAKXATTSFVO GDZVTPETFKWAASD KIX
EBFS 3 4 6  XENYERDAAIOjGKSrAAPIFKECVlCQLARAFKESQKXVXEA.QI, SFQDXVKKSEKTSCIYTKFASITPGLKS. VTQETZCWZKSE TLA
GAS 4 4 6  OASELISKLQDDVXTYQFEAERQQSATGVDSIZKTXGVSEKEAZDELKlWZEKAHKDXREGCIiC R * ■EVSKDVLA?ZLHIARMZ D W TR
GCS 4 3 5  RASALXARAHKDZVGEEDEQERG8VA5X.XE I  KDXGASKQETXZKFUCEVTKAWKDXRKQFSR T ,  , EVPXFVLERVLRLTRVADTLI K
TEAS 4 3 4  EA SV IIC K V IODTATYEVEK5RGQ ZATGIE  C RDTGZSTKEAHAKFQKJiAETAHKDIKEGIAR T . . PVSTF FLTPZLHIARZVEVTXZ
DCS 4 4 1  QA8TZXCRFXDDVAEHKFKHRREDDCSAIE X EEICVTAOEAXDVFKKHVESAKICDUKJEFXK T^EKPTEVLKRSUILARVNDTLIR
EBFS 4 3 4  TSTAKIGRXWKDTSSQUIESKGGEXLTALDFH K£XGZTKEEAA5KFEGLVEETWK!>IMXEFZACTKYKVGKEZAZTFIjlfXARZCEASXS
GAS 5 3 4  X . DDGFTFPGKTKXEXmXFVGSSPX
GCS 5 2 3  E . KT'TXSTAKGKI.KKKXKPZI.ZES VKZ
TEAS 5 2 2  HKX.DGXTHPEKVI.KPBITKXAVD8XKZ
DCS 5 2 9  E.GBGXTXVGKAAKGGXTSLLZEPIAL
EBFS 5 2 4  KTDGDAYUJPKVAKAKWAI^VDAIVF
Figure 5.1: Amino acid sequence alignment o f five plant sesquiterpene synthases. GAS: 
germacrene A synthase from Crepidiastrum sonchifolium; GCS: germacrene C synthase from 
Solanum lycopersicum; TEAS: 5-e/?/-aristolochene synthase from Nicotiana tabacum', DCS: 
6 -cadinene synthase from Gossypium arboreum; EBFS: (£)-P-famesene synthase from 
Mentha x piperita. Similarity and identity between residues are represented by different 
colours.
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The N-terminal regions (M1-S23 of TEAS, M1-P29 of DCS) are missing in the 
crystal structures of these plant sesquiterpene synthases and the mobility of this region 
may relate to the function of covering the active site. Based on the homology model 
and amino acid sequence alignment (Figure 5.1), the analogous region of EBFS is 
defined from Ml to S24 and this part of the N-terminal region could share the same 
function and therefore protecting the active site from bulk solvent.
Previous examination of the role of the N-terminal domain regions revealed that 
swapping the first 152 amino acids of a Hyoscyamus muticus vetispiradiene synthase 
with the analogous part of Nicotiana tabacum 5-epz-aristolochene synthase (TEAS) 
gave no novel product but only a slight decrease in specific activity {161). Another 
study of the N-terminal region of Ixeris dentate germacrene A synthase indicates an 
important role of this region towards the enzyme catalytic activity (777).
Our investigations based on the plant sesquiterpene synthase EBFS indicate dual roles 
of the N-terminal region in the catalytic reaction. Kinetic studies with mutated, 
truncated and chimeric enzymes demonstrate the importance of this loop for catalysis 
and suggest that this region regulates product release.
5.2 N-Terminal region truncated mutants
5.2.1 EBFSA14
According to the sequence alignment (Figure 5.1), the initial part of the N-terminal 
region (first 14 amino acids) of EBFS shares less than 20% similarity with other plant 
sesquiterpene synthases. In order to find out if this part of the N-terminal region could 
make contribution to catalysis, a truncated mutant (EBFSA14) was designed with the 
first 14 amino acids of EBFS removed. The full-length cDNA for EBFS (1.6 kb) was 
initially cloned into the vector pET32b (5.9 kb) with an Ncol restriction site at the 5’ 
end (Figure 5.2).
1 8 7
M1 K38 E223 
J e r r r n n a l  dom ain
F550
C-terminal domain
/Stool
pET 32b (+) EBFS
7.5 kb
Figure 5.2: pET-32b vector including the cDNA sequence for EBFS.
The N-terminal and the C-terminal domains are separated by residue 
E223. The N-terminal region is coloured blue, including sequence 
from M l to K38.
To construct the gene of EBFSA14, another Ncol restriction site was introduced into 
the DNA sequence o f the wild-type enzyme. The foreign Ncol restriction site was 
formed by replacing the DNA fragment 5’-GTAAGGCCA-3’ that encodes Vall4, 
Argl5 and Pro 16, with 5’-GCCATGGCA-3’ using site-directed mutagenesis (Figure 
5.3).
3 '  -CG AATTCCCTTCGGTACCGTGGATACTGCTTCG-5 '
1 ATGGCTACAAACGGCGTCGTAATTAGTTGCTTAAGGGAAGTAAGGCCACCTATGACGAAGC 
6 2  ATGCGCCAAGCATGTGGACTGATACCTTTTCTAACTTTTCTCTTGACGATAAG -  3 '
Figure 5.3: The 5 ’ to 3 ’ N-terminal region o f EBFS gene sequence (red) and the forward 
primer (purple, primer sequence is reversed and complementary) that generates Ncol 
restriction site (underlined) fo r construction o f EBFSA14.
The mutated plasmid was then treated with Ncol and the resulting large DNA 
fragment was intramolecularly ligated to give the desired plasmid (Figure 5.4). As a 
result of introducing the Ncol restriction sites, Argl5 of wild-type EBFS was changed 
to Ala2 in EBFSA 14. The truncated mutant was produced and purified by the same 
protocol for the wild-type enzyme (Figure 5.5). Typically, 16 mg of EBFSA14 was 
obtained per litre o f culture.
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Figure 5.4: 1% Agarose gel analyses o f the EBFSA 14 construct preparation. 
Lane 1: linearized plasmid that encodes EBFSA 14 after Ncol digestion. Lane 
2: plasmid that encodes EBFSA 14 after ligation. M: 1 kb DNA ladder.
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Figure 5.5: (A) Chromatogram for DEAE purification o f EBFSA14. (B) 13% SDS-PAGE 
analysis. Lane 1-12: eluent fractions. Lane M: protein marker. Lane C: concentrated protein.
The product profile was analysed based on an overnight incubation of 10 pM enzyme 
with 1 mM FDP. GC-MS revealed that the main product (iT)-|3-famesene still took up 
94% of the total production (Figure 5.6). In addition, an increased amount of the 
unknown cyclic product at retention time of 25.22 min was observed.
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Figure 5.6: GC trace fo r  incubation o f  10 pM  EBFSA 14 with 1 mM
FDP in the presence o f  5 mM Mg2+.
A n  o p tim ise d  in cu b a tio n  t im e  o f  15 m in  and  an  en zy m e con centration  o f  0.1 p M  w ere  
d eterm in ed  to  m e e t  th e req u irem en ts for  M ich a e lis -M en te n  k in etic  a ssay  b efore the 
actu al run (F ig u re  5 .7 ) .  T h e  ca lcu la ted  &cat o f  E B F S A  14 (0 .0 1 5  ±  0 .0 0 2  s '1) w a s  
e x a c tly  th e  sa m e  as w ild -ty p e  E B F S  (kcal =  0 .0 1 5  ±  0 .0 0 4  s '1). T h e Am (3 .7  ±  0 .6  p M )  
w a s a lso  co m p a ra b le  to  that o f  w ild -ty p e  e n zy m e (KM = 6 .4  ± 1 . 7  p M ). T his in dicates  
that th e in itia l part o f  th e  N -ter m in a l r e g io n  o f  E B F S  has nearly  n o  contribution  
tow ards th e ca ta ly tic  a c tiv ity . H o w e v e r , th e m in or ch an ge in  the product p rofile  
su g g ests  that th e  a b se n c e  o f  th is  re g io n  m a y  a ffe c t  b in d in g  o f  the substrate s ligh tly . In  
ad dition , it h a s b e e n  p r o p o se d  that R 15  o f  5 -e/? /-ar isto loch en e syn th ase p lays a ro le in  
co n tro llin g  th e o p e n -c lo s e  sta te o f  a c tiv e  site  con form ation  b y  h yd rogen  b ond ing  w ith  
the C -term in a l d o m a in  (91). T h e  corresp on d in g  resid u e in  E B F S  is  A r g l5 ,  w h ich  has  
b een  m u ta ted  to  A la 2  in  th e tru ncated  m utant E B F S A 1 4 . T h e fact that E B F S A 14  d o es  
n ot lo se  ca ta ly tic  e f f ic ie n c y  ru les ou t the p ro p o sed  fu n ction  for R 1 5 in  the cata lysis  o f  
E B F S .
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Figure 5.7: Kinetic analysis ofEBFSA14. (A) Time course (0.1 (iM enzyme, 10 pM FDP); (B) 
Plot of radioactivity level against enzyme concentration (10 pM FDP, 15 min incubation 
time); (C) Michaelis-Menten plot (incubation of 0.1 pM enzyme with radiolabelled substrate 
for 15 min at 22 °C).
5.2.2 EBFSA24
To further define the function of the N-terminal region of EBFS, another truncated 
mutant (EBFSA24) was generated by deletion of the first 24 amino acids from the 
wild-type sequence. The analogous polypeptide segments of TEAS and DCS were 
found missing in the crystal structures probably due to the mobility that relates to the 
function of covering active sites.
This mutant was prepared following a similar method to that used for constructing 
EBFSA 14, by introducing an Ncol restriction site into the DNA sequence of the 
wild-type EBFS (Figure 5.8). The mutated plasmid was then treated with Ncol and the 
resulting large DNA fragment was intramolecularly ligated to give the desired 
plasmid (Figure 5.9).
1 ATGGCTACAAACGGCGTCGTAATTAGTTGCTTAAGGGAAGTAAGGCCACCTATGACGAA 
6 0  GCATGCGCCAAGCATGTGGACTGATACCTTTTCTAACTTTTCTCTTGACGATAAG -  3 '
3 ' -CGTACGCGGTTGGTACCCCTGACTATGG- 5 '
Figure 5.8: The 5 ’ to 3 ’ N-terminal region o f EBFS gene sequence (red) and the forward 
primer (purple, primer sequence is reversed and complementary) that generates Ncol 
restriction site (underlined) for construction o f EBFSA24.
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Figure 5.9: 1% Agarose gel analyses o f the EBFSA24 construct preparation. 
Lane 1: linearized plasmid that encodes EBFSA24 after Ncol digestion. Lane 
2: plasmid that encodes EBFSA24 after ligation. M: 1 kb DNA ladder.
The gene expression, protein overproduction and purification were carried out using 
the same methods as wild-type EBFS (Figure 5.10). Typically, 11 mg of EBFSA24 
was obtained per litre of culture.
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Figure 5.10: (A) Chromatogram for DEAE purification o f EBFSA24. (B) 13% 
SDS-PAGE analysis. Lane 1-11: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
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10 pM of purified EBFSA24 was incubated with 1 mM FDP overnight at room 
temperature. GC-MS analysis of the hexane-extractable products showed no 
sesquiterpene product. The product profile of this mutant was further investigated by 
an ether extraction and GC-MS analysis revealed that no polar product was formed 
either. Activity loss in the truncated mutant EBFSA24 confirmed that the N-terminal 
region was an essential element for catalysis, which is in agreement with the proposed 
theory that the N-terminal domain may function by capping the active site.
5.3 N -Term inal region chim eras
5.3.1 D24AAE
The truncated mutants established an important role for the N-terminal region in 
catalysis. However, the question still remains whether the N-terminal region has any 
contact with the surrounding loops as proposed, or if it only positions above the active 
site, capping the pocket. As mentioned before, sequence alignment among five plant 
sesquiterpene synthases showed only three conserved residues, two prolines and a 
serine, in the mobile part of the N-terminal region. The conserved Pro 17 and Pro23 of 
EBFS may confer some rigidity to the structure but are unlikely to form strong 
interactions with other residues (Figure 5.11). The conserved Ser24 of EBFS shows 
no strong interaction with surrounding residues in the homology model and a similar 
conformation of the corresponding Ser relative to the surrounding residues was 
observed in the crystal structure of DCS. In this case, if the deleted segment has any 
specific interaction with the remaining part of the enzyme, the segment swapping 
mutants should compromise all these links and show changes either in product 
selectivity or catalytic activity.
1 9 3
N-tcrminal region
GAS 1 MAAVEANGTLQANTKTTTEPVRi LANFPPSVWGDRFLSFSLDNK 44
GCS 1 M AASS ADKCR LANFH SVWGYHFLSYT. HEI 31
TEAS 1 MASAAVANYEEEIVRPVADFSPSLWGDQFLSFSIKNQ 37
DCS 1 MASQVSQMPSSSPLSSNKDEMR KADFQi SIWGDLFLNCPDKNI 44
EBFS 1 MATNGWISCLREVRPPHTKHAL SMWTDTFSNFSLDDK 38
EBFSA 14 EBFSA24
D24AAE 1 MEPSSSPLSSNKDEMRh KADFQPSMWTDTFSNFSLDD 37
E24AAD 1 MATNGWISCLREVRPPMTKHAPSIWGDLFLNCPDKN 37
D 2 4A A E -S 24T /W 26G  1 MEPSSSPLSSNKDEMR KADFQ TMGTDTt SNFSLDD 37
E24A A D -S24W  1 MATNGWISCLREVRPl MTKHAPWIWGDLFLNCPDKN 37
Swapped N-tcrminal region
Figure 5.11: Amino acid sequence alignment o f N-terminal region offive plant sesquiterpene 
synthases and the N-terminal region for the chimeras. Conserved residues are coloured. Solid 
triangles denote cut positions for N-terminal region truncated mutants.
Mutant D24AAE was constructed by replacing the first 24 amino acids of EBFS with 
residues 1 and 7-30 of DCS (as residues 1-9 of DCS were shown to have very little 
effect on the enzyme activity (vide supra)) (Figure 5.12). The cDNA of D24AAE was 
created by ligation of the DNA encoding EBFSA24 following Ncol digestion with a 
DNA fragment encoding the chosen amino acids from DCS. The smaller DNA 
fragment was designed to anneal with Ncol restriction sites at both ends. To check 
whether the small DNA fragment was ligated with the insert DNA, a colony PCR 
method was designed by measuring the DNA length between the T7 promoter and the 
586th base pair position using T7 primer and primer EBFS-P586 (Figure 5.13). A 
blank experiment was carried out using the plasmid of EBFSA24 as template DNA.
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Ncol Ncol £coRI C-tenninal domain
DCS N H y v - r j-  | - 1 ■ —| - v r o o -
19 bp 91 bp 1665 bp
(7 aa) (31 aa) ( 5 5 4  aa)
Ncol Ncol
EBFS W  COO'
1 bp 73 bp 1653 bp
(1 aa) (25 aa) (550 aa)
Ncol
D24AAE NH3^
1653 bp 
(550 aa)
Ncol
E24AAD NH3' 5 ’ Wm   |-3  COO
1647 bp 
(548 aa)
Figure 5.12: Schematic diagram o f  the N-terminal region-swapping tests. Line drawings 
depict composite diagrams for wild-type DCS (coloured white), wild-type EBFS (coloured 
black), D24AAE and E24AAD genes.
Figure 5.13: 1% Agarose gel analyses o f  colony PCR products. Level 0: parent vector (i.e. 
encoding EBFSA24) with no oligonucleotide pair fragment ligated. Level 1 : parent vector 
with one oligonucleotide pair fragment ligated. Level 2: parent vector with two 
oligonucleotide pair fragments ligated. Lane B: PCR product using only parent vector as 
DNA template.
Since both ends o f  the designed primer fragment had the same Ncol restriction site, 
the correct orientation o f  the construct was confirmed by DNA sequencing. As a 
result o f the N col restriction sites introduced for construction o f the chimera, residues 
24 and 26 o f  D24AAE were initially Thr and Gly respectively rather than Ser and Trp 
in the wild type. M utant D24AAE-S24T/W 26G was overproduced the same way as 
WT-EBFS. However, very little protein was obtained after incubating cells at 16 °C
overnight. To solve the problem, a test expression was performed (Figure 5.14). Cells 
were grown at 37 °C to an OD60o o f  0.6 before addition o f IPTG (0.1 mg/ml) at 16 °C 
and 37 °C respectively. Protein production was monitored by SDS-PAGE up to 12 h. 
A slight im provement was observed at an expression temperature of 37 °C.
66.2 k 
45.0 k
Figure 5.14: 13% SDS polyacrylamide gel o f  test expression under 
different temperature. Lane 1: 37 °C for 1 hr. Lane 2: 16 °C for 2 hr.
Lane 3: 37 °C for 2 hr. Lane 4: 16 °C for 6  hr. Lane 5: 37 °C for 4 hr.
Lane 6 : 16 °C for 12 hr. Lane M: protein maker.
In addition, an increased amount o f IPTG (1 mg/ml) was applied to initiate expression. 
No obvious band around M W  63830 was observed (Figure 5.15).
1 2 3 4 5 6  7 M
Figure 5.15: 13% SD S polyacrylamide gel o f  D24AAE-S24T/W26G test expression 
induced by IPTG (1 mg/ml) under different temperature. Lane 1: before induction.
Lane 2: 37 °C for 1 hr. Lane 3: 16 °C for 2 hr. Lane 4: 37 °C for 2 hr. Lane 5: 16 
°C for 6  hr. Lane 6 : 37 °C for 4 hr. Lane 7: 16 °C for 12 hr. Lane M: protein maker.
Further expression testing was performed by employing BL21-CodonPlus(DE3)-RIL 
cells and BL21-Star(DE3) cells. Expression was induced by addition o f IPTG (0.1 
mg/ml) at 16 or 37 °C respectively. BL21-CodonPlus(DE3)-RIL cells yielded the best
196
protein production (F igure 5.16). A  good level o f  targeted protein was obtained after 4 
hr at 37 °C
Figure 5.16: 13% SD S polyacrylam ide gels o f  test expression with BL21-CodonPlus(DE3)-RlL 
cells (A) and BL21-Star(DE3) cells (B). Lane 1: 37 °C for 2 hr. Lane 2: 37 °C for 4 hr. Lane 3: 
before induction. Lane 4: 16 °C for 2 hr. Lane 5: 16 °C for 6  hr. Lane 6 : 16 °C for 12 hr. Lane 7: 
before induction. Lane 8 : 16 °C for 2 hr. Lane 9: 16 °C for 6  hr. Lane 10: 16 °C for 12 hr. Lane 
11: 37 °C for 2 hr. Lane 12: 37 °C for 4 hr. Lane M: protein maker.
The large-scale expression  w as carried  out by grow ing cells to an O D 6 0 0  o f  0.6 at 37 
°C. Expression w as in itia ted  by addition o f  IPTG  (0.1 m g/m l) and cells were 
incubated for another 5 hr. The overexpressed protein w as purified in the same way as 
wild-type EBFS and typically  10 m g o f  purified protein w as obtained per litre of 
culture (Figure 5.17). Incubation  o f  10 pM  o f  D 24A A E-S24T/W 26G  w ith 1 mM FDP 
gave no G C-M S detectable sesquiterpene product (Figure 5.18). A fter performing 
site-directed m utagenesis to return  position  24 and 26 the w ild-type residues and the 
recom binant protein  w as p roduced and purified by the same m anner as that of 
D 24A A E-S24T/W 26G  (F igure 5.17). Typically, 20 m g o f  purified protein was 
obtained per litre o f  culture. Incubation o f  D 24A A E w ith FDP overnight and analysis 
o f the hexane extractab le products by G C-M S show ed that (£)-|3-farnesene was the 
only sesquiterpene p roduct (F igure 5.18).
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Figure 5.17: Chromatograms fo r  DEAE purification o f D24AAE-S24T/W26G (A) and 
D24AAE (B) and 13% SDS-PAGE analyses o f  each purification (C) and (D). Lane 1-11: 
eluent fractions for D24AAE-S24T/W26G. Lane 12-24: eluent fractions for D24AAE. Lane M: 
protein marker. Lane C: concentrated protein.
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Figure 5.18: GC traces fo r  hexane extractable product profiles from an overnight incubation 
o f 10 pM  D24AAE-S24 T/W26G (A) and 10 pM  D24AAE (B) with 1 mM FDP.
An optimised incubation time o f 30 min and an enzyme concentration of 0.2 pM were 
determined to meet the requirements for Michaelis-Menten kinetic assay before the 
actual run (Figure 5.19). The kcat and Km were determined to be 0.005 ± 0.00005 s' 1 
and 7.5 ± 1.1 pM respectively. A slight reduction o f turnover rate was observed, 
while generally the kinetic efficiency was comparable to the wild-type enzyme, 
suggesting that no strong interactions between the loop region (M1-S24) and 
C-terminal domain are existed or they are unimportant for catalysis.
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F ig u re  5 .1 9 : Kinetic analysis o f  D24AAE. (A )  T im e cou rse (0 .2  pM  en zym e, 10 pM  FDP); 
(B ) P lot o f  v e lo c ity  a ga in st en z y m e  con centration  (1 0  p M  F D P , 3 0  m in  incubation tim e); (C) 
M ich aelis-M en ten  p lo t (in cu b ation  o f  0 .2  p M  en zy m e w ith  rad iolab elled  substrate for 30  m in  
at 22 °C ).
Nevertheless, the conserved Ser and Trp residues are essential for the catalysis since 
the double mutant D24AAE-S24T/W26G lost catalytic ability. A closer look into the 
homology model of EBFS, reveals that the conserved Ser residue is facing into the 
C-terminal domain (Figure 5.20). Although it does not appear to have any strong 
interaction with surrounding residues, it sits very closely to helix C and A-C loop, 
which are the key components of the active site pocket. Previous studies of TEAS 
showed that this region is essential for determining the product outcome, by 
specifically controlling the shift of the methyl group (91, 161). Our mutagenesis 
studies also revealed that the product specificity of DCS totally relies on the 
subdomain that consists of helix A to helix D (Section 3.2.2). Ser24 was found in a 
distance of 3-4 A with residues Asp265 from A-C loop and V268 from helix C in the 
homology model of EBFS, which suggested van der Waals interactions. Changes 
made to the Ser could introduce steric clash with A-C loop and helix C, leading to a 
change in volume of the active site cavity. Such change usually has a negative 
influence on catalytic activity, which was displayed before by the results of active site 
mutations of EBFS. The conserved Trp residue was also found to have a possible 
interaction with helix C, which was investigated by additional mutagenesis studies 
(Section 5.4.1).
1 9 9
Figure 5.20: Cartoon representation o f  EBFS showing the position o f S24 
relative to A-C loop and helix C in the homology model o f  EBFS. Bound 
FDP is shown as cyan sticks. A-C loop is coloured blue and helix C is 
coloured magenta. S24, D265 and V268 are shown as yellow sticks.
5.3.2 E24AAD
The equivalent experiment o f mutant D24AAE was also carried out based on DCS. 
The mutant E24AAD was prepared by replacing the first 30 amino acids of DCS with 
the first 24 amino acids o f EBFS (Figure 5.12). The cDNA of E24AAD was prepared 
by ligation o f the DNA encoding DCSA30 (constructed by Dr. Veronica Gonzalez in 
our group) following N col digestion with a DNA fragment encoding the first 24 
amino acids o f EBFS. The insert DNA fragment was designed to anneal with the Ncol 
restriction sites at both ends. DCSA30 was one of the N-terminal region truncated 
mutant based on DCS, o f which the first 30 amino acids were eliminated. Formation 
of the targeted construct was monitored by colony PCR using forward T7 primer and 
reverse DCS-P557 primer based on the same method used for D24AAE (Figure 5.21). 
A blank experiment was carried out using the plasmid o f DCSA30 as template DNA. 
Plasmids with the expected DNA length were sequenced and the confirmed construct 
was used for the following experiments.
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Figure 5.21: 1% Agarose gel analyses o f  colony PCR products. Level 0: parent vector {i.e. 
encoding DCSA30) with no oligonucleotide pair fragment ligated. Level 1: parent vector with 
one oligonucleotide pair fragment ligated. Level 2: parent vector with two oligonucleotide 
pair fragments ligated. Lane B: PCR product using only parent vector as DNA template.
To introduce Ncol restriction sites for the swapping strategy, Ser30 of DCS was 
mutated to Trp; The S30 of DCS became S24 in the chimeric enzyme E24AAD since 
the first 6  amino acids of DCS were omitted for the swapping strategy. The 
tryptophan mutant, E24AAD-S24W, was produced and purified following the same 
protocol as the wild type DCS (Figure 5.22). Typically, 23 mg of purified protein was 
obtained per litre of culture.
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Figure 5.22: (A) Chromatogram for DEAE purification o f E24AAD-S24W. (B) 13% 
SDS-PAGE analysis. Lane 1-10: eluent fractions. Lane M: protein marker. Lane C: 
concentrated protein.
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Incubation of this mutant with FDP gave two sesquiterpene products. 8-Cadinene, the 
main product takes up 90% of the total production and an unknown product 
(appearing at 24.87 min) contributes another 10% (Figure 5.23).
“O
24 2523 27
B 100
*
8  80
■S 60
3JO
>.gM 20
Time / min
23 24 25
Time / min
27
F ig u re  5 .23 : GC traces for hexane extractable product profile from overnight incubations of 
10 pME24AAD-S24W (A) and 10 pME24AAD (B) with 1 mMFDP.
In addition to the change of product profile, the kinetic parameters were greatly 
affected. A Km of 17.7 ±3.9 pM and a kcat of (1.4 ± 0.1) x 10"4 s’1 were obtained from 
kinetic analysis (Figure 5.24). Although the Km was not affected much, the A^at was 
reduced by about 100 fold.
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F ig u re  5 .24 : Kinetic analysis o f E24AAD-S24W. (A ) T im e cou rse (0 .3 4  p M  en zym e, 10 pM  
FDP); (B ) P lot o f  rad ioactiv ity  le v e l again st en zym e concentration  (1 0  pM  FD P, 15 m in  
incubation tim e); (C ) M ich a e lis -M en ten  p lot (incub ation  o f  1 .36 p M  en zym e with  
radiolabelled  substrate for 4 5  m in  at 2 2  °C ).
The S24W mutation was corrected by site-directed mutagenesis and the gene of 
E24AAD was expressed following transformation into BL21-CodonPlus(DE3)-RIL
cells. Expression and purification of E24AAD were carried out by the same method as 
wild-type DCS (Figure 5.25). Typically, 30 mg of purified protein was obtained per 
litre of culture. In agreement with the previous study of chimera D24AAE, the mutant 
E24AAD maintained high-fidelity as parental enzyme DCS by converting FDP into 
6-cadinene as the only product (Figure 5.23) and reserved similar catalytic activity at 
the same time. Kinetic analysis showed a KM of 12.5 ±1.3 pM and a &cat of 0.031 ± 
0.003 s '1 (Figure 5.26).
Figure 5.25: (A) Chromatogram for DEAE purification o f E24AAD. (B) 13% SDS-PAGE 
analysis. Lane 1-13: eluent fractions. Lane M: protein marker. Lane C: concentrated protein.
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Figure 5.26: Kinetic analysis ofE24AAD. (A) Time course (0.34 pM enzyme, 10 pM FDP); 
(B) Plot of velocity against enzyme concentration (10 pM FDP, 15 min incubation time); (C) 
Michaelis-Menten plot (incubation of 0.1 pM enzyme with radiolabelled substrate for 30 min 
at 22 °C).
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A single mutation S24W in the chimera E24AAD changes both the product profile 
and the catalytic activity, supporting the predicted role of the conserved Ser residue in 
maintaining the precise conformation of helix C. The swapped N-terminal reigon does 
not affect the catalysis, supporting the assumption that the region before the 
conserved Ser has no strong interaction with the rest of the protein. The main function 
of this region appears to be sequestering the active site during catalysis.
5 .4  S i t e - d ir e c t e d  m u t a t io n s  r e la t e d  to  N - t e r m in a l  r e g io n
5.4 .1  E B F S -W 2 6 E
A closer look at the homology model of WT-EBFS revealed that the conserved Trp 
residue had a possible interaction with helix C (Figure 5.27), which was also observed 
in the crystal structure of DCS. The indole side chain of Trp26 is positioned close to 
the carboxyl group of conserved E269 and a hydrogen bond could be formed in 
between. Compromising this interaction may increase the mobility of the loop, 
leading to the change of activity.
Figure 5.27: Cartoon representation o f EBFS showing the 
position o f  W26 relative to E269 in the homology model o f EBFS.
Mutation EBFS-W26E was designed to disrupt the proposed hydrogen bonding and 
instead introduce a repulsive interaction between the N-terminal region and helix C, 
to investigate the effect of this specific structure on enzyme selectivity or catalytic
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efficiency. To make the mutant, the native codon TGG was replaced by GAG using 
site-directed mutagenesis. EBFS-W26E was produced and purified in the same way as 
the wild type EBFS (Figure 5.28). Typically, 30 mg of purified protein was obtained 
per litre of culture. GC-MS analysis showed a single peak for (£)-P-famesene 
following an overnight incubation of EBFS-W26E with FDP (Figure 5.29).
250 i---------------------  1000
ohime
116.0 k
66.2 k
45.0 k
35.0 k
Figure 5.28: (A) Chromatogram for DEAE purification o f EBFS-W26E. (B) 13% SDS-PAGE 
analysis. Lane 1-11: eluent fractions. Lane M: protein marker. Lane C: concentrated protein.
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Figure 5.29: GC trace for incubation o f hexane extractable product profile 
from an overnight incubation o f 10 pMEBFS-W26E with 1 mMFDP.
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This mutation was predicted to increase the mobility of the N-terminal region, which 
would possibly lead to a reduction of enzyme activity since all the previous studies 
defined that the only function of the N-terminal region is to cap the active site. 
However, EBFS-W26E was found to be more active than wild-type EBFS. The of 
this mutant was determined to be 2.9 ± 0.6 pM, which is about 2 times lower than the 
wild enzyme (6.4 pM) and the kcat was 0.027 ± 0.001 s'1, which is a 2 fold increase 
compared to the wild type enzyme (0.015 s'1) (Figure 5.30).
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Figure 5.30: Kinetic analysis o f  EBFS-W26E. (A) Time course (0.1 pM enzyme, 4 pM FDP); 
(B) Plot of radioactivity level against enzyme concentration (4 pM FDP, 15 min incubation 
time); (C) Michaelis-Menten plot (incubation of 0.1 pM enzyme with radiolabelled substrate 
for 15 min at 22 °C).
According to the homology model of EBFS, this conserved Trp is located outside the 
C-terminal domain and is therefore unable to affect the actual reaction by contributing 
either chemical or steric effects. In this case, the most likely explanation for the 
increased catalytic efficiency is that the increasing mobility of the N-terminal region 
has a positive effect on the product releasing process, which is believed to be the most 
likely rate-limiting step of the reaction (775). Further studies need to be done to 
confirm this assumption.
5.4.2 EBFS-E269M
To compromise the proposed hydrogen bond between W26 and E269, the conserved
Glu residue was mutated to Met, which has a similar side chain length. EBFS-E269M
was prepared by replacing the native codon GAG with ATG. The mutant was
produced and purified in the same manner as the wild-type EBFS (Figure 5.31).
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Typically, 9 mg of purified protein was obtained per litre of culture. The 
EBFS-E269M mutant maintains the high fidelity since (£)-|3-famesene was the only 
hexane extractable sesquiterpene product after an overnight incubation with FDP 
(Figure 5.32).
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Figure 5.31: (A) Chromatogram for DEAE purification o f EBFS-E269M. (B) 13% SDS-PAGE 
analysis. Lane 1-11: eluent fractions. Lane M: protein marker. Lane C: concentrated protein.
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Figure 5.32: GC trace for incubation o f hexane extractable product profile 
from an overnight incubation o f 10 pM EBFS-E269M with 1 mM FDP.
Compared to the wild type enzyme, a 3 fold lower Km (1.8 ± 0.4 pM) was seen from 
kinetic assay of EBFS-E269M, whereas the kcat (0.00011 ± 0.00001 s'1) was reduced 
by roughly 140 fold (Figure 5.33). The reduction in the catalytic activity of the mutant 
EBFS-E269M may be due to the change of the active site contour. According to the 
modelling studies by mutating conserved Asp into Met in both crystal structure of 
DCS and homology model of EBFS, the side chain of Met showed a different 
conformation comparing to the original Glu; it pointed towards the active site centre 
rather than the conserved Trp. In the crystal structure of DCS, the mutated Met even 
introduced a steric clash with the substrate analogue 2F-FDP. Clearly, the mutation 
has caused a deleterious effect on the precisely defined active site contour and this 
could explain the observed reduction of enzyme activity. In addition, SDS-PAGE 
indicates poor binding affinity of this mutant to the anion exchange column, which 
could also indicate a change of the protein structure.
9000 400020000
4000
3000-  19000
3000
2000i t .  10000
2000
9000 1000
1000
T im e m in [EBFS-E269M]' jiM
Figure 5.33: Kinetic analysis o f  EBFS-E269M. (A) Time course (0.25 pM enzyme, 5 pM 
FDP); (B) Plot o f radioactivity level against enzyme concentration (5 pM FDP, 30 min 
incubation time); (C) Michaelis-Menten plot (incubation of 0.1 pM enzyme with 
radiolabelled substrate for 30 min at 22 °C).
5.4.3 EBFS-F30A
Another conserved residue Phe30 also seems to be involved in a special structure that
stabilizes the N-terminal region. In the homology model of EBFS, this residue appears
to be trapped in a pocket formed by residues from both the C-terminal domain and
N-terminal loop and deletion of the phenyl group from the pocket could possibly
increase the mobility of the N-terminal region (Figure 5.34). By introducing better
mobility to the N-termini, an improvement of catalytic efficiency was expected for
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this mutant as observed for the mutant EBFS-W26E.
Figure 5.34: Cartoon representation o f EBFS showing the position o f 
F30 and surrounding residues in the homology model o f EBFS.
EBFS-F30A was prepared by mutating the native codon TTT to GCT. The mutant 
was produced and purified by the same procedure used for the wild-type EBFS 
(Figure 5.35). Typically, 21 mg of purified protein was obtained per litre of culture. 
Incubation of purified EBFS-F30A with FDP gave (£)-(3-famesene as the only hexane 
extractable product (Figure 5.36).
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Figure 5.35: (A) Chromatogram for DEAE purification o f EBFS-F30A. (B) 13% SDS-PAGE 
analysis. Lane 1-13: eluent fractions. Lane M: protein marker. Lane C: concentrated protein.
209
Time / min
Figure 5.36: GC trace for incubation o f hexane extractable product profile 
from an overnight incubation o f 10 pM  EBFS-F30A with 1 mM FDP.
Kinetic assay of EBFS-F30A showed an improvement in both substrate binding 
affinity and catalytic turnover. The KM (1.5 ± 0.2 pM) was about 4 times lower than 
the wild type EBFS and the A^at (0.044 ± 0.002 s'1) increased by about 3-fold 
compared to the wild type enzyme (Figure 5.37); therefore a 12-fold increase in 
catalytic efficiency was observed for this mutant. Thus, increasing mobility of the 
N-terminal region appears to confer the enzyme with a better substrate binding 
affinity and also facilitates the product release step, leading to a better enzyme 
catalytic efficiency.
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Figure 5.37: Kinetic analysis o f  EBFS-F30A. (A) Time course (0.015 pM enzyme, 5 pM 
FDP). (B) Plot o f radioactivity level against enzyme concentration (5 pM FDP, 15 min 
incubation time). (C) Michaelis-Menten plot (incubation o f 0.025 pM enzyme with 
radiolabelled substrate for 15 min at 22 °C).
5.4.4 DCS-F36A
The mutants EBFS-W26E, EBFS-269M and EBFS-F30A revealed improved enzyme 
catalytic efficiency, with EBFS-F30A showing the biggest improvement. The 
corresponding mutation DCS-F36A was carried out to investigate if this pattern can 
be also applied to DCS. The mutant was made by replacing the native codon TTC 
with GCC. DCS-F36A was produced and purified by Dr Veronica Gonzalez. When 
DCS-F36A was incubated with FDP overnight, the only hexane extractable product 
determined by GC-MS was 6-cadinene (Figure 5.38).
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Figure 5.38: GC trace fo r  incubation o f  hexane extractable product profile 
from  an overnight incubation o f  10 p M  DCS-F36A with 1 m M  FDP.
In agreement with previous results, improvement was found for both substrate binding 
affinity and catalytic turnover rate. The Km value was found to be 1.9 ± 0.3 pM, 
which is about 5 times lower than the value of the wild type enzyme. The kcat (0.043 ±
0.012 s'1) increased 3-fold compared to the wild type enzyme (Figure 5.39). Both 
changes lead to an overall 15 times increase in catalytic efficiency. This mutant again 
supports the hypothesis that the N-terminal region could play an important role in 
regulating substrate binding and product release.
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Figure 5.39: Kinetic analysis o f DCS-F36A. (A )  T im e cou rse (0.06 pM  en zym e, 5 p M  FDP); 
(B ) P lot o f  rad ioactiv ity  le v e l again st en zy m e concentration  (5 p M  F D P, 15 m in  incubation  
time); (C ) M ich a elis-M en ten  p lo t (incubation  o f  0.06 p M  en zy m e w ith  rad iolabelled  substrate 
for 15 m in at 2 2  °C ).
5.5 Conclusions
Plant sesquiterpene synthases have variable length N-terminal region and little amino 
acid sequence similarity before the first conserved Pro. Therefore, this part of the 
segment might contribute veiy little to the catalysis. This is consistent with the result 
for the truncated mutant EBFSA14, which showed very similar catalytic activity to its 
wild-type counterpart. Sequence similarity and identity appear after Pro 17 (EBFS) 
and loss of residues 15-24 (EBFS) abolishes enzyme activity, suggesting that this part 
of the segment may have an important function causing it to be conserved among 
plant sesquiterpene synthases. In addition, the fact that EBFSA14 does not lose any 
catalytic efficiency rules out the proposed function for Argl5 of wild-type EBFS in 
closing the active site conformation.
Results from the chimeric enzymes indicate that the interactions between the 
N-terminal region and the C-terminal domain mainly start from the conserved Ser. 
The region before this residue is needed to cap the active site pocket but either no 
strong interactions exist between this region and the C-terminal domain or they are 
unimportant for catalysis.
The release of sesquiterpene product is believed to be the most likely rate-limiting 
step of the reaction (175). Site-directed mutagenesis studies toward the conserved Trp
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and Phe residues suggest that better mobility of the N-terminal region could facilitate 
this step. In addition, these mutations may increase the hydrophilicity around the 
active site, which could also accelerate the departure of the hydrophobic product. 
Notably, while the regions from Metl to Pro29 and Lys42 to Asp45 are missing from 
the crystal structure of DCS, residues 30-41 -  i.e. around the proposed stabilising 
regions -  are well defined. This observation further supports the role of the conserved 
Trp and Phe residues in stabilizing the N-terminal region.
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Chapter 6: General Conclusions and 
Future Work
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6.1 DCS
The catalytic specificity and activity of wild-type DCS (Gossypium arboretum) were 
in agreement to the previously published results (100). The secondary structure of 
DCS was determined by CD spectroscopy and agreed well with the proposed overall 
a-helical fold. The role of the aspartate-rich DDXXD motif was confirmed by alanine 
substitutions. The first and the last aspartate residues were shown to have potential 
interaction with magnesium ions, which is consistent with the observation from the 
crystal structure of DCS.
Despite reports of how individual or groups of amino acid residues contribute to 
reaction cascades of sesquiterpene synthases, several of these studies have actually 
reported on the premature termination of multistep reactions and the release of neutral 
reaction intermediates. In contrast, site-directed mutagenesis experiments revealed a 
different circumstance for DCS. Modifications by substitution of residues from both 
first and second tier of the active site did not bring any functional divergence. The 
enzymatic formation of S-cadinene form FDP has been showed to involve a 
conversion of C2,C3-double bond geometry and a 1,6-ring closure. At the meantime, 
DCS can also catalyse 1,10 or 1,11 cyclisation of some FDP analogues with 
preserving the original C2,C3-double bond geometry. The mechanistic versatility of 
DCS may indicate a relatively flexible active site contour and the overall function of 
this active site may not be easily compromised by a few amino acid substitutions. Or, 
in another case, an unusual substructural component would determine the product 
specificity of DCS.
Domain-swapping experiments, based on the conserved exon organization among 
plant sesquiterpene synthase genes, have illustrated that the N-terminal domain and 
the subdomains that are encoded by exons 1, 2, 3, 5, 6 and 7 may have very little 
contribution towards the product specificity. However, the N-terminal combines with 
part of the exon 4 encoded C-terminal to form an alternative subdomain to the usual
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sesquiterpene catalytic domain. This subdomain is also able to convert FDP to 
6-cadinene but with lower activity. These findings suggest that the product specificity 
of DCS is most likely determined by the subdomain encoded by exon 4, which is 
similar to the observation for TEAS. In addition, it seems that the product specificity 
of DCS totally relies on this subdomain since no other sesquiterpene product was 
formed by hybrids. However, similar hybrids for TEAS could generate alternative 
products determined by the vetispiradiene synthase. Additional domain swapping 
experiments need to be done to verify the function of this assumption.
The importance of this subdomain was also illustrated by the mutant E24AAD-S24W. 
The mutation S24W could possibly alter the conformation of A-C loop and helix C 
that belong to the subdomain encoded by exon 4. This modification led to a changed 
product profile by showing an alternative sesquiterpene product compared with the 
parent counterpart (E24AAD). In addition, the catalytic activity of this mutant showed 
a significant reduction compared to the parent counterpart.
6.2 EBFS
Wild-type EBFS (.Mentha x piperita) has been fully purified and determined to be a 
monomer in MOPS buffer (pH 7.2). An overall a-helical fold was confirmed by CD 
spectroscopy. In contrast to previously reports (115), the product distribution was 
defined as (£)-|3-famesene (95%), (Z)-p-famesene (1.5%), (3Z, 6£)-a-famesene 
(1.3%), (3E, 6£)-a-famesene (0.2%) and another 5 unknown cyclic sesquiterpene 
products (<2% in total) when Mg2+ was employed as the cofactor.
A new mechanism was proposed for the enzyme by the study of substrate analogue 
2F-FDP. It was believed that the enzymatic formation of (£)-|3-famesene went 
through the ionization of trans-trans-famesyl diphosphate to the corresponding 
transoid ally lie cation (167). In the case, an El elimination was proposed according to 
the ionization theory. However, the fact that this enzyme can catalyze the conversion
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of 2F-FDP with a relatively good activity indicates that the proposed carbocation 
intermediate is unlikely to be formed in the process since the C2 fluorine can greatly 
inhibit formation of this intermediate through an inductive electron withdrawing 
effect. In other words, it seems the enzymatic reaction catalysed by EBFS simply goes 
through a concerted E2 elimination rather than the previously proposed El 
elimination.
The predominant production of (£)-p-famesene suggests a rigid active site cavity for 
this enzyme, which is very likely because of the active site conformation keep the 
middle and distal double bonds in a distance that is not close enough for any 
electrophilic attack to take place. The precisely defined active site cavity was further 
demonstrated by mutations introduced to the magnesium binding motif. Previous 
studies showed that some promiscuous sesquiterpene synthases could be conferred 
with new function by manipulating the magnesium binding motif. These promiscuous 
enzymes usually contain large active site pockets and changes to the magnesium 
binding motif could lead to alternative substrate binding conformations which allow 
different structures to be formed. However, in the case of EBFS, mutations to the 
magnesium binding motif did not expand the product profile; a huge reduction in 
catalytic activity was the only effect, indicating that the active site contour of EBFS is 
constructed as product-like to ensure the high fidelity.
A variety of aliphatic and aromatic residues line the hydrophobic active site cavity of
sesquiterpene synthases to ensure the proper binding conformation of the substrate
and stabilize carbocation intermediates. For EBFS, the residues within the active site
contour mainly contribute to constructing the active site geometry since no
carbocation is likely to be formed during catalysis. Thus, product selectivity should
mainly rely on the composition of these residues if the active site contour is the key
component determining the product outcome. However, substitution of residues that
directly contribute to the active site contour with obvious size differences did not
confer the enzyme with improved ability to produce cyclic products. An increased
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production of (3Z, 6£)-a-famesene was observed among certain variants, suggesting 
the modifications forced the substrate FDP to bind in the active site with a different 
orientation. Still, it seems modifications within the active site of EBFS are not 
sufficient to reconstruct the active site template to catalyse cyclisation reactions. 
Construction of an active site hybrid by replacing the active surface of EBFS with the 
corresponding part from DCS further supports this assumption. The hybrid contains a 
nearly identical active site surface to DCS, but the expected product 6-cadinene was 
not detected. In addition, the hybrid almost completely lost the ability to convert FDP 
into any sesquiterpene product. This result strongly suggests that the product 
specificity of EBFS is not entirely determined by residues within the active site; the 
catalytic specificity of this enzyme might be modulated at a distance by residues 
surrounding the active site, which may have a huge influence on the active site 
volume.
6.3 N-terminal region
The truncated mutants of EBFS suggest an important role for the N-terminal region in 
catalysis. The function of this segment mainly relies on the sequence after R15 since 
deletion of the first 14 amino acids has little effect on catalytic activity, whereas loss 
of residues 15-24 abolishes enzyme activity. Results from the chimeric enzymes 
further define the function for the initial part of the N-terminal region to be capping of 
the active site pocket only, since either no strong interactions exist between this 
region and the C-terminal domain, or they are unimportant for catalysis.
The ‘communication’ between the N-terminal region and the C-terminal domain was 
identified to begin with the first conserved Ser (DCS S30; EBFS S24). Mutagenesis 
and tertiary structure studies suggested a role for the Ser that it maintains the proper 
conformation of helix C that plays an important role in catalysis. The conserved Trp 
(DCS W32; EBFS W26) and Phe (DCS F36; EBFS F30) residues were discovered to 
be involved in specific structures that stabilize the N-terminal region. Mutagenesis of
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these two residues could compromise the initial structures therefore potentially confer 
better mobility to the N-termini. Mutants of these residues in both EBFS and DCS 
showed improved catalytic efficiency compared to their parent enzymes. However, no 
alcohol products were produced by these mutants, suggesting either water molecules 
still could not enter the active site or the mechanism for producing (£)-|3-famesene 
goes through a concerted fashion (without generation of any carbocation). This 
improved catalytic efficiency is probably because the better mobility of the 
N-terminal region allows accelerated product release, which is believed to be the 
rate-limiting step in the parent enzymes. In addition, these mutations may increase the 
hydrophilicity around the active site, which could also accelerate the departure of the 
hydrophobic product.
6.4 Conclusions
The ultimate aim of this study is to explore the evolutionary pathway for creating a 
significant divergence of biological function among sesquiterpene synthases from a 
common ancestor. The most critical function of this enzyme family is to provide a 
template for orienting bound substrate and lowering the initial activation energy. The 
unique mechanistic character of this evolutionarily versatile enzyme family also 
depends on the repetitive electrophilic and nucleophilic functionalities in the substrate. 
Coupled with sufficient conformational flexibility, the intrinsic reactivity can be 
easily tuned by natural selection to favour formation of alternative sesquiterpene 
product. Therefore, in order to understand the evolutionary pathway of the 
sesquiterpene synthase family, we have to find out how the specific amino acid 
residues and unique tertiary structure components coordinate with each other. Based 
on this knowledge, it may be possible to predict the catalytic capability of a terpene 
synthase solely on the basis of sequence similarity, making it easier to trace back to 
the common ancestor(s) of terpene synthases along the evolutionary pathway.
The product specificity was believed to be determined mainly by the plasticity of
residues comprising the active site contour. Mutagenesis studies of 19 active site 
residues of y-humulene synthase in various combinations revealed the biosynthetic 
array of sesquiterpenes generated by this enzyme can be altered to generate alternative 
predominant products by replacing only three to five active site residues at a time, 
which represented a perfect example supporting this theory. However, our studies 
toward EBFS and DCS illustrated that sesquiterpene synthases can evolve by 
alternative patterns to control the product outcome. In the case of EBFS, it seems that 
the active site cavity was constructed in the way that only acyclic structures can bind. 
Modification of the active site surface does not enable the enzyme to produce cyclic 
products. In contrast, (£)-p-famesene is quite often found in the product profile of 
other sesquiterpene cyclases. These results indicate the overall conformation of the 
active site of EBFS is possibly modulated at a distance by residues surrounding the 
active site. In this regard, modifications toward residues within the active site may 
only slightly affect the orientation of the famesyl chain rather than creating a totally 
different contour to accommodate the cyclic intermediate and product. Studies of the 
enzymatic chemistry of DCS revealed another potential method by which nature 
engineers the catalytic pathway for sesquiterpene synthases. Active site mutations 
showed that the residue composition of the active site surface could not determine the 
product specificity for DCS. In addition, the swapping of more than half of the 
functional domain with the phylogenetically related sesquiterpene synthase GCS did 
not bring any promiscuity to this high-fidelity enzyme. These findings are 
incompatible with all previous mechanistic studies for other sesquiterpene synthases. 
The unexpected results suggest the product specificity of DCS might be strictly 
defined by a subdomain encoded by a specific exon. Even though this assumption 
need to be verified by additional domain swapping tests, it indicates the possibility of 
engineering diversity in terpenoid biosynthesis by using phylogenetic information.
6.5 Future work
Plant sesquiterpenes have important uses in medicine, agriculture and industry,
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however comparatively little is known about the biosynthesis of this large class of 
compounds. The studies described here suggest that the product specificity of 
sesquiterpene synthases could be determined by different patterns. The product 
specificity of DCS was closely related to the subdomain encoded by exon 4. The 
importance of this subdomain could be further investigated by translocating the 
DCS-specific subdomain to that region of GCS. In addition, mutations could be 
introduced into this subdomain to examine the effect of specific residues and 
mutagenesis work may also be used to identify the minimum number of residues or 
specific combinations of mutants that are necessary for interconversion of the enzyme 
activities. The mutagenesis work has been based on crystallographic studies of DCS, 
but the current crystal structure contains an unusual conformation of the bound 
substrate analogue (2F-FDP) which may not represent the realistic substrate binding 
conformation. Therefore, different substrate analogues could be co-crystalized with 
DCS to obtain alternative, potentially more realistic, substrate binding conformations.
Further studies of EBFS would be greatly assisted by a crystal structure of this
enzyme. Work to obtain a crystal structure of EBFS is underway in collaboration with
Prof. David Christianson (University of Pennsylvania, Philadelphia, USA). Visual
inspection of the crystal structure with a substrate analogue could possibly confirm
the function of residues investigated in this study. To further investigate the
biosynthetic strategy of EBFS, the equivalent experiment to the formation of the
active site hybrid described here could be performed by replacing the shell of the
C-terminal domain of EBFS with the corresponding region of DCS while maintaining
only the original active site surface of EBFS. If this hybrid can produce cyclic
product(s), then site-directed mutagenesis could be employed to identify the minimum
number of residues or specific combination of residues that are necessary for the
interconversion of enzyme activities. And also, it may suggest that the product
specificity of EBFS is determined by the structure outside active site which could
have a great influence on the volume of the active site pocket. In that case, it would be
clear that the limitation towards the product specificity of EBFS is due to the active
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site volume.
The conclusion that the N-terminal region regulates the catalytic efficiency of certain 
sesquiterpene synthases is currently based only on studies of DCS and EBFS. The 
corresponding experiments may be performed on other plant sesquiterpene synthase 
to test the predictions made here. Such experiments would also test the universality of 
the conclusions made here among other plant terpene synthases in general. Further 
studies to optimize the function of N-terminal region can be done by making different 
combinations of the various mutations.
Most of the current studies focused on identifying residues within and surrounding the 
active site that contribute directly to the reaction specificity of terpenoid synthases. 
Modifications of these residues may be useful for designing novel functions for 
terpenoid synthases. However, such application is usually limited by the avalibility of 
an efficient screening method. In addition, it seems that the specificity for terpene 
synthase families is not always determined by the plasticity of residues. Therefore, in 
the long-term, exploring the structural features that govern reaction product 
specificity for various members of terpenoid synthase families should reveal a general 
perspective into the evolution of these enzymes. Such knowledge would also 
potentially assist the development in rational design and engineering of different 
catalytic activities into existing terpenoid synthases.
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Appendices
A I  Sequence alignment o f  DCSs, EBFSs and some other plant terpene synthases
Black: aliphatic residues. Purple: hydroxyl residues. Salmon: acidic residues. Teal: 
basic residues. Brown: aromatic residues. Mustard: imino residue. Olive: sulfur 
residues. Green: amide residues. For key to enzymes see key for A I.
1
2
3
4
5
6
7
8
9
10 
11 
12
13
14
15
16
17
18  
19
MASQVSQMPSS SPLSSNXDEMRPKADFQPSIN  
MASQVSQMPSSS PISSNXDEIRPKADFQPSIN  
MASQVSQMPSSS PLSSNXDEMRPKADFQPSIN  
MASQVSQMPSSSPLSSNXDEMRPKADFQPSIN  
MASQASQVLAS. PHPAISSENRPKADFHPGIN 
MATNGWISCLREVRPPMTXHAPSMN 
MS7LP IS  S VS FS S S T S PLWDDXVS 7XPDVIRH7MNFNAS IN  
MKDM8IPLLAAVSSS7EE7VRPIADFHPIXN 
MAMPVKLr PASLSIXAVCCRF5SGGRALRF
............................................... SHEASYLINQ............. RRSANYXPNIN
MALA:PFNNEEE; VRPVANFSPSIW 
MASAAVANYSSEIVRPVADFS PSLN 
MAAVQANVT'GIXANI’X'rSAEPVRPLANFPPSVM
MAASS............................... ADXCRPLANFHPSVN
MGSEVNRPLADFPANIN
MS 11SMNVSILSXPLNCLHNLERRP. . SXALLVPC7AP7AR............. LRASCSSXtQSAHQIRR. SGNYQPALN
MALXLLTSLP. .MYNFSRVPVSSXDPILLV’ISRTRNGYLARPVQCMVANXVSTSPDILRRSANYQPSIN 
MALLS IVSLQVPXSCGLXSLISSSNVQXALCISI'AVP'rLRMRRRQXALVINMXLT'rVSHRDDNGGGVLCRRIADHHPNLN 
1 MSPVSVISLPS . DLCLPTSFI DRS. GRELIPLH IT  IPNVAMRROGXLMTR. . ASMSMNLRTAVSDDAVIRRRGDFHSNLN
MEFRVHLHADHEQXILQNCMXP.
1 33 GDLFWCPDKNIDAET. . EKRHCQLKEEVRKMIVAPMANS...........
2 33 GDFFLNCPDKNIDAGT. . EKRHCCLKEEVRKMIVAPMANS...........
3 33 GDFFLNCPDKNIDAET. . CKRHGGLKEEVRKMIVAFMANS...........
4 33 GDLFUTCPDKNIDAET. . EKRHCQLKEEVRKMIVAPMANS...........
5 32 GDMFIICPDTDIDAAT. . SLOYEELKAQVRKMIMEPVDDS........... ........... NQKLPFIDAVQRLGVSYHFEKEIEDEIiENI
6 27 TDTFSNFSLDDXSQQX. CSETlEAUCQEARGMIiMAATTPL............ .............. QCK7LID7LERLGLSFHFE7EIEYX:e L I
7 43 GDQFLIYDEPEDLVMX. . XC LVE ELKEEVKKEL17 1XGSNE PMQ. ____ HVXL1ELIDAVQRLGIAYHFEEEIEEALQHI
8 32 GNHFLXSAADVSTIDAA'IQECHAAUCCEVRRMirTTANXL...........
9 31 GSSLPCWRRTPTQRSTSSSTT’RPAASVSSGKSXQHDQEASEA?. .
10 44 XNDFLDQSLISXYDGDEYRKLSEXI.IEEVKIYISAE7XDL........... ............VAKLZLIDSVRXLGLANHFEKEIKEALD GI
11 26 GDRFHSFSLDNQVAEX. YAGEIE7LKEQ7RS' LSAAACGI7____
12 26 g d q f l s f s : k n q v a e x . y a k e : e a l k e q 7 r n m l . . l a t g m x ------ ____ l a d t l n l i d t ie r l g is y h f e k e id d i l d q i
13 34 GDRFLSFSLDRSELER. YAIAMEXPKEDLRKLIVDP7MDS...........
14 21 GYHFLSYT. H EI7NQ E. . XVEVDEYKE7IRKMLVE7CDNS........... ........... TQKLVLIDAMQRLGVAYHFDNEIE IS IQ N I
15 18 ED P. ITSFSKSDLG7E7FXEXHS7LICEAVKEAFMSSXANP............ ............IENIXFIDALCRLGVSYHFEKDIVEQLDXS
16 66 DSNYI. QSLN7PY7ESRHLDRXASL:VQVRILL. XSXMEP............ ........... VQCI^LIHDLXYLGLSDFFQDEIKEILGVI
17 68 NHDYI. ESiaiEFVGE7C7RQINVLKEQVR>94L. HXW NP............ ............LEQLELIEIIQRW LSYHFEEEIKRILDGV
18 81 EDDFIQSLSSPYGGSS . YSERAVTWEEVKEMFNSIPN. NRELFGSQNDLL7RI.WMVDS lERLGIDRHFQNEIRVALDYV
19 77 DDDLIQSLSS PYGEPS. YRERAERLIGEVKNSFNSMSNEDGESIT PLDDLIQR1WMVD S VERLGIDRHFKKEIKS AID HV
241
1 101Y ...H N N N T  XENDLYTTSlRFRLLREHGYNVSCDVFNKFKi: EQGNFKSSVTSDVRGLLELYQASYLKV.
2 101Y ...H N N N D  AE NTJ LYTT S LRFRLLRE HGYNVS C DVFNKFK: EQGNFKSSVTSDVQGLLELYQASYLRV.
3 101 Y . . . HNNN? AHMDLYTTSLRFRLLREHGFHVSCDVFUXFfC. EQGNFKS SVTS D VRGLLELYCAS YLRV.
4 101 Y. . .HNNNT AENDLYTTSLRFRLLREHGFNVSCDVFNKFKT EQGNFKSSVTSDVRGLLELYQASYLKV.
5 100 YRD.TNNND ADTDLYTTALRFRLLREHGFDISCDAFNKFKD EAGNFKASLTSDVQGLLELYEASYMRV.
6 95 NAAEDDGFD. LFATALRFRLLRQHQRHVSCDVFDKF1D KIXaCFEESLSNNVZGLLSLYEAAHVGF.
7 116 HVTYGEQWV.................... DKZNLQSISLWFRLLRQQGFNVSSGVFXDFVD EKGKFKESLCNDAQG1LALYEAAFMRV.
8 102  SHDLDS..................................DDLYWSLRFRLFRQQGVKISCDVFDKFKD DZGKFKESL1ND1RGMLSLYEAAYLA1.
8 105 YRSWLQRHEE.............. IMLDTMTCAMAFRILRI.NGYNVSSD2I.YHWEAS . . GLHNSLGGYrJTOTRTLLELHXASTVSlS
10 114 AAIZS. . . 0NLG-------TADDLYGTALHFKILRQHGYKVSQDIFGAFJ4DZ. . . KDT. UMHHFAHLHGMUELFEASNLGF.
11  97 YXADPNFDG......................... HDLNTLSLQFRILRQHGYNISOXFFSRFQD ANG. FKECLSN:: IRGLLNLY ASjfVRT.
12  95 YNQNSNCN ELCTSALQFRLLRQHGFNISPZIFSKFQD ■ ENGKFKESLASDVLGLLNLYEASHVRT .
13  103  FNKFSLQDY.................EEVDLYTISINFQVFRHVGYKLPCDVFNKFKDV. . . 55GTFKASITSDVG. WGLYESAQLRI •
14  88 FDASSKQND NDNNLYWSLRFRLVRQQGHYMSSDVFKQFTN____ SDGKFKE7LTN VQGLLSLYTASHLKV.
15  87 FDC1DFPQMVRQ EGCDLYTVG11FQVFRQFGFKLSADVFEKFKD ENGKFKGHLVTDAYQ4LSLYEAAQWGT.
16  134 YNEHKCFHNNEV------ SKMDLYFTALGFRLLRQHGFNISQDVFNCFKNE. . .KGIDFKASLAQDTKGHLQLYKASFLIR.
17  136  YNNDHGGDTKXA____ EN. . LYATALKFRLLRQHGYSVSQEVFNSFKDS. . . AGS . FKACLCEDTKGMLSLYEASFFll.
18  159 YSYWKEKZGIGCGRDStFPDLN5TALAl.RTLRI.HGYNVSSDV12YnCDQKGHFACPAHTEGClTRSVIiNIiYAASI.VAF.
19  156 YRYWSSK. GlGCGRESWTDLNSTALGlRTLRlHGYDVSADVLNHnCNQSGOFACTlKOTEDOlR. TVLNLYAASL1AF.
1 166 HGEDXLDEAXSFTTHHL5LAVA. . SLDHP......... LSEEVSHALKQSIRRGLPRVEARHYLS . VYQDIESHNK.......................
2 166 BGEDXLDEAISFTTNHLSLAVS . .SLDHP LSEEVSHALKQSIRRGLPRVEARHYLS . VYQDIESHNK.......................
3  166  HGEDILDEAISFTSNHLSLAVA. .SLDHP LSEEVSHALKQSIRRGLTRVEARHYLS .VYQDIESHNK........................
4 166  HGECILDEAISFTTNHLSLAVA. .SLDYP.........LSEEVSHALKQSIRRGLPRVEARHYLS . VYQDIESHNK.......................
5 167 HGEDILDEAISFTTAQLTLAL? . . TLHHP . LSEQVGHALKQSIRRGLPRVEARNFIS . IYQD1ESHMK.......................
6 159  AEERILQEAVNFTRHHLEGAE1D QSP111REKVKRALEHPLHRDFP1VYAR1FIS . IYEKDDSRDE.........................
7 184 EDETILDNALSFTKVHLD11AK. . DPSCDS. SLRTQIHQALKQPLRRALARIEAIHYX?. IYQQETSHNE.........................
8 165 RGEDILDEAIVFTTTHLKSV1STSDHSHANSNLAEQIAHSLQ1PLREAAARLEARYFLD.IYSRDDLHDZ.........................
9 177 EDESILDS1GSRSRT1LREQLE. SGGA1RKPSLFKEVEHALDGPFYTTLDRLHHRWNIENFN11EQHX1STPY1SN0HTS
10  182 EGEDILDEAKAS1T1ALRDSGH.1CYP. . DSNLSRDWHSLE1PSHRRVQWFDVKWQINAYEKDICRVNA.........................
11  162 HGEDILEEALVFSTAHLESAAP..HLZSP LSKQVTHALEQSLHKS1PRVETRYFIS . IYSZEEFKND.........................
12  159  HADCILEDALAFST1HLESAAP. . HLKSP LREQVTHALEQCLHKGVPRVETRFFISSIYDKEQSKNN.........................
13  171 RGEKILDEA5VFTEAXLKSWN. .TLEGD. . . LAQQVTQSLRRPFHQGKP1G1RQGSIS1TMKKNVP1MT.........................
14 156 RNEEILEEALTFTTTHLES1VS . . NLSNNNNSLKVEVGEALTQPIRMTLPRMGARKYIS . IYSNNDAHHH............
15  158  BGEDI1DEALAFSRSHLEE1S..................................... SRSSPHLA1RIKNALKHPYHKG1SR1ETRQYIS . YYEEEESCDP............
16  206  KGEDTLELAREFATKCLQKKLD.EGGNE1DENL11WIRHSLD1PLHWR1QSVEARWFIDAYARRPD MNP.........................
17  205  EGENILEEARDFSTKHLEEYVK . QNK. . . EKNLATLVNHSLELPLHWRMIRLEARWFINIYRHNQD VNP........................
18  238  PGEKVMEEAETFSASYLKEVLQ_____KTPVSSFSREIZYVLEYGWHTNLPRLEARNYIDVYGQDSYZSSNEMPYV. . .NT
19  233  PGEKVMDEAZSFSAKYLKEALQ_____KTPVSSFSREIGDVLEYGWHTYL?RI4£ARNYIDVFGQDTENSXS . . . YM. . .KT
242
1 230 .ALLEFAKIDFNMIQFLHRKELSEICRWWKDLDFQRKl.PYARDRWEGYE'WI.SGVYFEr'QYSLGRKMI.TKVIAMASIVD
2 230 .ALLEFAKIDrMaQEXHRKELSEICRWWKL'LrFQRia^YARDRVVECYFWI.SCVYFEi^YSICRKMLTKVIAMMIVD
3 230 . VUaEFAKXDFNMVQLLHRlCELSEXSRWWKDIiOFQRKLPYARDRWEGYFWX. SGVYFh ; QYSLGRKMLTKVXAMASIV.
4 230 .VLLEFAKIEF»*VQLLHRKELSEISRWWKDXDFQRKI.PYIURERWECYFWI.SGVyFElXJYSLGRKMLTKVIAMASIVD
5 231 . SI<LCFAKXDFNll£LXiHRKEI>SEICRWWKDX>uF'rRKI»PFARDRWEGYFWI. XGVYFr.; QYSLGRKMLTKVXAMASIV:
6 224 . -XiUQtSKVNFXFXQNLYKEELSGIaSRHWN'IVfNI.XSKIaPYARDRWEAYVWG. VGYHYKPQYSYVRMGIAKGVLICGIMD
7 250 .DLUOAKLDFSVLQSMHKKELSHICKiWKDLCLQNKLFrVRDRWEGYFWI.LSlYYEPQHARTRMFLKKTCXWLWLD
8 234 . TLLKFAKLYF'NILQAAHQKEASIMrRWWNDLGFPXXVPYARBRIIE'rYINXlLGVSYEPNLAFGRIFASKVVCMITYID
9 256 RDHAISIRDFSSSQFTYQQSXOHLESWVKSCRLD.0WFARQK1AYFY1SA.AGTMFSPE-SDARTlHAKNGVLTTrVD
10 249 . 7LLC1AKLNFNMYQACLQKDI^EASXWWANLGIADNLKFARTR1VEC FACA. VGVAFEPZYSSFR1CLTKVINLVIIID
11 226 .VLLKFAKLDYNLLQKLHKHELSEVSRHWKCI^FVTrLPYARDRAVECYFirr.MGVYAEPQYSGARVlLAKriAMISIVS
12 224 .VLLRFAKI£FNL1QKLHKCELA0VSRWWKDLDFV-7LPYARDRVVECYF*IX.LGVYFEPQYS0ARVHLVK7ISH1SIVD
13 236 .HCUOAKLHFXYl^lOGKEELRlVSKHWKDMRFHiTTPYlRDRVPElYLiri.LQLYFEPRySLARirATKITlFLWLD
14 223 .LLLKFAKLrFNMLQXFHQAELSDLTRWIIKDLDFANKYPYARDREVECYFWI.LGVYFEPXYSaARKMMTKVLNLrSXID
15 222 .TLLEFAKIDFNUiQlLHREELACVrRWHHEMZFXSKV-YrRHRirEAYLIIS.lGrYFEPQYSOARVirTMAllLFTAlD
16 274 .LIFELAKLNFNXIQXTHQGELXDLSRWMSRI.CFPEKI.PFVRDRIVESFFWA.VGXFEPHQHGYQRKKAATIIVLATVID
17 270  . ILI*t FAELT: FNXYQAtvHQAELXGVSTWWKSTGlVXNLSFARDRPVENFFWT . VGLIFGPQFGYCRPMFTKVFALIT7ID
18 311 CKXJUKLAKLEFNIFHSI^QKEJUJYISRHWKDSCSS.HLEFrRHRHVEYYTMA.SClSMEPXHSAFRI.GFVKrCHI^.TVLD
19 303 EXLLEUUaUEFNIFHALGKRELEYLVRHWKGSGSP.CKTFCRHRHVEYYriA.SClAFEPQHSGFRLGFAKACHlITVLC
1 308 DTYDSYATYEELXPYTHAXERMDIKCXDEl. .PEYMKPSYKALLDVYE EMVQLVAEHGRQYKVEYAKNAMIRLA. . QSY
2 308 DTYDSYATYEELIPYTNAIERHDIKCIDEL. . FEYMKPSYKALLDVYX. EMEQLVAEHGRQYRVflYAKNAMIRLA. .QSY
3 308 DTYDSYATYEEUPYTKAXERMDXKCXDEI,. .PEYMKPSYKALLDVYE EMEQLVAEHGRQYRVEYAKNAMIRLA. . QSY
4 308 -TYDSYATYEELIPYTXAIERWDIKCIDEL. . PEYMKPSYKALLDVYE . EMEQLYAKHGRQYRVEYAKXAMIR1A. .QSY
5 309  DTYDSYATYDELIPYTNAIERWLIKCMNOL. . ,  NYMKISYKALLNVY- J MEQLLANGGRQYRVEYAKKAMIRLV. . QAY
6 302  CTYDNYATLNEACUTQVLDXWDRDSAERI.. . PE YHKIVYXFILSI YE . NYE ADAAKIGXS FAA? Y FIG 7VKQLA. . RAF
7 328  CTFDNYGTYEEI^IFTCAVERWSISCLDML. . PEYMK1IYCSLVKG.HV. EMEESLGKGGXNISNSLCQGRUQKELGSQX?
8 313  DTFDAYCTFEEX.7XJTEAV7RWDIG1ID71. .PEYKKF1VKALLD1YR.EAEEELAKEGRSYG:PYAKG>MGEI.:. .1LY
9 334  DFFDVAGSiOUELENlVMlVEMWDEHHXVEFY.SEOVEXlFSSlYDSVN.O^GEXASlVGDRSirXHLVElMEDLl..XSM
10  327  DVYBZYGSEEELXHFTKAVDRHDSREYEQL.. PECMKMCF0VLYN77CE1AHE1EXDNGWNGVLPGL7KVWADFC. .KAL
11 304 DTFDAYGIVXEI^VYTDAIGIWDISQIDRI. . PEYWCVSFKALLDLYE . DYEXELSKDGRSDVVHYAKERMKEIV. .RNY
12 302 DTFDAYGrVKELEAYTDAIGRWDINEIDRl. . >DYMKISYKA:LD:.YX.DYEXELS5AGRSH:VCHA:EPMKEW. .RNY
13 314 DTYDAYATIEEIRLLTDAINKNDISAMEGI. . PEY:RPFYK:LLDEYAGNWRAXWEKXGSQllX.LLGiaCRSKrLA. .RGY
14 301 DTFDAYATFDELVTFNDAXGRWDANAIDS: . .CPYMRPAYGAUiDIYS.EMEQVLSKEGXLDRVYYAlQiEIOGCLV. . ray
15  300 DMYDAYGTKEEI£I«ETDAMDEWLPWPDEI P1PDSMKF1YNVTVEFYD. XLDEELEKEGRSGCGF;1LKKS7GX7A. . NGY
16  352  DIYDVYGTLDELELFTD7FXRND7ESI7RL. . PYYMQLCYWGVHNYISDAAYDILKEHGF. FCLGYLRKSVVDLV. .EAY
17  348 DVYDVYGTI^ELEIJTDWERWDINAMDGL. .PDYMKICFl'rLHHSVNSMAEDTiCCECAF.HllXYIjaaWVDLC. .RSY
18  389  DMYD7FGTUiEI£LFT7AFXRirD:_SE7XCI.. .PEYMKAVYMDLYQClN.ElAQEAZKGGGRDGLNYiaKAYSSHF. .DSF
19  381 DMYD7FGTU5ELELFT3AIXRNDPSA7ECL. . PEYMKGVYM1VYN7VN.EMSQEADKAGGAD7LNYCRGAWEEY: . .DAY
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1 383 LVKAKWTLQN. YKPSFEEFKANAI.PTCGYAMLAXTSFVGMGD IVT ik.TFKWAAS" i K I I  ©AST 11CRFKD DVAE HKFXH
2 383 LVfARWTLQN. YKPSFEEFKANXLI T CGYAMLAITSFVGMGU IVTFLTFKWAANDIKIIQASTIICRf>CCV*.KHKF:<H
3 383 LVKARWTLQN Y K iSFEY.FKANALFTCGYAMLAITSFVGMCl' IVTP£TFKWAANCPKIIQASTIICRFXDL'V7EHKFKH
4 383 LVEARWTLQN.YKPSFEEFKA1IALFTCGYAMLAITSFVGMGD IVTi tTFKWAAN- i KIIQASTIICRFKI'L'VAi-.HKFKH
5 384 LLEAKWTHQN. YKPTFEEFRDHAI.PTSGYAKLAXTAFVGMGZ. VlTPETFKMAJtSDPKXXXASTXXCRYHDDXAUianai
6 377 NEEQJWVMZR.QLPSFGDYVXKSEKTSCIYTMFASIIPGLXS. .VTQET1DW:XSZP7ZA7S7AMIGRYWND7SSQ:.RES
7 405  XffSnMAXROVHAQPLKEYMSVSMVTGTYGLMXARSYVGRGD IVTSDTFIWVSSYPPIIXASCVIVRLMDDrVSHKEEQ
8 388 F7EAICWLYXG.YVPTFDEYKSVALRS:G1R7LAVASFVD1GDFIATXDNFECI:.XNAKSLXA7Z7XGRLHDDIAGYKFEG
9 410  M7EVZWRLSX.YVPTSKEYMINASLIFGLGPIVLPALYFVGP. .XISES1VXDPEYDELFXLMS7CGRLLNDVQTFEREY
10 403  LVEAZWYNXS.H:PTLEEYUUHGCDSSSVSIL7VHSFFS:7aE.GTXEKADFLHXNEDLLYNl,SLIVRI2INDlGTSAAEQ
11 379  FVEAKWFISG. YMPPVSEYLSKALATS7YYH.77TSYLGVXS . . ATXEDFEWLA7NPKILEANV7LCRWDDIATYEVEX
12 377 NVES7WFIZG. Y7PPVSEYLSNAIAT77YYYLA7TSYLGMXS . . ATECDFEWLSKNPKILEASVIICRVZDDTATYEVEK
13 390 LEEAEWTNSG.YVASFPEYMXNGLITSAYNVISXSA1VGMGZ.IVSZDAI_A*IYZSHPK71QASE1ISR1CDDVMTY0FER
14 376  FKE7QWLNDCDHIPXYEEQVZRAIVSAGY>*4XS7TCL.VGIZS. FISHETFEWLMNZSVIVRASAlIARAMNDrVGHEDEC
15 377 MCEA1CW1.XXD. Y IATFDEYKZHA1LSSGYYAL1AK7EVRM7D . 7AX1DAFEWLSSHPKIRVASZII5RF72DI5SYEFEH
16 427  FiJEAKWYHSG. Y7PSLDEYLN1 AX 1SVASPAI1SP7YF7FANASHD7AV1 DSX.Y0YHDILCLAGII7RLPDD1GTSYFE1
17 4 23  L1EAKHYYNX. Y7PSI£EYIENAWISISAP7II.VHVYFFV7NP. 1TXEA7DCLEEYPNIIRHS87ILRLADDLGTS7DEL
18 464 MXEAKW:SSG.Y1PTFEEYLXNGXVSSGSR7A71GP:17LDVP.LPNY:L0E1DYPSRFND^ASS11RLRGDTRCYKADR
19 456  MQEAKWIASG.EVPTFEEYYENGXVSSGHRVSA1G?:1-7D:P.FPEHVLKEVDIPSQLNDLASAILRLRGD7RCYGADR
1 461 RREDDCSAXECYMZEY . GVTAQEAYDVFNKHVESAHKDUtCEFLKPT. . EMPTEVLNRSUOAKVMDVLYRE GDGYTYV
2 4 61 RREDDCSAIECYMZEY.GVSAQEAYDVFNKHVESAWKDVNCKFCKPT. .EMPTEVLNRSLNLARVMDVLYRE GDGYTYV
3 461 RREDDCSAIECYMZEY.GVTAQEAYDVFNKHVESAWKDVNGCFLKPT. . EMPTEVLNRSLNLARVMDVLYRE GDGYTYV
4 461 RREDDCSAIECYMSEY.GVTAQEAYDVFNKHVESAWKDVNXEFLKPT. .EMPTEVLNRSUOARVMDVLYRE GDGYTYV
5  462 RREDDCSAIECYMKQY.GVTAQEAYNSFNKHIESSWKEVNEEFLKPT. . EMPTPVLCRSLN1AKVMDVLYRE GL'GYTHV
6 454 XGGEMLTALDFHMKEY. GLTXEEAASKFSGIVEE7WKDINXEFIA7TNYNVGREIAI7FLNYARICZASYSX7DGDAYSD
7 484 ERGHVASSIECYSKES.GASEEEACEYISRXVEEAHKVINRESLRPT. . AVPFFILI-'PAINLARMCEVLYSV.NDGFTHA
8 467 XRGHNPSAVECYXNQH.GVSEEEAVXZLLLZVANSHKDIWEELLNPT. . TVPLPMLQRLLYFARSGHFIYDDGHDRYTHS
9 487 NEGXLNSVS1LVLHGG.PK31SEAXRK1QICPID7CRRDI^.SLVXJIEE.SWPRPCXS1FWXMCXVCYFFYS7.7DGFSSG
10 481 ERGDSPSSIVCYMREV. NASEEIARXNIXGMIDNAWKXVNGXCF77NQVPF1SSFMNNA7NMARVAHSLYKD. GDGFGDQ
11 4 56  GRGC1ATGIECYMRDY.DVS7EVAMEKF0EMAE1AWKDVKEG1LRPT. .PVSTEILIRIUILARIIDVTYRJNGDGYTHP
12 454 SRGG1ATGIECCMRDY.G1S7XEAMAKFCNMAE7AWICDINEGLLRPT. .PVSTEFLIPILNIARIVEVTYIHNIDGYTH?
13 468  ERGCSATGVDAYIKTY.GVSEXEAIDALXIMIENAWKDINEGCIAPR. . CVSXDliAPILNIARKIDVVYRY. DDGFTFP
14 455  ZRGHVASLIECYMKDY.GASKQEGYIKFIKSVGNAWKDINXCFFRPT. EVPMFVLERVLNL7RVAD7I.YICE XD7YTNA
15 455  XREHVATGIDCY^GF.GVSXERAVEVMGNIVSEAHKDLHQEI^RPH. .VFPFP1L!<RVLNI^RV1DVFYRY.0DAYTNP
16 506 ARGDVPX7IQCYMICE7 . NASEEEAVEHVXF1IRSAWKDMN7A1AAG. . YPFPDGMVAGAAN1GKVAQFIYLH. GDGFGVG
17 501 XRGDVPXA10CYMNE7.GASEEDAREY1XY1ISA7WKXMNEDRVAS. .SPFSHIFIEIALHIARMAQCMYOH.GDGHGHG
18 542 ARGZEASAISCYHKDHPG5TEEDAI.NH1NVMISDAI RELNWELLRPD. SXSPI55XXHAFDI7RAFHHLY1CY. RDGYTVA
19 534 ARGEEASCISCYMKDNPGGTEEDALNHLKAMISDVIKGLNWELUCPN.SSVPISAXXHAFDISRAFHCGYICY.RDGYSVA
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L 537 GKAA1CG6ITSLLIL p i a l
! 537 GKAAKGGITSLLIKPIAL
537 GKAAKGGIT S LLI PIAL
537 GKAAKGGITSLLIc pv a l
538 GKAAKGGI TS LL I L P IQ I
533 PNVAKANWALFVD AIVF
560 EGDMKSYMKSFFVHPMW
544 . LMMKRQVALLLTL PLAI
564 VERAX. ZVDAVINEPLKLOGSHTIVSDV
0 559 EKGPR7HILSLLFGPLVN
1 533 EKVLKPHIZALLVDSIEI
2 531 EKV1KPHI1NLLVDSIKI
3 544 RKDSERVYQSFCLWVLYPV
531 KGK1KNMINS1LIESVKI
531 . K1LKEHXVSLLIE7IPI
582 HSX7YEHIAGLLFEPYA
577 NHS7KDRILS1LIQPIPLNXD
620 S S E TKNLVMXTVEE PVAL
612 NIE7KS1VKR7VIDPV7L
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Key to alignment
No. Enzyme name
1 (+)-§ cadinene synthase 
isozyme XC1
2 (+)-6 cadinene synthase 
isozyme C2
3 (+)-& cadinene synthase
4 (+)-6 cadinene synthase 
isozyme XC14
5 (+)-5 cadinene synthase 
isozyme A
6 (£)-|3-famesene synthase
7 (£)~p-famesene synthase
8 (£)-(3-famesene synthase
9 (£)-|3-famesene synthase
10 a-famesene synthase
11 Vetispiradiene synthase
12 5-epi-aristolochene synthase
13 Germacrene A synthase
14 Germacrene C synthase
15 p-caryophyllene/a-humulene 
synthase
Plant
G. arboreum (Tree cotton)
G. arboreum (Tree cotton)
G.hirsutum (Upland cotton) 
(G. mexicanum)
G. arboreum (Tree cotton)
G. arboreum (Tree cotton)
Mentha piperita 
(Peppermint)
Artemisia annua (Sweet 
wormwood)
Citrus junos 
Zea mays (com)
Pyrus communis (Pear) 
Solanum. tuberosum 
(Potato)
N. tabacum (Common 
tobacco)
A. annua
Solanum lycopersicum 
(Tomato) (Lycopersicon 
esculentum).
Arabidopsis thaliana 
(Mouse-ear cress)
ID number 
Q39761
049853
P93665
Q39760
Q43714
048935
Q4VM12
Q94JS8
Q84ZW8
Q2PQC0
Q9SBJ0
Q40577
Q1PDD2
064961
Q84UU4
2 4 6
16 (+)-bomyl diphosphate 
synthase, chloroplast
17 Pinene synthase
18 Limonene/ a-pinene 
synthase, chloroplast
19 (-)-a-pinene synthase
Quercus ilex (Holly oak) A1JH12
Abies grandis (Grand fir) Q9M7C9
Salvia officinalis (Sage)
Pinus taeda
081192
Q84KL6
A 2 Primers and DNA fragments for mutagenesis work
DCS-L413I-Fwd 5’-GGTTATGCCATGATTGCTATTACATCTTTC-3’ 
DCS-L4131-Rev 5 ’-GAAAGATGTAATAGCAATCATGGCATAACC-3 ’
For construction of mutant DCS-M1. Annealing temperature: 55 °C.
DCS-I300L-Fwd 5’-GATGTTGACAAAAGTGCTAGCAATGGCATC-3’ 
DCS-I300L- Rev 5*-GATGCCATTGCTAGCACTTTTGTCAACATC-3»
For construction of mutant DCS-M2. Annealing temperature: 55 °C.
DCS-E455G- Fwd 51 - GTTT AT GG AT GAT GTT GCT GG AC AC A AGTT C AAG 
CATAGGAG-3'
DCS-E455G- Rev 5'-CTCCTATGCTTGAACTTGTGTCCAGCAACATCAT
For construction of mutant DCS-M3. Annealing temperature: 60 °C.
DCS-T407S/C408A-Fwd5,-GGCTAATGCATTGCCAAGTGCTGGTTATGC
CATGCTTGC-3'
DCS-T407S/C408A-Rev 5 '-GC AAGC ATGGCATAACCAGCACTTGGCAAT
For construction of mutant DCS-M5. Annealing temperature: 63 °C.
DCS-M523A-Fwd5'-CTAAACCTTGCAAGGGTGGCGGATGTGC
TTT AC AGGG-3'
DCS-M523A-Rev 5'-CCCTGTAAAGCACATCCGCCACCCTTGC
For construction of mutant DCS-M6. Annealing temperature: 63 °C.
CCATAAAC-3
GCATTAGCC-3
AAGGTTTAG-3
2 4 7
DCS-G276C-Fwd5'-GCAAGAGATAGAGTTGTTGAATGTTACTTTTGGA
TCTCTGGAG-3'
DCS-G276C-Rev 5'-CTCCAGAGATCCAAAAGTAACATTCAACAACTCT 
ATCTCTTGC-3'
For construction of mutant DCS-M7. Annealing temperature: 62 °C.
DCS-D307A-Fwd 5'-CAATGGCATCCATTGTAGCGGATACATATG 
ACTCATATG-3'
DCS-D307A-Rev 5'-CATATGAGTCATATGTATCCGCTACAATGG 
ATGCCATTG-3'
Annealing temperature: 60 °C.
DCS-D308A-Fwd 5'-CAATGGCATCCATTGTAGATGCGACATATGACTC 
ATATGCAAC-3'
DCS-D308A-Rev 5'-GTTGCATATGAGTCATATGTCGCATCTACAATGG 
ATGCCATTG-3'
Annealing temperature: 60 °C.
DCS-D31 lA-Fwd 5'-CCATTGTAGATGATACATATGCCTCATATGCAACAT 
AT G AAGAGC-3'
DCS-D31 lA-Rev 5'-GCTCTTCATATGTTGCATATGAGGCATATGTATCAT 
CTACAATGG-3'
Annealing temperature: 60 °C.
DCS-G276F-Fwd5'-GCAAGAGATAGAGTTGTTGAATTCTACTTTTGGATC
TCTGGAGTG-3'
DCS-G276F-Rev 5'-CACTCCAGAGATCCAAAAGTAGAATTCAACAACTCT 
ATCTCTTGC-3'
For construction of EcoRl restriction site on DCS. Annealing temperature: 63 °C.
EBFS-Y514L-Fwd 5'-CATCACATTCCTCAACCTGGCTCGGATATGTGAAG-3' 
EBFS-Y514L-Rev 5'-CTTCACATATCCGAGCCAGGTTGAGGAATGTGATG-3' 
Annealing temperature: 60 °C.
EBFS-I404Y-Fwd5'-GAGAAAACCAGCTGCTATTATACCATGTTTGCTTC-3' 
EBFS-I404Y-Rev 5'-GAAGCAAACATGGTATAATAGCAGCTGGTTTTCTC-3' 
Annealing temperature: 57 °C.
EBFS-Y277V-Fwd 5’-CTTATGTTTGGGGAGTAGGTGTGCATTACGAACC
CCAATACTC-3'
EBFS-Y277V-Rev5’-GAGTATTGGGGTTCGTAATGCACACCTACTCCCC
AAACATAAG-3'
Annealing temperature: 63 °C.
2 4 8
EBFS-N444D-Fwd5'-GGTCGGTATTGGGAIGACACCAGCTC-3' 
EBFS-N444D-Rev 5'-GAGCTGGTGTCATCCCAATACCG ACC-3'
Annealing temperature: 57 °C.
EBFS-A529Y-Fwd 5'-CTGACGGAGACTATTATTCAGATCC-3' 
EBFS-A529Y-Rev 5 '-GG AT CT G A AT AAT AGT CT CCGT C AG-31 
Annealing temperature: 55 °C.
EBFS-S402C-Fwd 5'-GAATTCAGAGAAAACCTGCTGCATTTATACCATG-3' 
EBFS-S402C-Rev5,-CATGGTATAAATGCAGCAGGTTTTCTCTGAATTC-3' 
Annealing temperature: 55 °C.
EBFS-G440C-Fwd 5,-CGACCGCTATGATCTGTCGGTATTGGAATG-3l 
EBFS-G440C-Rev 5t-CATTCCAATACCGACAGATCATAGCGGTCG-3, 
Annealing temperature: 58 °C.
EBFS-Y271 S-Fwd 5 ’ -GAGTCGTGGAGGCTAGCGTTTGGGG AGT AG-3 ’ 
EBFS-Y271 S-Rev 5 ’-CTACTCCCCAAACGCTAGCCTCCACGACTC-3 *
For construction of NheI restriction site on EBFS. Annealing temperature: 62 °C.
EBFS A14-1-Fwd 5'-GTTGCTTAAGGGAAGCCAGGCCACCTATGAC-31 
EBFS A14-1-Rev S'-GTCATAGGTGGCCTCGCTTCCCTTAAGCAAC-S' 
Annealing temperature: 60 °C.
EBFS A14-2-Fwd 5 '-GCTT AAGGGAAGCC ATGGC ACCT AT GACG AAGC-3' 
EBFS A 14-2-Rev 5'-GCTTCGTCATAGGTGCCATGGCTTCCCTTAAGC-3' 
Annealing temperature: 60 °C.
EBFS A24-Fwd 5' -GC AT GCGCC AACCATGGGG ACT GATACC-3'
EBFS A24-Rev 5'-GGTATCAGTCCCCATGGTTGGCGCATGC-3'
Annealing temperature: 61 °C.
EBFS A24-G2W-Fwd
5 '-G AAGG AG ATAT ACC AT GT GGACT GATACCTTTT C-3'
EBFS A24-G2W-Rev
5'-GAAAAGGTATCAGTCCACATGGTATATCTCCTTC-3'
Annealing temperature: 57 °C.
D24AAE-T24S/G26W-Fwd
5'-CAAAGCCGATTTTCAGCCTAGCATGTGGACTGATACCTTTTCTAAC-3' 
D24 A AE-T24 S/G2 6 W-Re v
5'-GTTAGAAAAGGTATCAGTCCACATGCTAGGCTGAAAATCGGCTTTG-3' 
Annealing temperature: 63 °C.
2 4 9
E24A A D-W 24S-Fw d5,-G AAG CATG CG CCAA G C A TTTGGGGAGATC-3' 
E24AAD-W 24S-Rev 5'-G A TC TC C C C A A A TG CTTGGCGCATGCTTC-3' 
Annealing temperature: 59 °C.
EBFS-W  26E-Fwd 5 '-CAT GCGCC A A G C  A TG G A G A C T G A TA CCTTTTC-3' 
EBFS-W 26E-Rev 5,-G A A AAG G TATCAG TCTCCATG CTTG G CG CATG -3' 
Annealing temperature: 59 °C.
EB FS-E269M -Fw d5'-G ATCG A G TCG TG ATG G CTTATG TTTG -3' 
EBFS-E269M-Rev 5l-C A A A C A TA A G C C A TC A C G A C TC G A TC -3,
Annealing temperature: 55 °C.
EBFS-F30A-Fwd 5 '-C A TG TG G A C TG A TA C C G C ITC TA A C TTTTC TC TTG -3' 
EBFS-F30A-Rev5,-CAAGAGAAAAGTTAGAAGCGGTATCAGTCCACATG-3, 
Annealing temperature: 57 °C.
DCS-F36A-Fwd 5,-CATTTG G G G A G ATCTCG CCCTCAATTG TCCCG AC-3' 
DCS-F36A-Rev 5,-G TC G G G A C A A TTG A G GGCGA G A TC TC C C C A A A TG -3, 
Annealing temperature: 63 °C.
Synthetic gene fragment encoding part o f GCS (Section 3.3.2):
S ad  site
5 ’ -G A G C TC G T  G A C T T T  C A A T  G A T GC A A T  CC A G  A G  A T  GGG A T  GCT A A T  GC A  
A T T  G A T T  C A A T  A C  A A C C  A T  A T  A T  G AG  A C C T G CTT A T  C A A G C T C TT CT AG A  
C A T T T  AC A G T  G A A A T  G G A A C  A A G T G TT GT CC A A A G  A A G G T A A A C T GG AC  
CG TG T A T  A C T  A TG C  A A A A A A T  G A G  A T  G A A A A  A G TT  GGT GAG AG CCT A TT  
TT  A A G G A A A C C C  A  A T G G TT  G A A T  G A TT GT GACC A T  A T T  CC A A A A T A T  GA  
G G A A C A A G TG G A G A A TG C A A TC G TA A G TG C TG G C TA TA TG A TG A TA TC A  
AC A A C TTG C TTG G TC G G T A T  A G  A A G  A  A T T T  A T  A T  CCC A C G A G A C TTTT GA  
A TG G TTG  A TG  A A T G  A G TC TG T G A TT G TT CG A G CTT CCGC A T T  G A TT GCC A  
G AG C A A T G  A A C G  A T  A TTG TTG G  A C  A T  G A A G  A T  G A A C  A A G A A A G A G G  AC  
A TG T A G C TTC  A C T T  A T T  G A A T  G TT AC A T  G A A A G  A T T  A T  GG A G C TT C A A A G  
C A A G  A G  A C T T  A C  A T T  A A G T T  CCT G A A A G  A G G T C ACC A A T  GC A T  GGAAGG  
A C A TA A A C A A A C A A TTC TC C C G TC C A A C TG A A G TA C C A A TG TTTG TC C TT  
G A A C G  A G T T C T  A A A T T T  G AC A C G T G T GGCT GAC A C G TT A T  A T  A A G G AG A  
A A G A TA C A TA TTC A A C C G C C A A A G G A A A A C TTA A A A A C A TG A TTA A TC C  
A A T  A C T  A A T T G  A A T  CT G T C A A A A T  A T  A A G G  A TC C G A A TT CGAGCTC-3 ’
stop codon Sad  site
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Synthetic fragment for construction of EBFS-active site hybrid (Section 4.2.14):
Nhel site
5 ’ -GCT AGCTTTT GGAT CGT AGGT GT GC ATT ACG A ACCCC AAT ACT CAT AT 
GTTCG AAT GGGACTT GCC AAAGT GAT AGC AAT GGC ATCC ATCGT AG ACG 
AT AC AT AT GAT AATT AT GCT AC ACT C AAT G A AGCT C AACTTTTT ACTC AA 
GT CTT AG AC AAGT GGGATAG AG AT G AAGCT G AACGACTCCC AG AAT AC A 
T G AAAAT CGTTT ATCGATTT ATTTT G AGT AT AT AT GAAAATT AT G A ACGT 
GAT GC AGCG A AACTT GG AAAAAGCTTT GC AGCTCCTT ATTTT AAGG AAA 
CCGT G AAAC AACT GGC AAGGGC AT AT AAT GAGG AGC AG AAGT GGGTT AT 
GG AAAGGC AGCTACCGTC ATT CC AAG ACTACGT AAAG AATT C AG AG AAA 
ACCT GT GGT ATT GCC AT GAT GTTT GCTT CT AT CAT CCC AGGCTT G A A ATCT 
GTT ACCC AAG AAACC ATT GATT GGAT C AAGAGT G A ACCC ACGCT CGC AA 
CAT CG ACCGCT AT G ATCT GT CGGT AT AT GGAT G AC ACCGCT G AAC AGCT C 
TT C AAGC AT AGGAGAGAAG ACGAT CTGACT GCGTT GGATTTCC AC AT GA 
AAG AAT AT GGT CT G ACG AAGG AAGAGGCGGC AT CT AAGTTT G AAGG ATT 
GGTT GAGG AAAC AT GG AAGG AT AT A A AC AAGG AATTC AT AGCC AC AACT 
AATT AT AAT GT GGGT AG AG AAATT GCC AT C AC ATT CCTC AACCTT GCTCG 
GGT GAT GGAT GT GCTTT AC AGGA AAACT GACGGAGACGCTT ATT C AGAT 
CCT AAT GTT GCC AAGGC AAATGTCGTT GCTCT CTTT GTT GAT GCC AT AGT 
CTTTT GAGGATCC-3 ’ 
stop codon BamHI site
D24AAE-Fwd
5'-CAT GG AACCTT CTT CAT C ACCCCTTTCTT CC AAT AAGGAT GAAAT GCGT 
CCC AAAGCCGATTTTCAGCCT AC-3'
D24AAE-Rev
5 '-CAT GGT AGGCT G A A AAT CGGCTTT GGG ACGC ATTT C ATCCTT ATT GG A 
AG AAAGGGGT GAT G A AG AAGGTT C-3'
For construction of N-terminal segment hybrid D24AAE that encoding Ncol at both 
5’ and 3’ ends.
E24AAD-Fwd
5 ’ -C ATGGCT AC A AACGGCGT CGT AATT AGTT GCTT AAGGGAAGT AAGGCC 
ACCT AT GACGA AGC AT GCGC-3 ’
E24AAD-Rev
5 ’ -C ATGGCGC ATGCTT CGT CAT AGGT GGCCTTACTT CCCTT AAGC A ACT A 
ATT ACGACGCCGTTT GT AGC-3 ’
For construction of N-terminal segment hybrid E24AAD that encoding Ncol at both 
5’ and 3’ ends.
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